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Stellingen 
1. De rol van niet-adrenerge, niet-cholinerge neurotransmitters in het maag-darm-
kanaal bij het werkingsmechanisme van prokinetische benzamiden zou wel eens 
onderschat kunnen zijn. dit proefschrift 
2. Stimulatie van 5-HT4-receptoren in de plexus myentericus verklaart slechts ten 
dele de prokinetische werking van de gesubstitueerde benzamiden. 
dit proefschrift 
3. Afwezigheid van een remming van een respons door tetrodotoxine duidt niet 
per se op een direct effect op de gladde-spiercellen, daar een deel van de door 
neuronen gemedieerde effecten in het maag-darmkanaal ongevoelig is voor 
tetrodotoxine. 
Hirst GDS & Spence I (1973) Nature 243:54-56; North RA (1973) Br J Pharmacol 49: 709-710; 
dit proefschrift 
4. De hypothese, dat niet alleen facilitatie van vrijzerting van contraherende, maar 
ook van relaxerende neurotransmitters belangrijk is voor de werking van pro-
kinetische benzamiden, verdient nader onderzoek. dit proefschrift 
5. De stelling dat 5-HT4-receptoren uitsluitend op de enterische zenuw uiteinden 
en niet op het cellichaam voorkomen, is onvoldoende gefundeerd en niet nood-
zakelijkerwijs waar. Tonini M et al. (1991) Pharmacol Res 24:5-14; dit proefschrift 
6. De wetenschappelijke ogen worden bijna volledig gericht op NO, maar de 
twintig jaar eerder ontdekte neurotransmitter ATP krijgt terecht thans ook weer 
aandacht. dit proefschrift 
7. De studies, waarop de hypothese is gebaseerd dat dopamine een neurotrans-
mitter is in het maag-darmkanaal, vormen in het licht van de huidige kennis een 
onvoldoede gefundeerde basis voor deze hypothese. 
Willems JL et al, (1985) Pharmacol Rev 37:165-216 
De karakterisering van neurotransmitter-receptoren dient bij voorkeur te 
gebeuren met behulp van agonisten en antagonisten met een structuur die niet 
wezenlijk afwijkt van die van de endogene agonist. 
LeffP & Martin GR (1988) Med Res Rev 8:187-202 
9. Dat de rol van de longitudinale spierlaag van het maag-darmkanaal in maag-
darmmotiliteit meestal onderbelicht wordt duidt op een gebrek aan kennis over 
de functie van deze laag. 
10. De relatief geringe belangstelling die het wetenschappelijk onderzoek naar de 
motoriek van het maag-darmkanaal krijgt, is waarschijnlijk het gevolg van ener-
zijds de schijnbare eenvoud van bouw en functie, en anderzijds de onaantrek-
kelijke aard van haar inhoud. 
dr A.j.P.M. Smout, oratie ter gelegenheid van de aanvaarding van het hoogleraarschap 
Pathofysiologie en Kliniek van de Gastro-intestinale Motoriek aan de UU, 9-11-1994 
11. Voor farmacologische contractie-relaxatie-studies in orgaanbaden met geïso-
leerde weefsels zouden bij voorkeur condities en weefsels moeten worden 
gekozen opdat zowel relaxatie als contractie gemeten kan worden, teneinde 
maskeringseffecten te kunnen opmerken. 
12. De beschouwing dat eten niets anders is dan je over je voedsel heen schuiven 
getuigt van een grove onderschatting van de complexiteit van de gastro-
intestinale motiliteit. 
13. Politisering van de wetenschap is een rem op haar vooruitgang. 
14. Hoe ouder een verondersteld feit in de farmacologische wetenschappen is, des 
te groter is de kans dat zij onwaar of achterhaald is. 
15. Gelet op de geringe selectiviteit van nagenoeg elke 5-HT-receptorligand is het 
onverstandig om uit in-vivo- studies, op grond van met een beperkt aantal van 
dergelijke stoffen verkregen informatie, stellige conclusies te trekken met 
betrekking tot het type 5-HT-receptor, dat is betrokken bij het bestudeerde 
fenomeen. 
Stellingen behorend bij het proefschrift Gastrointestinal motility, prokinetic 
benzamides and serotonin. A study on the guinea-pig colon. Michel R. Briejer 
Wageningen, 2 juni 1995. 
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Abstract 
Briejer, M.R. (1995) Gastrointestinal motility, prokinetic benzamides and 
serotonin. A study on the guinea-pig colon. PhD Thesis, Department of Human 
and Animal Physiology, Wageningen Agricultural University, Wageningen, The 
Netherlands. 
The prokinetic substituted benzamides stimulate gastrointestinal motility in 
animal models and in man. Studies done on the isolated guinea-pig ileum have 
led to the hypothesis that the benzamides act through facilitation of cholinergic 
transmission due to stimulation of serotonine (5-HT4) receptors on the intra-
mural enteric neurons. However, many questions as to their mode of action 
remain. The substituted benzamides are known to interfere with a variety of 
5-HT receptor types. In this thesis the pharmacological action and interaction of 
substituted benzamides and 5-HT on the guinea-pig proximal colon were 
studied. This preparation was found to be endowed with 5-HT3 and 5-HT4 recep-
tors on the nerves, mediating contraction via the release of acetylcholine and a 
non-cholinergic neurotransmitter (probably substance P, which stimulates 
smooth muscle NKi receptors), and 5-HT2A receptors on the smooth muscle. 
The benzamides cisapride and R 76 186 were found to be agonists at this 5-HT4 
receptor, but cisapride was also found to have an additional direct effect on the 
smooth muscle. Furthermore, an unknown neuronal 5-HT2-Hke receptor was 
found to mediate relaxation involving nitric oxide (NO) and adenosine triphos-
phate (ATP). Cisapride and some other benzamides were found to selectively 
enhance the ATP-mediated relaxation. It is thus proposed that the benzamides 
do not only facilitate the excitatory cholinergic transmission, but also the 
inhibitory purinergic transmission. As in peristalsis coordinated contraction and 
relaxation are important, the benzamides might thus promote peristalsis by 
enhancing both relaxation and contraction on demand. An in vivo model for 
faecal pellet propulsion in the guinea-pig distal colon was developed to investi-
gate this hypothesis in future studies. 
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10 General introduction 
Serotonin (5-hydroxytryptamine; 5-HT) is abundantly present in the gut. It is 
contained in high concentrations in the enterochromaffin cells (Erspamer, 1966; 
Racké & Schwörer, 1991), and its presence in neurons of the enteric nervous sys-
tem has been demonstrated (Costa et al, 1982; Furness & Costa, 1982; Legay et al, 
1984; see also Gershon et al, 1989). 5-HT plays a role as a neurotransmitter (see: 
Gershon & Erde, 1981; Gershon et al., 1990) in secretion processes (Cussato et al, 
1982; Johnson et al, 1994) and gastrointestinal motility (see: Gershon et al., 1990; 
Dhasmana et al, 1993). Furthermore, 5-HT is involved in the regulation of blood 
flow (see: Parks & Jacobson, 1987) influences vascular permeability, and it is 
contained in mast cells, suggesting a role in the immune system of the gut (see: 
Kraneveld, 1994). 
The effects to 5-HT are mediated by a wide array of 5-HT receptor types. It has 
been shown, that in the guinea-pig1 gastrointestinal tract, 5 - H T I A , 5-HT2A, 5-HT3 
and 5-HT4 receptors are involved in motor responses to 5-HT (see: Gershon et al, 
1990; Dhasmana et al, 1993). 5 - H T I A , 5-HT3 and 5-HT4 receptors are located on 
the enteric nerves and regulate the release of excitatory neurotransmitters, e.g. 
acetylcholine and the neurokinin substance P (Fox & Morton, 1991; Kilbinger & 
Wolf, 1992; Broad et al, 1993; Pan et al, 1994; Ramirez et al, 1994) (see Figure I). 
Other 5-HT receptors have been shown to be present on the smooth muscle of 
the guinea-pig gut: 5-HT2A receptors mediate contraction of the ileum (Engel et 
al, 1984), and stimulation of "orphan" 5-HT receptors causes relaxation in the 
stomach fundus and ileum2 (Feniuk et al, 1983; Kalkman et al, 1986; Kojima et 
al. 1992) (see Figure I). Furthermore, putative 5-HTip receptors3 and other 
orphan 5-HT receptors have been shown to exist in the gut of this species. In the 
guinea-pig colon, Kojima (1991) and Elswood & Bunce (1992) demonstrated the 
presence of an unknown neuronally located 5-HT receptor, which mediates the 
release of a relaxing substance. Currently, several neurotransmitters are 
considered to be a candidate of non-adrenergic non-cholinergic (NANC) 
inhibitory nerves, e.g. adenosine triphosphate (ATP) (Burnstock, 1972), vaso-
1
 Historically, most studies on neuronal projections, neurotransmitter contents of neurons and 
electrophysiological, functional and pharmacological studies have been done in the guinea-pig. 
Especially the ileum has been subject of research. 
2
 By "orphan" receptors it is indicated that these receptors cannot be classified according to the 
current classification criteria. The pharmacological profile of the orphan receptor in the guinea-
pig ileum mediating myogenic relaxation resembles that of the recently cloned 5-ht7 receptor, 
whose mRNA has been shown to be present in the gut. 
3
 5-HTip receptor-mediated effects have only been found in electrophysiological experiments and 
are as yet poorly defined from a pharmacological point of view; as such, their naming is not (yet) 
recognized by the Receptor Nomenclature Committee of the Serotonin Club. 
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active intestinal polypeptide (VIP) (Goyal et al, 1980) and nitric oxide (NO) (Bult 
et al., 1990). It has however not been investigated which of these substances are 
involved in the 5-HT-induced relaxation in the guinea-pig colon. 
serotoninergic 
interneuron 
NANC 
inhibitory 
motor neuron 
longitidinal 
smooth 
muscle layer 
Figure I Schematic representation of the proposed innervation of the guinea-pig ileum. The longi-
tudinal muscle layer and some myenteric neurons are depicted. The scheme has been greatly simpli-
fied as only the excitatory serotoninergic, cholinergic and inhibitory non-adrenergic non-cholinergic 
(NANC) neurons are shown. Serotonin (5-HT) released from interneurons and other consecutively 
released neurotransmitters can stimulate a variety of both neuronal and smooth muscle receptors in 
the ileum causing either stimulation (+) or inhibition (-). After stimulation of 5-HT3 and 5-HT4 receptors, 
the release of acetylcholine (ACh) and neurokinins (NKs) is enhanced. The NANC inhibitory neuro-
transmitters are likely to include vasoactive intestinal polypeptide (VIP), nitric oxide (NO) and possibly 
adenosine triphosphate (ATP) or related purines. On the smooth muscle, 5-HT 2A and unknown 5-HT 
receptors are present. 
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Drugs with a substituted benzamide moiety4 (see Table 1.1) are used in the 
treatment of impaired gastrointestinal motility, which manifests in disorders 
like gastro-esophageal reflux, gastroparesis, functional dyspepsia and constipa-
tion (Reynrjens et al, 1986; Müller-Lissner, 1987; Reynolds & Putnam, 1992). For 
some decades, metoclopramide (see: Pinder et al, 1976) has been used, but is has 
now been largely superseded by cisapride (Wiseman & Faulds, 1994), while clebo-
pride and cinitapride5 are also applied in some countries (Massingham et al, 
1985; Reynolds & Putnam, 1992). Other prokinetic6 benzamides are represented 
by dazopride, renzapride and zacopride, which are not therapeutically used 
(Reynolds & Putnam, 1992; Gullikson et al, 1992). 
The mechanism of action of the prokinetic benzamides is to date still poorly 
understood. Already in 1970, Bianchi et al (1970) observed that metoclopramide 
inhibited contractions to 5-HT on the guinea-pig ileum, an effect which was later 
shown to be mediated by 5-HT3 receptors. Two decades later, a 5-HT receptor type 
was characterized in mouse colliculi neurons in primary culture (Dumuis et al, 
1988), and consecutively also in guinea-pig ileum and colon, rat oesophagus and 
heart atrium of several species (see: Bockaert et al, 1992; Ford & Clarke, 1993). It 
was found that stimulation of these 5-HT4 receptors, as they were soon called, in 
guinea-pig gut tissues causes facilitation of cholinergic (and possibly also non-
cholinergic) excitatory transmission (Schuurkes et al, 1985; Elswood et al, 1991; 
Bingham & Andrews, 1992; Kilbinger & Wolf, 1992). The prokinetic benzamides 
were found to be relatively specific (partial) agonists at these 5-HT4 receptors 
(Dumuis et al, 1989; Bockaert et al, 1990; Taniyama et al, 1991). 
The 5-HT4 receptor agonist action of the prokinetic benzamides has been put 
forward as the mechanism by which motility is enhanced (see: Tonini et al, 
1991), and the non-benzamide 5-HT4 receptor agonist BIMU 1 has an action in 
vivo which is similar to that of benzamides (Rizzi et al, 1994). However, several 
papers have appeared, suggesting that other mechanisms could be important as 
well. De Ridder & Schuurkes reported that in the dog gastric antrum in vitro, 
cisapride enhanced field stimulation-induced cholinergic contractions via a 
mechanism that was not sensitive to 5-HT4 receptor blockade (De Ridder & 
Schuurkes, 1993). In the human colon, cisapride did even not enhance the 
4
 2-Methoxy-4-chloro-5-amino-substitution for most prokinetic benzamides; these compounds differ 
significantly from the antipsychotic benzamides, which are potent dopamine D2 receptor antago-
nists, while possessing no prokinetic activity. 
5
 2-Ethoxy-4-nitro-5-amino substitution on the benzene ring. 
6
 A prokinetic drug is a substance that enhances co-ordinated gastrointestinal motility and 
promotes propulsion. 
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release of acetylcholine (Burleigh & Trout, 1985). In this tissue, 5-HT4 receptors 
are located on the smooth muscle and mediate inhibition. Nevertheless, cisa-
pride stimulates colonic motility and can help to treat mild constipation (Miiller-
Lissner, 1987; Reynolds & Putnam, 1992). With metoclopramide, sensitization to 
acetylcholine has been observed in the isolated guinea-pig colon (Beani et al, 
1970), and similar results have later been obtained by other workers with differ-
ent benzamides and tissues. In electrophysiological experiments with guinea-pig 
myenteric neurons, direct 5-HT4 receptor-mediated effects could not be demon-
strated, though cisapride has been shown to enhance cholinergic excitatory post-
synaptic potentials, suggesting an increased release of acetylcholine (Nemeth et 
al, 1985; Mawe et al, 1986; Tonini et al, 1989; Wade et al, 1991, Pan & Galligan, 
1994). In similar experiments, 5-HT can induce a slow prolonged depolarization 
via the stimulation of putative 5-HTip receptors. Some of the prokinetic benza-
mides interfere with this 5-HTip receptor-mediated response, either as agonist 
(S-zacopride) or antagonist (cisapride, R-zacopride, renzapride) (Nemeth et al, 
1985; Mawe et al, 1986; 1989; Wade et al, 1991). Enhancement of gastric emptying 
in mice has been associated with antagonism of 5-HTip receptors on inhibitory 
neurons (Mawe et al, 1989) but other reports on functional effects mediated by 
5-HTip receptors are not available. Hence, it is clear that many mechanisms addi-
tional to 5-HT4 recepor agonism could account for the prokinetic action of 
benzamides. 
In many investigations, the actions of 5-HT and benzamides have been 
studied on the isolated guinea-pig ileum, using it either as an intact segment or 
as a preparation of the longitudinal smooth muscle layer together with the 
myenteric nerves. The colon however shows pharmacological and physiological 
characteristics that are very different from those of the ileum. For example, in 
contrast to the longitudinal muscle of the ileum, the colon actively develops a 
resting tone, allowing the study of both relaxation and contraction. After 
electrical transmural stimulation, the larger part of the relaxation-contraction 
response of the longitudinal muscle is mediated by NANC transmitters, while in 
the ileum the contraction is mainly cholinergic in nature (Bianchi et al, 1968; 
Furness, 1970; Galligan, 1993). Also at receptor level, there are striking dif-
ferences. For example, the relaxation-mediating orphan 5-HT receptor (see 
footnote 2) on the ileum is located on the smooth muscle, while on the colon 
orphan receptors are located on the enteric nerves. Thus, the colon might reveal 
novel pharmacological characteristics of the substituted benzamides. 
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The aims of the investigations described in this thesis, were to establish: 
• in the isolated guinea-pig colon: 
1. which 5-HT receptor types mediate the responses to 5-HT, and what their 
location is (on the smooth muscle or on the enteric nerves); 
2. which neurotransmitters are involved in the relaxing (NO, ATP, VIP) and 
contracting (acetylcholine, substance P) actions of 5-HT after neuronal 
5-HT receptor stimulation; 
3. the action of substance P and determine the receptor type that mediates 
this action; 
4. the contraction to cisapride and a structural analog, R 76 1867, and to 
investigate how their effects are mediated; 
5. the exact 5-HT receptor subtype via which 5-HT induces neurogenic relax-
ations; 
6. whether and how cisapride interferes with the 5-HT-induced relaxations; 
• in the guinea-pig colon in vivo: 
7. a new in vivo model for the study of peristalsis in the distal colon. 
7
 Contractions to R 76186 are fully blocked by tetrodotoxin while those to cisapride are inhibited 
merely partially. Thus, R 76 186 could provide a tool for better understanding the effects of 
cisapride. 
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Introduction 
Substituted benzamides (Table 1.1) are currently widely used to treat motility 
disorders like gastro-esophageal reflux (heartburn), gastroparesis, functional dys-
pepsia and constipation (Reyntjens et al, 1986; Müller-Lissner, 1987; Reynolds & 
Putnam, 1992). The very first benzamide to be used for this indication was meto-
clopramide. Nowadays, the most widely applied prokinetic benzamide (a pro-
kinetic drug is a compound that enhances gastrointestinal propulsion and 
co-ordinated motility) is cisapride, though cinitapride and clebopride are also 
available in some countries (Table 1.1). Currently, there are some novel 
benzamides being evaluated in clinical trials, e.g. mosapride and lintopride 
(Table 1.1). Though the benzamide derivatives are known now for three decades 
to be effective gastrointestinal motility stimulants, still many questions as to 
their mechanism of action remain. In this review it is attempted to give an 
overview of the pharmacological data that have been obtained from in vitro and 
in vivo experiments as well as from studies in man. As different theories on the 
mechanism of action of prokinetic benzamides have been proposed during the 
last decades, a large part of this review places data in a historical perspective. 
The development of metoclopramide 
The local anaesthetic procaine (4-aminobenzoic acid 2-(diethylamino) ethyl 
ester) has served as the lead compound for the development of metoclopramide. 
Chemical modification of the procaine structure, making it less susceptible to 
hydrolysis, yielded procainamide (ester moiety changed into amide moiety), 
which showed increased anti-arrhythmic and local anaesthetic activity, and 
which also had some anti-emetic effects. These anti-emetic effects were found to 
be more pronounced if the benzene ring was chlorinated. Further substitution of 
the benzene ring by Delagrange chemists produced metoclopramide (which is an 
acronym for 2-m^hoxy-5-c.hloro-procainamide) (Table 1.1). Metoclopramide was 
found to have negligible local anaesthetic and anti-arrhythmic activity (Justin-
Besançon et al, 1964). Instead, the compound antagonized apomorphine-induced 
emesis and it was serendipitously found to improve upper gut motility (Justin-
Besançon & Laville, 1964). As this improvement of motility (Jacoby & Brodie, 
1967) was recognised to differ in a positive sense from drugs with similar actions 
known in those days (e.g. bethanechol, a cholinoceptor agonist), the therapeutic 
value of metoclopramide was soon appreciated. Today still, metoclopramide is 
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used to treat gastrointestinal symptoms related to impaired motility, and to 
tackle emesis (see for review on metoclopramide: Pinder et al, 1976; Schulze-
Delrieu, 1979). 
The anti-emetic properties of metoclopramide have been explained to be 
caused by its anti-dopaminergic properties, i.e. by blocking dopamine D2 receptors 
in the area postrema (see: Pinder et al, 1976). However, not all types of emesis are 
dopamine-mediated, as McRitchie et al. (1984) pointed out, and they attempted 
to explain how metoclopramide antagonizes cisplatin and radiation-induced 
emesis in man. It has been suggested that its weak serotonin 5-HT3 receptor 
antagonistic properties are responsible for the blocking of cisplatin-induced 
emesis in the ferret and man (see: Sanger & King, 1988). 
Many mechanisms have been put forward in the 1970s and 1980s to explain 
the prokinetic action of metoclopramide. In 1975 a structural analogue to 
metoclopramide, clebopride, was synthesized. Clebopride is a more potent 
dopamine D2 receptor antagonist, as is the chemically unrelated domperidone 
synthesized one year before, in 1974 (Laduron & Leysen, 1979; Roberts, 1982). As 
both compounds have a prokinetic action similar to metoclopramide (Brogden et 
al, 1982; Roberts, 1982; Schuurkes et al, 1982), is was soon hypothesized that the 
antidopaminergic properties were responsible for these effects. 
The dopaminergic theory 
Metoclopramide crosses the blood-brain barrier only to a minor extent, while 
clebopride does so easily (Niemegeers et al., 1980). Domperidone, however, has 
been shown not to cross the blood-brain barrier (Laduron & Leysen, 1979; 
Niemegeers et al, 1980). If it is supposed that metoclopramide, clebopride and 
domperidone stimulate gastrointestinal motility via a common mechanism, i.e. 
the blocking of dopamine D2 receptors, these receptors must thus be localized in 
areas unprotected by the blood-brain barrier, e.g. on peripheral nerves. 
The motility of the stomach and intestine is controlled autonomously by the 
intrinsic enteric nervous system, which is modulated by extrinsic sympathetic 
and parasympathetic nerves. In such extrinsic nerves, catecholamine histo-
fluorescence and dopamine beta-hydroxylase immunoreactivity have been 
detected suggesting that these nerves contain noradrenergic and possibly also 
dopaminergic neurons (Gershon & Erde, 1981). The enteric nerves are however 
completely devoid of catecholamines (except in the guinea-pig colon) (Gershon 
& Erde, 1981). 
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Table 1.1 Structural formulas of the currently known gastro-intestinal motility stimulating substituted 
benzamides with their respective manufacturer and developmental status. 
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Table 1.1 Continued 
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Dopamine is a precursor of noradrenaline, and it has some affinity and 
activity at a- and ß-adrenoceptors (Shepperson et al, 1982; see: Willems et al, 
1985). A specific neurotransmitter role for dopamine would require specific 
dopamine receptors to be present on the intrinsic and/or extrinsic nerves. The 
dopamine receptor antagonists available in the late 1970s are only moderately 
specific for dopamine receptors and may block 5-HT or a-adrenoceptors (Kohli & 
Cripe, 1979; Spedding, 1980; Cox & Ennis, 1980; see: Willems et al, 1985). This lack 
of specificity of both dopamine and its antagonists probably accounts for much of 
the confusion caused by several findings argueing pro and contra implication of 
dopamine receptor-mediated modulation of gastrointestinal tract motility (see 
for a more extensive review on this subject: Willems et al; 1985). 
Many of the studies on the dopaminergic issue have been done on guinea-pig 
isolated gastrointestinal smooth muscle preparations. The isolated guinea-pig 
gastroduodenal preparation (Van Nueten et al, 1978) exhibits spontaneous activ-
ity. In this preparation, intra-arterially administered dopamine caused relaxation 
which was antagonized by domperidone, clebopride and metoclopramide, in this 
respective rank order of potency (Schuurkes et al, 1985a). Furthermore, these 
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compounds enhanced the amplitude of the contractions in the antrum and 
propagation of antral contractions over the pyloric region into the proximal 
duodenum (Schuurkes et al, 1985a). These results led the authors to propose that 
dopamine D2 receptors are present in this preparation, and that the enhanced 
motility is caused by blockade of these dopamine D2 receptors. To exclude possi-
ble involvement of a-adrenoceptors, Schuurkes & Van Nueten (1981; 1984) 
showed that domperidone did not antagonize relaxations to intra-arterially 
administered noradrenaline and that relaxations to intra-arterially administered 
dopamine were unaffected by the ai-adrenoceptor antagonist prazosin. Hence, 
involvement of 0C2-adrenoceptors was not excluded. 
Detailed analysis of the effects of dopamine and several adrenoceptor agonists 
and antagonists on stimulated and unstimulated circular muscle strips from 
several regions of the guinea-pig stomach, did not provide evidence for the 
presence of dopamine receptors in this preparation (Sahyoun et al., 1982a, b, c; 
Costall et al, 1983; 1984). Instead, it was suggested by the authors that dopamine 
(and domperidone) acted on oci- and 0C2-adrenoceptors (Sahyoun et al, 1982a, b; 
Costall et al, 1983; 1984). Ennis & Cox (1980) have suggested that domperidone is 
a competitive antagonist at oii-adrenoceptors. Comparing receptor binding affin-
ity data at dopamine receptors and oc-adrenoceptor subtypes with data on gastric 
contractility and the release of acetylcholine from the guinea-pig stomach, it was 
suggested by Takeda et al (1991) that clebopride enhanced motility by blocking 
peripheral dopamine 02-receptors and (X2-adrenoceptors. 
Similarly, it has been suggested that in guinea-pig isolated longitudinal 
muscle strips of the oesophageal junction, domperidone produced a preferential 
blockade of dopamine-induced relaxations (Ennis et al, 1978) though later results 
did not support the presence of a dopaminergic system in this preparation (Cox & 
Ennis, 1980). In a consecutive study it was shown that there was a close correla-
tion between the ability of a series of dopamine receptor antagonists to block oti-
adrenoceptors in the aorta and to inhibit dopamine-induced relaxations in the 
gut (Ennis & Cox, 1980). In the same study, the effects of a series of catechol-
amines on the lower oesophageal sphincter of the guinea-pig was investigated, 
and it was shown that domperidone blocked the effects to noradrenaline and 
dopamine via oc-adrenoceptor antagonism (Ennis & Cox, 1980). 
Thus, although it is difficult to explain all of the above described and other 
results solely by an interaction with adrenoceptors, the presence of functional 
specific dopamine receptors in the guinea-pig gastrointestinal tract has as yet not 
convincingly been demonstrated. 
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As clebopride and metoclopramide are both indirect stimulants of the cholin-
ergic system, and since side effects to these drugs were observed in some patients 
due to central antidopaminergic actions, screening programs were initiated for 
compounds devoid of anti-dopaminergic properties but retaining the cholinergic 
actions. This resulted in the birth of the second generation benzamides, e.g. 
cisapride, dazopride and BRL 20627 (see Table 1.1). Cisapride and dazopride show 
increased potency as gastrointestinal prokinetics, whereas they have less affinity 
for dopamine receptors. Schuurkes et al. (1987) showed, both in vitro and in 
vivo, that there was no correlation when potency to stimulate motility vs. 
affinity for dopamine receptors of 5 prokinetic benzamides were studied. For 
example, the ratio in binding affinity for cisapride and metoclopramide at 
dopamine D2 receptors is only 3, in sharp contrast to the potency ratio of almost 
200 to stimulate a guinea-pig ileum preparation (Schuurkes et al, 1987). 
Thus, for individual compounds such as the non-benzamide domperidone 
and the substituted benzamides clebopride and metoclopramide, interference 
with dopaminergic extrinsic innervation (e.g. in the sympathetic ganglia; see 
Willems et al, 1985) may play a role in the mechanism of action of these drugs. 
However, it is no longer believed that the common factor in the mechanism of 
prokinetic action of the substituted benzamides is dopamine D2 receptor 
antagonism. 
Cholinergic mechanisms 
Already in 1957, Paton showed that electrical field stimulation of a longitu-
dinal muscle-myenteric plexus preparation (LMMPP) of the guinea-pig ileum 
causes a contraction that is due to acetylcholine release from the enteric nerves 
(Paton, 1957). Metoclopramide was shown to enhance these field stimulation-
induced cholinergic contractions (Fontaine & Reuse, 1972; 1973; 1979), as do 
cisapride, dazopride, cinitapride, renzapride and clebopride (Massingham et al, 
1985; Schuurkes et al, 1985b; 1987; Sanger, 1987a). In the presence of either the 
Na+ channel blocker tetrodotoxin (TTX) or the muscarinic cholinoceptor antago-
nist atropine, but not after hexamethonium (ganglionic nicotinic cholinoceptor 
antagonist) treatment, these contraction-enhancing effects were blocked 
(Massingham et al, 1985; Schuurkes et al. 1985b; 1987) which shows their critical 
dependence on the postganglionic cholinergic transmission. Such an enhance-
ment of cholinergic contractions in this preparation can be explained in several 
ways. Firstly, the benzamides could inhibit acetylcholinesterase activity or cause 
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sensitization of cholinoceptors. However, it has been shown that the benzamides 
did not shift the concentration-response curve to acetylcholine and metha-
choline on the guinea-pig ileum, whereas the acetylcholinesterase inhibitor 
neostigmine did (Massingham et al, 1985; Schuurkes et al, 1985b; 1987). Thus, 
inhibition of acetylcholinesterase or sensitization of cholinoceptors cannot 
account for the enhancement of contraction of the stimulated ileum. Secondly, 
the benzamides could have a direct effect on either muscarinic or nicotinic 
receptors. However, on the LMMPP preparation of the ileum the benzamides 
have ho or only a small effect, while muscarinic and nicotinic cholinoceptor 
agonists induce large contractions (Massingham et al, 1985; Schuurkes et al., 
1985b; 1987). Furthermore, cisapride does not have affinity for muscarinic 
cholinoceptors in receptor binding studies (Hasler et al., 1991; Heylen et ah, 1992). 
Hence, it seems most likely that cisapride enhanced the release of acetylcholine. 
Indeed, in more recent studies it has been repeatedly shown that benzamides 
increase the amount of [3H]-acetylcholine that is released upon electrical stimula-
tion of the guinea-pig ileum LMMPP (Kilbinger et al., 1982; Pfeuffer-Friederich & 
Kilbinger, 1984; Bou et al, 1988; Taniyama et al, 1991). 
The responses to benzamides of the guinea-pig colon are more complex. 
Beani et al (1970) observed metoclopramide to contract the colon through a 
partially TTX and atropine-sensitive but hexamethonium-insensitive pathway. 
In their study, they did not find metoclopramide to increase acetylcholine release 
(determined by bioassay) or to affect Cholinesterase activity. Instead, it was shown 
that metoclopramide selectively sensitized contractions to exogenous acetyl-
choline in the presence of TTX. Hence, it was suggested that in the colon meto-
clopramide sensitizes the muscarinic cholinoceptors on the smooth muscle, 
instead of increasing acetylcholine output. As in the colon there is constant basal 
release of acetylcholine, the atropine and TTX-sensitive increase in tone due to 
metoclopramide was thus also explained via sensitization by the authors (Beani 
et al, 1970). To date, a similar study on the guinea-pig colon has not been 
repeated, nor has it been investigated whether other benzamides could have 
similar sensitizing actions. In rabbit distal colon, however, cisapride has also 
been observed to selectively sensitize cholinergic responses mediated by post-
junctional muscarinic receptors (prof. M. Tonini, personal communication). In 
the intact guinea-pig ileum and the taenia coli, as well as in the rabbit ileum and 
duodenum, metoclopramide increased tone and potentiated contractions to 
substance P, acetylcholine, barium ions, carbachol and nicotine (Bury & 
Mashford, 1976; Okwuasaba & Hamilton, 1976). According to Bury & Mashford 
(1976), contractions to histamine were also potentiated, at variance with the 
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observations of Okwuasaba & Hamilton (1976). In both studies, TTX and atropine 
partially or fully prevented the sensitization after metoclopramide treatment. 
Hence, it was suggested that all of the mentioned contractile agents act (partially) 
on the enteric nerves to release acetylcholine, and that metoclopramide 
enhances this cholinergic transmission (Bury & Mashford, 1976; Okwuasaba & 
Hamilton, 1976). Birtley & Baines (1973) found metoclopramide at 10 and 30 
H-g/ml to enhance submaximum contractions to histamine and acetylcholine in 
both circular and longitudinal muscle of the guinea-pig ileum. Fontaine & Reuse 
(1973) reported an enhancement of contractions to nicotine and acetylcholine, 
but not histamine, on the guinea-pig ileum longitudinal contraction. However, 
in both studies TTX was not tested on the metoclopramide-induced amplifica-
tion responses, and therefore presynaptic effects rather than postsynaptic sensiti-
zation were not excluded. 
In isolated guinea-pig gastroduodenal preparations (Van Nueten et al, 1978), 
only metoclopramide and cisapride enhanced antroduodenal coordination of 
spontaneous pressure waves, while clebopride and BRL 20627 tended to; dazo-
pride had no stimulating effect. Atropine prevented the stimulating effect of 
cisapride, indicating that cholinergic nerves are involved (Schuurkes et al, 
1985b; 1987). Cisapride and metoclopramide were also shown to enhance the 
spontaneous contractions in this preparation (Schuurkes et al, 1985b). In isolated 
longitudinal muscle strips of the guinea-pig stomach, metoclopramide stimu-
lated the spontaneous movements. This stimulation was inhibited by the 
muscarinic cholinoceptor blocker hyoscine but not by TTX or the ganglionic nico-
tinic cholinoceptor blocker hexamethonium (Hay, 1977). Na+-action potential-
independent release of acetylcholine from the nerve endings could explain these 
results. The release could be enhanced by metoclopramide or it could sensitize 
the smooth muscle muscarinic receptors. However, metoclopramide-induced 
enhancement of contractions to exogenous acetylcholine in this preparation 
were prevented by TTX and hexamethonium, suggesting that this effect depends 
upon ganglionic stimulation by the exogenous acetylcholine rather than a post-
junctional sensitization. Hence, metoclopramide probably stimulates motility of 
this preparation by increasing the amount of acetylcholine that is released (Hay, 
1977). In a subsequent study (Hay & Man, 1979), this hypothesis was further 
elaborated. Stomach strips were loaded with hemicholinium-3 to diminish 
acetylcholine content. In such strips, the contractile activity to metoclopramide 
was prevented, providing further support for a neuronal acetylcholine-release 
enhancing action of metoclopramide in this tissue (Hay & Man, 1979). 
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It is now fully accepted, that nerves contain usually more than one neuro-
transmitter (see for review on co-transmission: Burnstock, 1990). In enteric 
nerves of the guinea-pig it has been shown with immunostaining techniques 
that motor neurons that stain for choline acetyltransferase (a marker for acetyl-
choline) usually contain substance P-immunoreactive material as well (Furness 
et al., 1988). This suggests that both neurotransmitters are released upon nerve 
stimulation, though the ratio of the released amounts might depend upon the 
stimulation frequency (Furness et ah, 1988; Burnstock 1990). It is thus conceivable 
that benzamide-induced facilitation of cholinergic transmission through an 
increase in acetylcholine release would also lead to an increase in substance P 
release. Furthermore, benzamides could interfere with the release of other non-
cholinergic substances that are released from non-cholinergic neurons. These 
non-adrenergic, non-cholinergic (NANC) neurotransmitters are believed to play 
an important role in gut motility (see Bingham & Andrews, 1992). In the guinea-
pig colon, it has been demonstrated that cisapride enhances the field-stimula-
tion-induced relaxation under NANC conditions (Schuurkes, 1992), suggesting 
enhanced release of an inhibitory neurotransmitter. In the presence of atropine, 
cisapride facilitated the contractions in the gastric corpus and antrum in response 
to submaximal vagal efferent stimulation of the anaesthetized ferret (Bingham & 
Andrews, 1987; 1992). Cisapride and other benzamides have been shown to facili-
tate 5-HT-evoked purinergic inhibitory transmission in the guinea-pig proximal 
colon (Briejer et al., 1994). In circular smooth muscle tissue of the guinea-pig 
ileum renzapride facilitated the field stimulation-evoked release of non-cholin-
ergic inhibitory (purinergic) and excitatory transmitters (King & Sanger, 1992). 
These results strongly suggest that not only facilitation of cholinergic trans-
mission, but also facilitation of non-cholinergic transmission might contribute to 
the motility-stimulating effects of the benzamides. Future studies should address 
this question in more detail. 
Though it was becoming more and more evident that benzamides facilitate 
cholinergic transmission, it was not known via which receptor type(s) this could 
be established. Schuurkes et al. (1988) investigated whether cisapride could 
enhance acetylcholine release in guinea-pig ileum LMMPP by antagonizing 
presynaptic muscarinic Mi cholinoceptors. Stimulation of Mi cholinoceptors is 
known to cause inhibition of acetylcholine release (autoreceptors) (North et al., 
1985; Buckley & Burnstock, 1986). However, cisapride could not antagonize the 
inhibition of field stimulation-induced twitch contractions caused by the Mi 
cholinoceptor agonist McN-A-343, while the Mi cholinoceptor antagonist piren-
zepine did. Furthermore, enhancement of twitch contractions induced by 
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cisapride on the ileum was not affected by the presence of pirenzepine, nor did 
pirenzepine itself cause stimulation. Hence, it was concluded that cisapride does 
not interact with Mi cholinoceptors to stimulate cholinergic transmission 
(Schuurkes et al, 1988). 
Summarizing, it has been established that the most important property of 
substituted benzamides is their ability to facilitate cholinergic neurotrans-
mission. This is done by increasing the amount of acetylcholine that is released 
per stimulus, but in some cases results have also suggested that postjunctional 
cholinoceptors are sensitized. Facilitation of non-cholinergic neurotransmission 
might also play a role. The former and latter hypotheses deserve to be studied in 
more detail. 
Interactions with 5-HT3 receptors 
Already in 1970, Bianchi et al. reported that metoclopramide inhibited 
contractions to 5-hydroxytryptamine (5-HT; serotonin) on the guinea-pig colon. 
Similar observations have been made on other guinea-pig gastrointestinal 
preparations as well (Fontaine & Reuse, 1973; Birtley & Baines, 1973). At that 
time it was still presumed that two types of 5-HT receptors existed in the guinea-
pig gut, M and D receptors. In 1957, Gaddum and Picarelli had shown that 
contractions to 5-HT could be partially inhibited by morphine (M-receptors) and 
dibenzyline (= phenoxybenzamine; D receptors) (Gaddum & Picarelli, 1957). 
However neither compound is a specific 5-HT receptor antagonist. Dibenzyline is 
an alkylating agent, blocking smooth muscle responses to many compounds 
(Boyd et al, 1963; Day & Vane, 1963), and morphine inhibits acetylcholine release 
by stimulating presynaptic inhibitory opioid receptors (Paton, 1957; Schultz & 
Cartwright, 1974). Due to a lack of selective 5-HT receptor antagonists, no great 
progress was made in the 1960s and 1970s in the classification and identification 
of 5-HT receptor types. In the 1970s, the radioligand binding technique was 
developed, and it was found in 1979 that 5-HT binds at two different binding sites 
in the central nervous system for which lysergic acid diethylamide has a high 
affinity. These binding sites were designated 5-HTi and 5-HT2 (Peroutka & 
Snyder, 1979). Subsequent studies showed that 5-HT antagonists with affinity for 
the 5-HT2 site showed a good correlation with D receptors measured on func-
tional studies in vascular and gastrointestinal smooth muscle (Humphrey et al, 
1982; Engel et al, 1984; 1985; Maayani et al, 1984). 
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Cocaine was found to be a relatively selective antagonist at M receptors on 
sympathetic nerve endings in the rabbit heart (Fozard et al, 1979). From cocaine, 
more potent and selective M receptor blocking drugs were derived, e.g. MDL 
72222 (Fozard, 1984) and ICS 205-930 (= tropisetron; Richardson et al, 1985). With 
these compounds, it could be confirmed that M receptors do not fall into the 
5-HTi and 5-HT2 category (see Table 1.2). The confusion in the 5-HT receptor 
classification field was greatly abolished by Bradley et al by publishing their 
proposals for 5-HT receptor classification (Bradley et al, 1986; see Table 1.2). The 
M receptor was now called 5-HT3. Within the 5-HTi subtype there was evidence 
for heterogeneity, but lack of selective tools did not allow further subclassifi-
cation at the time. 
Table 1.2 Ligands for the classification of 5-HT receptor types according to Bradley et al. (1986) 
5-HTrlike* 5-HT2 5-HT3 
former name D M 
"selective" antagonists 
known in 1986 
methiothepin 
methysergide 
methiothepin 
methysergide 
ketanserin 
spiperone 
MDL 72222 
tropisetron 
(-)-cocaine 
"selective" agonist 5-CT (+)-s-a-methyl-5-HT 2-methyl-5-HT 
phenylbiguanide 
5-CT = 5-carboxamidotryptamine;*evidence for heterogeneity within this receptor type. 
As stated before, it was known that metoclopramide antagonizes neurogenic 
contractions to 5-HT in the guinea-pig gut (Bianchi et al, 1970; Fontaine & Reuse, 
1973; Birtley & Baines, 1973), which suggests an interaction with 5-HT3 receptors. 
In strips of guinea-pig stomach, metoclopramide as well as the 5-HT3 receptor 
antagonists tropisetron and MDL 72222 enhanced field stimulation-induced 
contractions (Buchheit et al, 1985a). Again these results suggest that metoclo-
pramide is an antagonist at 5-HT3 receptors. In the same year, several groups 
suggested that 5-HT acts upon two different neuronal 5-HT receptors in the 
guinea-pig ileum to facilitate field stimulation-induced acetylcholine release 
(Kilbinger & Pfeuffer-Friederich, 1985; Fozard, 1985). It was also suggested that in 
this ileum preparation 5-HT causes contractions via two different 5-HT receptors 
(Buchheit et al, 1985b). Renzapride (BRL 24924) was observed to enhance field 
stimulation-induced twitch contractions more potently but similarly to metoclo-
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pramide in the ileum, which could be prevented by high concentrations of 5-HT 
but not by a 5-HT3 receptor blocking concentration of tropisetron. Renzapride 
also antagonized 5-HT-evoked, cholinergically mediated, contractions on this 
preparation (Sanger, 1987a). Also cisapride has been shown to enhance the 
cholinergic field-stimulation-induced contractions both in the absence and 
presence of a 5-HT3 receptor blocking concentration of tropisetron (Schuurkes & 
Van Nueten, 1988). In the guinea-pig ileum, contraction and facilitation of 
cholinergic transmission to metoclopramide was prevented by desensitization 
with 5-HT (Kilbinger et al, 1982). Sanger, as well, showed that on the guinea-pig 
ileum preparation, at low concentrations metoclopramide acted upon a receptor 
susceptible to desensitization by 5-HT to induce facilitation of cholinergic trans-
mission (at higher concentrations of metoclopramide 5-HT could not produce 
desensitization, suggesting an additional mechanism) (Sanger, 1987b). Also for 
cisapride and cinitapride, actions on the guinea-pig ileum and colon similar to 
those described above have been observed (Pfeuffer-Friederich & Kilbinger, 1984; 
Schuurkes et ah, 1985b; Massingham et ah, 1985). These observations indicate that 
two different 5-HT receptor types are present on the myenteric neurons, that both 
facilitate cholinergic transmission. One is the 5-HT3 receptor, at which most 
benzamides are moderate affinity antagonists (see Table 1.3). The other 5-HT 
receptor, at which the benzamides are agonists, was unknown. 
Much effort has been made to elucidate whether the 5-HT3 receptor blocking 
property of benzamides can explain their motility-stimulating action. The devel-
opment of the potent and selective non-benzamide 5-HT3 receptor antagonists 
GR 38032F (ondansetron; Brittain et ah, 1987), tropisetron (Richardson et ah, 1985) 
and BRL 43694 (granisetron; Sanger & Nelson, 1989) (see Table 1.3) gave an 
impetus to answer this question. Motility experiments with 5-HT3 receptor 
antagonists have been performed in the guinea-pig, rat, dog, and to a lesser 
extent in man. 
Guinea-pig 
Facilitation of cholinergic transmission could explain the gastrointestinal 
motility-stimulating properties in vivo of the benzamides, as acetylcholine is the 
main excitatory neurotransmitter involved in both nerve-nerve and nerve-
smooth muscle communication. Stimulation of neuronal 5-HT3 receptors causes 
facilitation of cholinergic transmission in guinea-pig gastrointestinal prepara-
tions, as described above. Thus, the 5-HT3 receptor antagonist properties of most 
benzamides is difficult to reconcile with their prokinetic properties, if it is 
supposed that facilitation of cholinergic transmission is their key property. 
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Table 1.3 Potency of 5-HT3 receptor antagonists and prokinetic benzamides in several established 
in vitro and in vivo 5-HT3 receptor models and in in vivo gastrointestinal motility models. 
compound 
5-HT3 antagonists 
ondansetron 
granisetron 
tropisetron 
benzamides 
metoclopramide 
cisapride 
renzapride 
zacopride 
compound 
5-HT3 antagonists 
ondansetron 
granisetron 
tropisetron 
benzamides 
metoclopramide 
cisapride 
renzapride 
zacopride 
1
 Radioligand 
binding 
5-HT3 sites 
rat cortex Kj (nM) 
0.4-4.8 
0.1-2.7 
0.2-3.2 
120-457 
135 
-
0.1-2.0 
Repolarization 3Bezold-Jarisch 
isolated rat vagus reflex 
nerve to 5-HT anaesthetized rat 
4Gastric emptying 
solid meal dog 
ED50 (ng/kg 
-
-
-
-
200 
100 
-
•g.) 
Kb (nM) 
2.5 
0.2 
0.01 
251 
-
-
0.1 
ED50 (ng/kg 
5.23 
0.70 
0.6 
1398 
2022 
12.4 
0.4 
antiemetic activity 
cisplatin-induced 
dog 
ED50 (mg/kg 
0.008 
-
0.01 
0.6 
0.6 
0.03 
60.002 
emesis 
•v.) 
i.V.) 
3Gastric emptying 
solid beads rat 
ED50 (ng/kg i.p.) 
-
-
9.7 
1054 
509 
26.8 
4.5 
3Heidenhain pouch 
gastric motility dog dose 
(ug/kg i.v.) 
resp. pos/tested 
-
-
100: 0/3 
100: 5/6 
100: 3/4 
30: 3/3 
30: 5/5 
References: 1 Kilpatrick era/., 1990; 2Butler et al. 1990; 3Schiavone era/., 1990; 4Gullikson era/., 
1993; 5Gullikson et ai, 1991; 6Cohen era/., 1989. 
It has been shown that metoclopramide, but also tropisetron and 
ondansetron, increase the rate of gastric emptying of radio-opaque beads in 
conscious guinea-pigs (Buchheit et al., 1985a; Costall et al., 1987). Costall et al. 
(1986) investigated whether a possible central 5-HT3 receptor mechanism could 
be involved in gastroprokinetic effects. Tropisetron was injected directly into the 
hypothalamic region of conscious guinea-pigs, which caused an increase of the 
rate of gastric emptying. 5-HT and 2-methyl-5-HT had decreased gastric emptying, 
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which could be antagonized by tropisetron injection in the hypothalamus 
(Costall et al. 1986). Hence, extra-enteric 5-HT3 receptors might play a role in the 
regulation of stomach motility in the guinea-pig. In conscious guinea-pigs, 
ondansetron, tropisetron and granisetron delayed fecal pellet transit. In contrast 
to these in vivo experiments, ondansetron was without activity on spontaneous 
pellet propulsion in the isolated colon, though granisetron and tropisetron did 
inhibit transit (Sanger et al, 1991). The conflicting results obtained with 
ondansetron vs. granisetron and tropisetron might reflect differences in ability to 
reach the receptor site. Wade & Gershon (1991) also found that, in a similar 
preparation, 5-HT3 receptor blocking concentrations of tropisetron, granisetron 
and zacopride did not affect colonic propulsion, while renzapride inhibited 
propulsion. In the Trendelenburg (1917) setup of the guinea-pig ileum, 5-HT3 
receptor blocking concentrations of tropisetron, ondansetron and granisetron did 
not affect the peristaltic reflex, while benzamides like cisapride, metoclopramide, 
renzapride and others facilitated the reflex (Craig & Clarke, 1991; Buchheit & 
Buhl, 1991; 1993; Wade & Gershon, 1991). In the Trendelenburg experiment, 
zacopride had a pECso value of 5.7 (Buchheit & Buhl, 1991), while it has nano-
molar affinity for 5-HT3 receptors, indicative for a non-5-HT3 receptor mecha-
nism. From the above described results it can be concluded that the prokinetic 
benzamides are not likely to stimulate gastrointestinal motility in the guinea-pig 
by blocking 5-HT3 receptors. 5-HT3 receptor blockade might however contribute 
to the effects on gastric emptying in this species. 
Rat 
In the rat, stomach-to-caecum transit was delayed by subcutaneously adminis-
tered ondansetron and granisetron. However, lipid-delayed transit was reversed 
by ondansetron and granisetron (Brown et al, 1993b). Ondansetron enhanced the 
action of a protein-rich solution in delaying gastric emptying in conscious fistula 
rats, but it did not affect emptying of isotonic or hypertonic saline, acid or FOY-
305, which delays gastric emptying by release of cholecystokinin (Forster & 
Dockray, 1990). These data show that drug effects on motility may greatly depend 
upon the experimental conditions, especially the type of meal. The effects of the 
benzamides cisapride, zacopride, metoclopramide and renzapride, as well as the 
5-HT3 receptor antagonist tropisetron, were tested on the rate of gastric emptying 
of 20 Amberlite® beads in conscious rats (see Table 1.3). All tested compounds 
accelerated gastric emptying with potencies that correlated well with the poten-
cies for inhibiting the Bezold-Jarisch reflex (5-HT-induced bradycardia in the 
anaesthetized rat, an established in vivo 5-HT3 model) (Schiavone et al, 1990). 
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Hence, 5-HT3 receptor antagonism could well account for the stimulating effects 
of benzamides on gastric emptying in this species. Cohen et al. (1990), however, 
showed that zacopride, but not the potent and selective 5-HT3 receptor antagonist 
LY277359, accelerated gastric emptying of a complex meal. Despite the fact that 
only 2 compounds were tested, these observations plea against a 5-HT3 antago-
nistic mechanism in the stimulating effect of gastric emptying in the rat. Colonic 
transit as measured by counting fecal pellet output in conscious rats, was not 
affected by ondansetron and granisetron p.o. (Kadowaki et al, 1993), but effects of 
benzamides on colonic transit are not available. Hence, in the rat 5-HT3 receptor 
blockade seems an important feature of the benzamides to stimulate gastric 
motility, though it is likely that other properties are also important. 
Dog 
In conscious dogs equipped with strain gauge force transducers, tropisetron 
slightly reduced gastroduodenal motility, while cisapride enhanced it (even in 
the presence of tropisetron). Cisapride accelerated gastric emptying of a liquid 
meal, but ondansetron did not affect gastric emptying (Schuurkes & Van Nueten, 
1988). Gullikson et al. (1991) tested a number of benzamides and 5-HT3 receptor 
antagonists in the conscious dog. All drugs tested were 5-HT3 receptor anta-
gonists as they blocked cisplatin-induced emesis (see: Andrews et ah, 1988) with 
relative potencies of granisetron = tropisetron > renzapride > cisapride = meto-
clopramide. In contrast, the order of potency for stimulation of antral motility 
was: renzapride = cisapride > metoclopramide > tropisetron = granisetron (see 
Table 1.3). Renzapride and cisapride stimulated jejunal myoelectric activity but 
tropisetron was not active. Renzapride and cisapride also increased the rate of 
emptying of solid and liquid meals, but tropisetron only enhanced liquid empty-
ing whereas granisetron had no effect at all (Gullikson et al., 1991). In conscious 
dogs chronically implanted with force transducers, ondansetron, granisetron and 
tropisetron did not affect digestive gastrointestinal motility, whereas renzapride 
stimulated digestive motility from stomach to colon (Yoshida et ah, 1991b). 
Hence, in the dog the prokinetic activity of benzamides seems unrelated to 5-HT3 
receptor blockade. 
Human 
In man, ondansetron, did not accelerate gastric emptying or small bowel 
transit, while large bowel transit was slowed (Gore et al, 1989; 1990; Talley et al, 
1989; 1990; Nielsen et al, 1990). Tropisetron has been found to slightly increase 
and reduce gastric emptying in man, depending on the dose (Akkermans et al, 
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1988; Stacher et al, 1990) and to produce mild constipation and colonic hyper-
motility (Stacher et al, 1989). Furthermore, tropisetron has been observed to 
speed up mouth-to-caecum transit in man (Meleagros et al, 1987). Recently, 
ondansetron, given intravenously, has been found to inhibit the initiation of 
gastric phase-3 activity of the interdigestive cyclical pattern of motor activity 
(migrating motor complex) in humans (Wilmer et al, 1993), suggesting 5-HT3 
receptor involvement. It is however difficult to extrapolate the significance of 
these findings to gastroprokinetic effects, as the latter take place in the digestive 
state, in which motility patterns totally different from those in the fed state 
(when prokinetics ought to exert their effect) play a role. Nevertheless, these 
observations suggest that 5-HT3 receptors do play a role in the motility of the 
intestines in humans. However, benzamides such as cisapride stimulate gastric 
and bowel motility in healthy humans as well as in patients with a variety of 
motility disorders (see: Wiseman & Faulds, 1994). Lack of consequent stimulating 
effects on motility of 5-HT3 receptor antagonists render the possibility that the 
benzamides stimulate motility in man solely by antagonising these 5-HT3 
receptors rather unlikely. 
Interactions with 5-HT4 receptors 
In the mouse colliculi neurons and in guinea-pig hippocampal membranes, 
Shenker et al. (1987) and subsequently Dumuis et al. (1988) identified a high 
affinity 5-HT receptor which was positively coupled to adenylate cyclase. The 
pharmacological and radioligand binding profile of the tested agonists and anta-
gonists differed completely from the profile for the 5-HTi-like, 5-HT2 and 5-HT3 
receptors (Table 1.2). Hence, this receptor was proposed to be designated 5-HT4 
(Dumuis et al., 1988) In subsequent studies, it was shown that the gastrointestinal 
prokinetic benzamide derivatives, such as cisapride, renzapride, zacopride, BRL 
20627 and metoclopramide were agonists at this 5-HT4 receptor, in this respective 
rank order of potency (Dumuis et al., 1989a; b; Bockaert et ah, 1990). The only 
antagonist available at the time appeared to be tropisetron, be it at micromolar 
concentrations (pKi = 6.0-6.3 at 5-HT4 receptors versus 8-10 at 5-HT3 receptors) 
(Dumuis et al, 1988; 1989a; b). 
Guinea-pig 
In most tissues, the neurogenic M receptors as defined by Gaddum and 
Picarelli (1957) were shown to correspond to the 5-HT3 receptors, as proposed by 
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Bradley et al. (1986). However, observations made on the guinea-pig ileum have 
led to considerable debate as to whether the M receptor and 5-HT3 receptor are 
the same entity. As discussed above, it was suggested that two types of neuronal 
5-HT receptor with similar action exist in this tissue (Buchheit et al., 1985b; 
Kilbinger & Pfeuffer-Friederich, 1985; Fozard, 1985). M-receptors were originally 
defined to account for the neuronally-mediated effects to 5-HT in the ileum. 
Hence, the question which of these two receptors corresponded to the M-receptor 
gave rise to confusion. The discovery of the 5-HT4 receptor solved this issue (see 
for more extensive review on this issue: Hoyer, 1990). The high and low affinity 
phase of the biphasic concentration-response curve to 5-HT on the ileum, and 
also on the colon, were shown to be mediated by 5-HT4 and 5-HT3 receptors, 
respectively (Eglen et al., 1990; Briejer et al, 1993a). Tropisetron antagonized the 
enhancement of the electrically-induced twitch contractions due to 5-HT, as well 
as to cisapride, zacopride and renzapride with micromolar affinity (Craig & 
Clarke 1990). Elaborating the observation originally made by Fozard (1985), who 
observed that with 5-methoxytryptamine (5-MeOT) two neurogenic receptors on 
the guinea-pig ileum could be discriminated, Craig et al. (1990) showed that 
5-HT3 and 5-HT4 receptors could be selectively desensitized by 2-Me-5-HT (a 
5-HT3 receptor agonist, see Table 1.2) and 5-MeOT, respectively. The presence of 
5-HT4 receptors mediating the release of acetylcholine from the ileal enteric 
nerves has been confirmed in several studies with different techniques, e.g. 
determination of [3H]acetylcholine release (Kilbinger & Wolf, 1992) and mutual 
desensitization of cisapride, 5-HT and 5-MeOT (Meulemans & Schuurkes, 1992). 
The development of novel, more selective and potent 5-HT4 receptor antagonists 
(SDZ 205-557, DAU 6285) and agonists (BIMU 1, BIMU 8) allowed further identi-
fication of 5-HT4 receptors in this preparation (Buchheit et ah, 1992; Rizzi et al., 
1992). Tonini and co-workers showed that also on the enteric nerves innervating 
the circular smooth muscle of the guinea-pig ileum, 5-HT4 receptors are present. 
Also in this preparation, cisapride induced an increase in field stimulation-
induced cholinergic twitch contractions (Tonini et al., 1992). 
The 5-HT4 receptor was soon identified in other tissues. The remaining 
contractions to 5-HT after 5-HTi, 5-HT2 and 5-HT3 blockade on the guinea-pig 
colon were shown to be sensitive to micromolar concentrations of tropisetron, as 
were those to cisapride, renzapride, metoclopramide and zacopride. The contrac-
tions were strongly, but not fully inhibited by atropine and abolished by TTX, 
demonstrating involvement of cholinergic nerves (Elswood et al., 1991). The fact 
that in the presence of atropine still a part of the contraction remained might 
indicate that also a non-cholinergic transmitter (substance P) is involved, as has 
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been shown after 5-HT3 and 5-HT4 receptor stimulation in the ileum (Fox & 
Morton, 1991; Ramirez et al, 1994; see discussion above on co-transmission). 
Hence it was concluded that 5-HT4 receptors are present on the guinea-pig colon 
enteric nerves (Elswood et al, 1991). These observations have later been con-
firmed (Briejer et al, 1993a; b; Gale et al, 1994). In LMMPP of guinea-pig distal 
colon, 5-HT4 receptors have also been shown to be present. They seem very effec-
tively coupled to their second messenger system, as reflected by a high pECso 
value of 9.2 (Wardle & Sanger, 1993; Wardle et al, 1994). The same workers 
recently also showed 5-HT, 5-MeOT, renzapride and zacopride to induce 
tropisetron and SDZ 205-557-sensitive contractions of the circular muscle prepa-
ration of the distal colon. The location on cholinergic nerves of these 5-HT4 
receptors however was not verified (Ellis et al, 1994). On isolated circular smooth 
muscle strips from the guinea-pig stomach fundus and antrum, 5-HT, metoclo-
pramide and renzapride enhanced electrical field stimulation-induced contrac-
tions by 300-400 %. These effects could be antagonized with SDZ 205-930 but not 
by tropisetron in a 5-HT3 receptor blocking concentration. 2-Me-5-HT also caused 
stimulation, but this effect was insensitive to SDZ 205-557. The authors con-
cluded that despite the presence of 5-HT3 receptors in their preparation, these 
effects were mediated predominantly by 5-HT4 receptors (Buchheit & Bertholet, 
1992). Hence, along the guinea-pig gastrointestinal tract, 5-HT4 receptors, for 
which benzamides are agonists, are abundantly present on the enteric nerves. 
Rat 
Crossing the species border, very different results have been obtained. In con-
trast to the guinea-pig, 5-HT4 receptors in the rat gastrointestinal tract generally 
appear to be located on the smooth muscle, mediating relaxation. Like in the 
guinea-pig, rat 5-HT4 receptors have been found to be positively coupled to 
adenylate cyclase, which is in agreement with a direct smooth muscle relaxation 
(Ford et al, 1992; Moummi et al, 1992). On intact segments of the rat oesophagus, 
the benzamides were partial 5-HT4 receptor agonists with the following rank 
order of potency: renzapride > R,S-zacopride > metoclopramide = cisapride 
(Reeves et al, 1991a). However, in tunica muscularis mucosae preparations of 
the oesophagus, the rank order of potency was cisapride > S-zacopride = renza-
pride > R,S-zacopride > R-zacopride (Baxter et al, 1991). These differences might 
be explained either to be caused by diffusion difficulties of cisapride to the 5-HT4 
receptor sites, or by an additional mechanism in the intact preparation. In the 
ileum, 5-HT4 receptor stimulation also caused relaxation via an atropine-insensi-
tive mechanism, suggesting also a smooth muscle location of the 5-HT4 receptors 
38 Chapter 1 
(Taludhar et al, 1991; 1992). In subsequent studies it was confirmed that these 
5-HT receptors were indeed 5-HT4 receptors (Taludhar et al, 1994a; b). Facilitation 
of cholinergic transmission as the mechanism for prokinetic action of the 
benzamides is difficult to reconcile with smooth muscle 5-HT4 receptor activa-
tion inducing relaxation. Therefore, in vivo studies in the rat might provide 
new insights as to their mechanism of action. In rats fed with a methylcellulose 
test meal containing radioactive microspheres, metoclopramide, renzapride and 
R,S-zacopride dose-dependently stimulated cholecystokinin-delayed gastric 
emptying. The increase in gastric emptying could not be mimicked or inhibited 
by 5-HTi, 5-HT2, 5-HT3 or dopamine D2-receptor antagonists, but 5-HT4 receptor 
blocking doses of tropisetron or the potent 5-HT4 receptor antagonist GR125487 
prevented the stimulation after metoclopramide administration (Reeves et al, 
1991b; Gale et al, 1993). Unfortunately, no in vitro study on the location -either 
neuronal or muscular- of 5-HT4 receptors in the stomach has been published for 
comparison. In conscious rats equipped with a duodenal cannula, neither zaco-
pride nor cisapride could stimulate small intestinal transit of a methylcellulose 
test meal containing radioactive microspheres after slowing of transit by the 0C2-
adrenoceptor agonist p-aminoclonidine (Clayton & Gale, 1994). This observation 
is in agreement with the smooth muscle localization of 5-HT4 receptors on the 
smooth muscle, and a consequent lack of stimulation of cholinergic transmis-
sion. In anaesthetized rats, gastric emptying of a radiolabelled liquid was acceler-
ated by intra-arterial 5-HT and by R-zacopride, which is a potent 5-HT3 receptor 
antagonist but only a low potency 5-HT4 receptor agonist (see Tables 1.3 and 1.4). 
Moreover, the benzamide SC-53116, which has been reported to be a potent 
5-HT4 receptor agonist but only a moderate potency 5-HT3 receptor antagonist 
(Flynn et al, 1992; Gullikson et al, 1993; see Table 1.4) had a much less 
pronounced effect on gastric emptying (Valdovinos et al, 1993). These observa-
tions are in agreement with the previously drawn conclusion that 5-HT3 receptor 
antagonism rather than 5-HT4 receptor agonism could be important in benza-
mide-induced acceleration of gastric emptying in the rat. However, the fact that 
only one dose of the drugs was tested in this study and no other 5-HT3 or 5-HT4 
receptor (ant)agonists were used limits the strength of this conclusion. More in 
vitro and in vivo studies in the rat with benzamides and non-benzamide 5-HT3 
and 5-HT4 receptor antagonists to investigate how and to what extent different 
benzamides exert their prokinetic effects would be welcomed. 
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Dog 
Another species which has been studied with respect to benzamides and 
gastrointestinal motility, is the dog. In vivo, cisapride and the 5-HT4 receptor 
agonist BIMU 1 dose-dependently increased gastric motility as assessed in the 
Heidenhain pouch (a denervated gastric pouch) in the conscious dog. These 
stimulating effects could not be inhibited by ondansetron, suggesting an action 
on 5-HT4 rather than on 5-HT3 receptors (Rizzi et ah, 1994). In a similar experi-
ment, it was shown that the 5-HT-induced stimulation of gastric motility could 
be inhibited by the non-benzamide 5-HT4 receptor antagonist SB 204070 
(Bingham et ah, 1993). Cisapride and BIMU 1, but not ondansetron, accelerated 
gastric emptying of a liquid meal in the conscious dog, and this effect could be 
blocked by the relatively selective non-benzamide 5-HT4 receptor antagonist 
DAU 6285 (Rizzi et ah, 1994). In similar experiments, gastric emptying of a liquid 
meal containing oleic acid to delay emptying, was shown to be accelerated by 
cisapride, metoclopramide and clebopride (in this respective order of potency) 
(Schuurkes et ah, 1987). <X2-Adrenoceptor agonist-induced delayed gastric empty-
ing of liquid and solid meals was shown to be enhanced by cisapride, renzapride, 
S-zacopride and the benzamide 5-HT4 receptor agonist SC-49518 (see Table 1.1) 
with about equal potency (SC-49518 has only micromolar affinity at 5-HT3 recep-
tors) (Gullikson et ah, 1992; 1993). In fasted dogs chronically implanted with force 
transducers or electrodes, cisapride, renzapride, R- and S-zacopride and SC-49518 
also enhanced antral contractile and myoelectric activity (Gullikson et ah, 1992; 
1993). In a similar study on dogs equipped with strain gauges, it was found that 
cisapride, mosapride (AS-4370; see Table 1.1) and less potently metoclopramide 
stimulated antral and duodenal motor activity, whereas cisapride also stimulated 
colonic motility (Yoshida et ah, 1991a). These effects of mosapride could not be 
antagonized by 5-HT3 receptor-blocking doses of tropisetron, but they were sensi-
tive to desensitization by continuous infusion of 5-HT, as were the stimulating 
effects to cisapride and metoclopramide (Yoshida et ah, 1991a). The 5-HT4 recep-
tor antagonist SDZ 205-557 (1.25 mg/kg s.c.) inhibited the stimulation to cisapride 
(1.25 mg/kg p.o.) of antropyloric motility in conscious dogs, but SDZ 205-557 per 
se had no effect (unpublished observations). Taken together, these observations 
obtained in conscious dogs suggest that a 5-HT4 receptor mechanism indeed is 
involved in the prokinetic action of the benzamides. 
Cisapride as well as 5-HT have been shown to enhance electrical field stimu-
lation-induced cholinergic contractions of longitudinal muscle strips of the dog 
gastric antrum. Though it was suggested that both substances acted via different 
receptors, involvement of 5-HT4 receptor could not be shown (De Ridder & 
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Schuurkes, 1993). However, this evidence was merely based upon the use of the 
low potency non-selective tropisetron. Recently the selective and highly potent 
5-HT4 receptor antagonist SB 204070 has been tested in the same preparation, and 
it was found that the effects to 5-HT, but not those to cisapride could be inhibited 
(W.E. De Ridder, personal communication), suggesting that cisapride acts 
through a mechanism other than 5-HT4 receptors in this preparation. These 
results with longitudinal muscle strips of the gastric antrum (De Ridder & 
Schuurkes; 1993), suggesting that 5-HT4 receptors are not involved in the effects 
of cisapride, may have only little relevance for gastric motility effects in vivo. 
Human 
Only few in vitro studies with human tissues have been conducted with 
respect to benzamides and 5-HT. In circular muscle strips from the fundus, 
corpus and antrum electrical field stimulation caused cholinergic contractions, 
which were enhanced by cisapride, 5-HT and 5-MeOT. These compounds anta-
gonized each others action (mutual desensitization), and tropisetron in a 5-HT4 
receptor blocking concentration was an antagonist (Schuurkes et al., 1991). 
Renzapride (0.0028-28 uM) enhanced field stimulation-induced cholinergic 
contractions, but not the non-cholinergic relaxations, of longitudinal muscle 
strips of the stomach. Only at high concentrations (28 and 280 uM) renzapride 
enhanced contractions to exogenous acetylcholine (Burke & Sanger, 1988). 
Metoclopramide up to 100 M-g/ml (= 0.33 mM) had no effect on stomach strips, 
but from 1 ug/ml (= 3.3 uM) onwards it sensitized contractions to exogenous 
acetylcholine (Eisner, 1968). Hence, in human stomach the benzamides facilitate 
cholinergic transmission, probably due to an increase in acetylcholine release. 
Sensitisation of postsynaptic cholinoceptors cannot be excluded, but this effect 
probably only contributes to facilitation of cholinergic transmission at very high, 
non-therapeutical, concentrations of benzamide. 
Eisner (1968) reported that metoclopramide had no effect on longitudinal 
muscle strips of the colon. Metoclopramide (0.1-10 ug = 0.33-33 uM) sensitized 
contractions to acetylcholine on longitudinal strips (Eisner, 1968). Burleigh (1977) 
found that 5-HT induced contraction via a methysergide (5-HTi/2 receptor anta-
gonist-sensitive mechanism, and also relaxation of longitudinal muscle strips of 
the colon. On the similar preparation, Hillier et al. (1994) showed that inhibitory 
5-HTi-like receptors are present on the longitudinal smooth muscle. 
Metoclopramide (0.1-10 ug = 0.33-33 uM) caused atropine-insensitive contrac-
tion of circular muscle strips of the colon (Eisner, 1968). On such strips contracted 
with carbachol, 5-HT induced a relaxation which was partially inhibited by TTX 
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but not by methysergide (Burleigh, 1977). Tarn and co-workers (1994) observed on 
inter-taenial circular muscle strips of the isolated human colon, that 5-HT and 
5-MeOT, concentration-dependently inhibited spontaneous activity. This effect 
was slightly attenuated by TTX, and it was mimicked by renzapride, zacopride, 
metoclopramide and cisapride (in this respective rank order of potency, though 
the irregular shape of the curves made a reliable estimate of potency difficult). 
Furthermore, tropisetron was an antagonist to the effects of 5-MeOT and 5-HT 
with an estimated pKb of 6, corresponding to its affinity for 5-HT4 rather than for 
5-HT3 receptors (Tarn et al., 1994). In a consecutive study, these autors showed 
that the 5-HT4 receptor agonists BIMU 1 and BIMU 8 also caused inhibition of 
spontaneous activity, and that the 5-HT4 receptor antagonists DAU 6285 and 
GR 113808 were antagonists (Hillier et al., 1994). On histamine-precontracted 
circular smooth muscle strips from human sigmoid colon, 5-HT induced 
relaxations that were insensitive to TTX and atropine, but which were inhibited 
by the 5-HT4 receptor antagonist SB 204070 (Meulemans et ah, 1995). These 
results suggest that inhibitory 5-HT4 receptors are present on the circular smooth 
muscle of the human colon. The contractile effect to metoclopramide on circular 
muscle, as observed by Eisner (1968), might be caused via other mechanisms. 
In order to evaluate whether cisapride can facilitate cholinergic transmission 
by causing an increase of acetylcholine release in the human colon, Burleigh & 
Trout (1985) measured release of [3H]-acetylcholine in sigmoid taenia coli. 
Cisapride did not affect basal or field stimulation-induced release of acetylcholine 
(Burleigh & Trout, 1985). On field stimulation-induced cholinergic contractions 
of taenia strips, renzapride had no effect up to 282 uM. Hence, these observations 
with cisapride and renzapride are consistent with 5-HT4 receptors being located 
on the smooth muscle instead of on cholinergic nerves in the colon. 
Cisapride has been reported to stimulate colonic motility as it is effective in 
mildly constipated patients (see: Longo & Vernava, 1993). Altaparmakov (1985) 
studied the effects of cisapride on descending colonic and sigmoid motility, as 
assessed with extracellular electrodes, in healthy volunteers and chronically 
constipated patients (randomized design, double blind, placebo controlled). It was 
observed that in both groups propulsive motility was enhanced, an effect which 
was not affected by i.v. injection of atropine. These results led the author to 
conclude that the stimulation of colonic motility by cisapride does not depend 
upon cholinergic pathways (Altaparmakov, 1985). 
Summarizing, the benzamides are likely to enhance stomach motility by 
enhancing cholinergic transmission, possibly by stimulation of 5-HT4 receptors. 
On the colon, the benzamides act as agonists on the inhibitory circular smooth 
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muscle 5-HT4 receptors. Seemingly in contradiction to this, benzamides have 
moderatly stimulating effects on lower gut motility. Cholinergic transmission is 
not enhanced by relevant concentrations of benzamide. It is not clear how these 
phenomena relate to each other. 
Electrophysiology of 5-HT and benzamides 
The electrophysiology of the myenteric neurons has been explored in detail 
only in the last two decades. Single neurons in isolated myenteric ganglia 
(usually dissected from the guinea-pig small intestine) can be impaled with 
microelectrodes to measure membrane potentials and conductance. Thus, 
despite of the many different types of neuron that can be distinguished on an 
immunohistochemical basis, only 4 types of neuron can be distinguished elec-
trophysiologically to occur in the enteric nervous system (see Bornstein et al, 
1994; Wood, 1994). With respect to the effects of 5-HT on myenteric neurons, 
only two types are important. S-Neurons (also called type I) respond with 
multiple spike discharges upon a depolarizing stimulus, while AH-neurons (also 
called type II) only show one or two spike discharges upon a depolarizing 
stimulus, and show a prolonged after-hyperpolarization (for more details, see 
Galligan & North, 1989; Gershon & Wade, 1993; Bornstein et al, 1994; Wood, 
1994). Three types of direct response can be observed after application of 5-HT, 
mediated by respectively 5-HT3, 5 - H T I A and 5-HTip receptors (Nemeth et al, 
1985; Mawe et al, 1986; see Galligan & North, 1989). 
Interactions with 5-HT3 receptors 
In S/type I as well as in AH/type II neurons, 5-HT can induce a transient fast 
depolarization prone to rapid desensitization, associated with spike discharge 
and a decrease in membrane resistance due to opening of kation channels. This 
response is inhibited by tropisetron and MDL 72222 and mimicked by 2-methyl-
5-HT (Mawe et al, 1986; Nemeth & Gullikson, 1989; see Galligan & North, 1989), 
suggesting that it is mediated by 5-HT3 receptors. As described above, most 
benzamides are 5-HT3 receptor antagonists. In electrophysiological experiments 
with myenteric neurons, cisapride, renzapride, zacopride and to a lesser extent 
metoclopramide have been demonstrated to inhibit the fast transient depolariza-
tion to 5-HT (Nemeth et al, 1985; Nemeth & Gullikson, 1989; Wade et al, 1991; 
Schemann, 1991). These results confirm the 5-HT3 receptor antagonistic proper-
ties of the benzamides. 
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Interactions with 5-HTIA receptors and relation to motility effects 
A second effect of 5-HT is hyperpolarization of a subset of neurons associated 
with a decrease in membrane resistance (opening of K+-channels). This effect is 
now known to be mediated by 5 - H T I A receptors (Wade et al., 1991; Tack et al., 
1992; Pan & Galligan, 1994; see Galligan & North, 1989). Presynaptic suppression 
of fast excitatory postsynaptic potentials (EPSPs) recorded from S/type I-cells that 
are evoked by electrical stimulation of the ganglia or interganglionic fiber tracts 
(North et al, 1980; Nemeth et al, 1985; Tonini et al, 1989) is also caused by 
5 - H T I A receptor stimulation. These fast EPSPs are mediated by acetylcholine 
acting on nicotinic (hexamethonium-sensitive) cholinoceptors. Thus, an inhibi-
tion of the fast EPSPs has been explained by a presynaptic inhibition of acetyl-
choline release (North et al, 1980; Nemeth et al, 1985). 
High concentrations of cisapride (1-5 \iM) suppressed or abolished the fast 
cholinergic EPSPs evoked by electrical stimulation of the interganglionic fiber 
tracts (Nemeth et al, 1985). Furthermore, cisapride induced a hyperpolarization 
in some neurons at high concentrations (3-10 uM) (Tonini et al, 1989). Galligan 
et al. (1988) found cisapride (1 uM) not to block 5-CT-induced presynaptic inhibi-
tion. Renzapride (1 uM) did not affect the hyperpolarization response or inhibi-
tion of the fast EPSPs induced by 5-HT (Tack et al, 1992). Wade et al. (1994) 
showed that even 100 uM renzapride did not affect the 5 - H T I A receptor-mediated 
response. Hence, renzapride and cisapride do not seem to interfere with 5 - H T I A 
receptors up to a concentration of 1 uM, but at higher concentrations cisapride 
behaves as a (partial) 5 - H T I A receptor agonist. These results have been confirmed 
in another electrophysiological study (Pan & Galligan, 1994). The low affinity of 
cisapride at 5 - H T I A receptors in electrophysiological experiments, and also in 
radioligand binding studies (see Table 1.4), contrasts sharply with the potent 
antagonism (IC50 =1.5 nM) of cisapride against the 5-HT-induced inhibition of 
field stimulation-induced cholinergic contractions of the guinea-pig ileum 
(Taniyama et al, 1992), a response supposedly mediated by 5 - H T I A receptors 
(Galligan, 1992). The electrophysiological and radioligand binding data are 
however in agreement with the observation of Pfeuffer-Friederich and Kilbinger 
(1984), who reported that 10 uM cisapride, but not lower concentrations, inhib-
ited acetylcholine release from guinea-pig ileum strips, an effect which could be 
antagonized by methiothepin. 
Could a 5 - H T I A receptor mechanism account for the prokinetic effects of 
benzamides? Firstly, the concentration necessary for cisapride to have an action 
on 5 - H T I A receptors (> 1 uM, see above) is not likely to be attained under thera-
peutical conditions. Renzapride seems to lack even low affinity for 5 - H T I A recep-
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tors (Wade et al, 1994), while it does stimulate motility in vivo (see Table 1.2). 
Secondly, 5 - H T I A receptor agonism would lead to inhibition of cholinergic 
transmission, and selective 5 - H T I A receptor antagonists, like NAN-190 and 
spiperone, do not enhance field stimulation-induced cholinergic contractions in 
the guinea-pig ileum (Buchheit et al., 1985b; Galligan, 1992). Therefore, a 5 - H T I A 
receptor mechanism is unlikely to account for the facilitation of cholinergic 
transmission, if it is assumed that the latter subserves the motor stimulating 
properties of the benzamides. Moreover, methiothepin (5-HTi/5-HT2 receptor 
antagonist) and spiperone did not affect gastric emptying in the guinea-pig 
(Buchheit et al, 1985a). Therefore, the prokinetic action of the benzamides is not 
considered to involve a 5 - H T I A receptor mechanism. 
Interactions with 5-HTip receptors and relation to motility effects 
A third direct effect of 5-HT, found exclusively in AH/type II neurons, is a 
slow long lasting depolarization associated with an increase of membrane resis-
tance (Mawe et al., 1986; Nemeth et ah, 1985). These effects are mimicked by 
5-hydroxyindalpine (5-OHIP), 6-hydroxyindalpine (6-OHIP) and 2-Me-5-HT, and 
inhibited by methysergide. The dipeptide of 5-hydroxytryptophan, 5-hydroxy-
tryptophyl-5-hydroxytryptophanamide (5-HTP-DP), is a specific antagonist (Mawe 
et al, 1986; Takaki et al, 1985). This receptor was called 5 - H T I P ("P" of "Peri-
pheral"; Mawe et al, 1986) as it does not resemble any of the currently known 
5-HT receptors with respect to its pharmacological profile (it does not belong to 
the 5-HTi receptor family). Slow EPSPs in a subset of neurons after stimulation 
of interganglionic nerve tracts are thought to be due to release of 5-HT acting on 
5 - H T I P receptors (see Galligan & North, 1989; Gershon & Wade, 1993). 
Cisapride (0.1-5 uM) reversibly suppressed the prolonged excitatory responses 
to 5-HT in AH/type II neurons, as well as the slow EPSPs due to focal electrical 
stimulation of the nerve fibers, suggesting it is an antagonist of 5-HTip receptors 
(Nemeth et al, 1985). Renzapride (0.5-1 uM) and R-zacopride mimicked this 
action of cisapride (Mawe et al, 1989; Wade et al, 1991) and can thus also be 
considered 5-HTip receptor antagonists. In contrast, S-zacopride was found to 
mimiek the 5-HT-induced 5-HTip receptor-mediated slow depolarization (EC50 = 
1 uM). This effect to S-zacopride was sensitive to 5-HT desensitization and to 
inhibition by renzapride and 5-HTP-DP, suggesting s-zacopride is a 5-HTip 
receptor agonist (Wade et al, 1991). Slow depolarization responses due to 5-HTip 
receptor stimulation by 5-HT of benzamides were not inhibited by tropisetron up 
to 10 uM, a concentration which blocks 5-HT3 as well as 5-HT4 receptors (Wade & 
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Gershon, 1991). Hence, whereas S-zacopride is a 5-HTip receptor agonist, 
R-zacopride, cisapride and renzapride act as antagonists on 5 - H T I P receptors. 
Is there a relation between the effects of the benzamides on 5-HTip receptors 
and gastrointestinal prokinetic activity in vivo? Mawe et al. (1989) found renza-
pride, a 5-HT3/5-HT1P receptor antagonist and a 5-HT4 receptor agonist, to 
enhance the rate of gastric emptying, but not the transit through the small intes-
tine of a 51Cr-labeled meal of conscious mice. In contrast, tropiserron in a 5-HT3 
receptor blocking dose did not accelerate gastric emptying, but the 5 - H T I P recep-
tor antagonist 5-HTP-DP did. From these results the authors concluded that 
antagonism of 5-HTip receptors caused the acceleration of gastric emptying 
(Mawe et al, 1989). However, 5-HTP-DP (a dipeptide) might be metabolized to 
5-hydroxytryptophan or other products, causing acceleration of gastric emptying 
through a non-5 HTip mechanism (Banner et ah, 1993). Moreover, at the time, 
5-HT4 receptors were not yet known. Furthermore, electrophysiology of 
myenteric neurons and thus of 5-HTip has always been done in guinea-pig ileum 
and stomach, and is not necessarily relevant for gastrointestinal motility in the 
mouse. Thus, these results do not convince that 5-HTip receptors are important 
in the prokinetic action of benzamides. 
Propulsion of a solid pellet in isolated guinea-pig distal colon was inhibited by 
5-HTP-DP (IC50 = 30 uM), renzapride and tropisetron (IC50 = 5 uM), but not by 
R-zacopride and granisetron. From these observations the authors concluded that 
5 - H T I P receptor and 5-HT4 receptors participate in mediating the peristaltic reflex 
in vitro (Wade & Gershon, 1991). However, the extremely high concentration of 
5-HTP-DP, necessary to inhibit the reflex raises questions as to its specificity for 
5 - H T I P receptors. Furthermore, like renzapride, R-zacopride was reported by the 
same authors to be a 5 - H T I P receptor antagonist (Wade et al, 1991), but in 
contrast to the 5 H T I P receptor antagonist 5-HTP-DP, it did not affect propulsion. 
Thus, the arguments for involvement of a 5-HTjp receptor mechanism are weak. 
Buchheit & Buhl (1993) tested the effects of the 5 - H T I P receptor agonist 6-OHIP 
(Mawe et al, 1986) on the peristaltic reflex of the guinea-pig ileum, using the 
Trendelenburg technique. However, 6-OHIP had no effect up to 10 uM (Buchheit 
& Buhl, 1993), suggesting a lack of importance of 5-HTip receptors in this 
response. 
Interactions with 5-HT4 receptors and post-receptor mechanisms 
Although direct electrophysiological actions to 5-HT on enteric neurons such 
as depolarization, hyperpolarization and change in membrane conductance have 
been found to be due to 5-HT3, 5 - H T I A and 5 - H T I P receptor stimulation, no such 
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direct effects due to 5-HT4 receptor stimulation have been observed to date. 
Tonini et al. (1989) showed, that cisapride (10 nM - 1 uM) can enhance the fast 
cholinergic EPSPs after fiber tract stimulation recorded from S neurons. Pan and 
Galligan (1994) found that not only cisapride, but also renzapride, 5-MeOT and 
the 5-HT4 receptor agonist BIMU 8 amplified the electrical stimulation-evoked 
cholinergic EPSPs. Furthermore, tropisetron (1 uM) but not ondansetron (1 uM) 
could inhibit the potentiating effects of these compounds (Tonini et al., 1989; Pan 
and Galligan, 1994). These results strongly suggest that 5-HT4 receptors are 
present on the enteric nerves, whose stimulation causes an increase in 
acetylcholine release. This observation parallels the observation made in 
functional models of the guinea-pig gut, as described before. 
5-HT4 receptors in mouse colliculi neurons, guinea-pig hippocampal mem-
branes, rat oesophagus and in human heart and frontal cortex have been shown 
to be positively linked to adenylate cyclase (Dumuis et al, 1988; Bockaert et al, 
1990; Kaumann et al, 1990; Ford et al., 1992; Monferini et al, 1993). Stimulation 
of enteric 5-HT4 receptors in association with cholinergic facilitation has been 
reported from preliminary experiments to involve cAMP and K+ channels (Yau 
& Youther, 1993). In mouse colliculi neurons, stimulation of 5-HT4 receptors 
inhibited K+ current via activation of a cyclic AMP-dependent protein kinase 
(Fagni et al, 1992). Extrapolating, such an action on K+ current could cause a slow 
membrane depolarization as shown after 5-HT4 receptor stimulation in rat 
hippocampal pyrimidal CA1 neurons (Andrade & Chaput, 1991). An elevation of 
cAMP levels in the cell has been shown to mimiek slow synaptic excitation and 
an enhanced excitability in myenteric neurons of the guinea-pig (Nemeth et al, 
1986; Palmer et al, 1986). However, in most electrophysiological studies on 
myenteric neurons, cisapride, renzapride and BIMU 8 did not have an effect on 
the membrane potential up to 1 uM (Tonini et al, 1989; Mawe et al, 1989; Pan & 
Galligan, 1994). Metoclopramide, cisapride and renzapride slightly depolarized (< 
10 mV) some cells in other studies but it was not verified whether this was due 
to 5-HT receptor stimulation (Nemeth et al, 1985; Nemeth & Gullikson, 1989). 
R-Zacopride never caused more than 2 mV depolarization in AH/type II neurons 
in the study by Wade et al. (1991). Thus, it has been postulated, but not proven, 
that at least the majority of the 5-HT4 receptors are not located on the soma, 
where the membrane potential is measured, but rather on the processes or nerve 
terminals (see: Tonini et al, 1991). 
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Smooth muscle effects 
It has been reported that part of the contraction to cisapride on the isolated 
guinea-pig colon is caused by a direct action on the smooth muscle without 
involvement of 5-HT receptors (Nakayama et al, 1985; Schuurkes et al, 1985b; 
Briejer et al, 1993b). Den Hertog & Van den Akker (1986) studied the effects of 
cisapride on smooth muscle preparations of the taenia coli, both mechanically 
and with the sucrose-gap method. Cisapride caused depolarization, enhancement 
of spike activity, increase in muscle tone and potentiation of the contraction 
evoked by transmural electrical stimulation. These effects were only partially 
inhibited by atropine and TTX. Inhibitory junction potentials represented by 
hyperpolarization and the rebound response were also enhanced. It was 
concluded from these and other observations, that cisapride inhibits calcium 
extrusion from the smooth muscle cells by a direct action, leading to depola-
rization and thus to enhanced excitability (Den Hertog & Van den Akker, 1986). 
Using glass intracellular microelectrodes impaled on guinea-pig stomach circular 
smooth muscle, cisapride was found to cause a depolarization of the smooth 
muscle membrane (Ohno et al, 1993). These electrophysiological actions on the 
smooth muscle of cisapride could well parallel the mechanical effects described 
above (Nakayama et al, 1985; Schuurkes et al, 1985b; Briejer et al, 1993b). In 
contrast to the above described observations with cisapride on guinea-pig 
intestinal smooth muscle, renzapride did not affect the membrane potential of 
circular smooth muscle cells of the guinea-pig ileum (King & Sanger, 1992). 
Hasler et al (1991) observed that cisapride contracts isolated smooth muscle 
cells from the guinea-pig stomach. From their results they concluded that these 
effects could be mediated by glandular M2 cholinoceptors (currently called M3 
cholinoceptors) linked to the calcium-phosphoinositide pathway. However, the 
relative ineffectiveness of atropine against the cisapride-induced contraction of 
the isolated smooth muscle cells undermines these conclusions. It is unclear 
how these results relate to the findings, as described above. 
Thus it is clear that cisapride has direct stimulating effects on gastrointestinal 
smooth muscle tissue. It is however unclear how these effects are induced, and 
whether they are relevant for its prokinetic effects. The sensitization to direct 
smooth muscle contracting agonists after metoclopramide and cisapride, as 
previously described, might be related to a partial depolarization of the smooth 
muscle by these benzamides. 
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Radioligand binding studies 
An overview of binding affinities of several benzamides for binding sites of 
5-HT and other endogenous neurotransmitters is given in Table 1.4. The recent 
development of the selective and highly potent 5-HT4 receptor antagonists 
GR113808 and SB 207710 has allowed the development of a 5-HT4 receptor radio-
ligand binding assay (Brown et al, 1993a; Grossman et al, 1993). The benzamides 
displaced [3H]-GR 113808 and [125I]-SB 207710 binding on 5-HT4 sites in guinea-pig 
and piglet brain with affinities varying from pKj = 5.5 to 7.7. Also in this kind of 
studies, benzamides such as cisapride, SC 53116 and renzapride are more potent 
than metoclopramide. Most benzamides also bind with moderate to high 
potency at 5-HT3 receptor sites (see Tables 1.3 and 1.4). Cisapride, but not the 
other benzamides listed in Table 1.4, has repeatedly been reported to bind with 
high affinity at 5-HT2A receptor sites, and also in functional studies it behaved as 
a potent 5-HT2A receptor antagonist (Moriarty et al, 1987). As other benzamides, 
such as zacopride, renzapride and SC-53116 lack affinity for 5-HT2A receptors, 
5-HT2A receptor antagonism cannot be the common property to explain the 
prokinetic effects of the benzamides. Similar observations can be made with 
respect to affinity for 5 - H T I A binding sites. Also in electrophysiological experi-
ments, cisapride had detectable (micromolar) affinity for these sites whereas 
renzapride had no affinity (see paragraph on 5 - H T I A receptors). For adrenergic 
binding sites the benzamides lack affinity, except for cisapride, which binds to 
cci-adrenoceptors. Clebopride binds potently at dopamine D2 receptors, while 
cisapride and metoclopramide have only moderate affinity. Binding at other sites 
(histamine, acetylcholine and opioid binding sites) is low as far as data are 
available (see Table 1.4). 
In rabbit ileum, [3H]-5-HT binding was not affected by 5-MeOT, but it was 
inhibited by the 5-HTip receptor antagonist 5-HTP-DP (Takaki et ai, 1985). In the 
similar preparation, also the 5-HTip receptor agonist [3H]-5-OHIP bound with 
high affinity, and this binding could be displaced by 5-HT, 2-Me-5-HT, and 5-HTP-
DP, but not by 5-MeOT or tropisetron (Ki > 500 nM) (Branchek et al, 1988). In 
guinea-pig small intestinal preparations, similar results have been obtained 
(Mawe et al, 1989). Furthermore, it has been shown that renzapride (up to 
50 uM), and R- and S-zacopride do not affect [3H]-5-HT binding (Mawe et al, 1989; 
Wade et al, 1991). However, radioautography studies showed that [3H]-zacopride 
binds at specific sites in guinea-pig, rat and rabbit intestine. An effective displacer 
of this [3H]-zacopride binding was renzapride, while tropisetron and 5-HTP-DP 
were partially effective. In the presence of tropisetron, R- and S-zacopride and 
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renzapride still caused inhibition of [3H]-zacopride binding, but 5-HTP-DP did not 
(Wade et al, 1991). These results suggest that in the gut, with respect to the 
compounds used, at least two binding sites exist. Firstly, binding sites are present 
which recognize 5-HT, 5-HTP-DP and 5-OHIP, but not tropisetron and 5-MeOT, 
suggesting that these sites correspond to 5-HTip rather than to 5-HT4 receptors. 
The benzamides do not bind on these 5 - H T I P sites. Secondly, binding sites are 
present which selectively recognize benzamides such as renzapride and the 
stereoisomers of zacopride. These sites do not recognize 5-HT or tropisetron, and 
therefore, these sites are specific benzamide sites, which after occupation prevent 
binding at 5-HTip sites. 
In mouse colliculi neurons, Bockaert and coworkers (1991) showed that 
[3H]-renzapride binding could be inhibited by the benzamides R 76186, metoclo-
pramide and zacopride, confirming that also in these cells benzamide binding 
sites are present. As in the gut, 5-HT and 5-MeOT could not displace 
[3H]-renzapride binding, though the benzimidazolone 5-HT4 receptor agonist 
BIMU 8 displaced [3H]-renzapride binding partially, suggesting that renzapride 
binds on at least two binding sites. In contrast to the findings described above 
with [3H]-zacopride binding in the gut, in the mouse colliculi neurons 
[3H]-renzapride binding could be inhibited by tropisetron but not by 5-HT3 recep-
tor antagonists (Bockaert et ah, 1991). Hence, in mouse colliculi neurons benza-
mides and 5-HT bind to different binding sites, though functional effects 
(elevation of cAMP levels) can both be inhibited by micromolar concentrations 
of tropisetron. These two sites could both be subsites of the 5-HT4 receptor, and 
occupation of either site might activate the second messenger system. The 5-HT4 
receptor antagonists tropisetron, DAU 6285 and SDZ 205557 have been shown to 
be competitive antagonists against 5-HT-induced responses in several tissues. 
However, against benzamide-induced responses in some reports non-competi-
tive inhibition has been described (Elswood et al, 1991; Buchheit et al, 1992; 
Briejer et al, 1993b). These observations could be explained with 5-HT and 
benzamides not binding on the same site of the 5-HT4 receptor molecule. 
50 Chapter 1 
Table 1.4 Receptor binding affinities (pKj) as obtained from radioligand displacement studies on 
5-hydroxytryptamine (5-HT) binding sites. 
cisapride 
metoclopramide 
renzapride 
R,S-zacopride 
R-zacopride 
S-zacopride 
SC-53116 
clebopride 
5-HT1A 5-HT1B 5-HT1D 5-HTi 5-HT2A 5-HT2C 5-HT3 5-HT4 
8.3 6.8 7.5 
6.9 7.5 
<5 8.2 6.9 
7.2/7.5 
8.6 5.6 
5.3 8.1 5.8 
6.1 <5* <5* 8.6 5.8 6.4 
7.2 
6.4 6.0 
6.9 6.0 
6.2/6.3 
<5 6.0 6.6 
5.5 
8.6 6.9 
<5 <5 8.3 
<5 <5 <5 <5 <5 8.4 
6.9/7.0 
6.2 
9.2 6.1 
9.5 6.4 
<5 <5 <5 <5 5.9 9.3 
6.7/6.8 
8.8 5.7 
<5 6.3 8.1 
6.0/6.3 
10.0 6.5 
<5 <5 9.6 
6.6/6.7 
<5 <5 6.8 
7.3 7.7 
6.7 
ref 
1 
2 
5 
6 
7 
9 
10 
11 
3 
2 
6 
9 
11 
2 
5 
4 
6 
11 
3 
2 
4 
6 
2 
5 
6 
2 
5 
6 
5 
2 
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Table 1.4 (Continued) Receptor binding affinities (pKj) as obtained from radioligand displacement 
studies on respectively adrenergic, dopamine, histamine, acetylcholine and opioid binding sites. 
cisapride 
metoclopramide 
renzapride 
R,S-zacopride 
R-zacopride 
S-zacopride 
SC-53116 
clebopride 
d i OC2 ß 
8.0 
7.5 5.3 <5 
7.4 < 5* < 5* 
D-\ D2 hh ACh U. 
6.7 
5.8 6.6 
6.6 
<5* 7.0 5.9 <5* 5.9 
6.8 
<5 <5 <5 
<5 < 5 <5 
<5 <5 < 5 
<5 <5 < 5 
<5 <5 <5 
<5 <5 <5 
5.8 6.1 
<5 <5 
< 5 < 5 <5 
<5 <5 <5 
<5 <5 
<5 <5 
<5 <5 
<5 8.5 <5 <5 <5 
ref 
1 
5 
9 
10 
9 
5 
4 
4 
5 
5 
5 
8 
*plC5o value instead of pKj value. References: (1) Rizzi era/., 1994; (2) Schiavi era/., 1994; (3) 
Langlois et ai, 1994; (4) van Wijngaarden et al., 1990; (5) Flynn era/., 1992; (6) Grossman era/., 1993; 
(7) Leysen, 1990; (8) Takeda era/., 1991; (9) Linnik et ai, 1991; (10) Heylen et ai, 1992; (11) Brown 
et ai, 1993a. 
In rat brain, and later also in human brain, but also in the gastrointestinal 
tract (and many other tissues), high affinity R-zacopride binding sites have been 
found which do not recognize S-zacopride, and which do not represent 5-HT3 
binding sites (Kidd et al, 1992; 1993). [3H]-R-zacopride binding could not be inhib-
ited by 5-HT, dopamine, histamine, noradrenaline, and many other 
(neurotransmitter) compounds. Hence, this 'R-site' does not seem to be related to 
a known neurotransmitter receptor. Only prazosin and mianserin showed 
moderate affinity for the 'R-site' (Kidd et al, 1992; 1993). Unfortunalely, no data 
with respect to displacement of [3H]-R-zacopride binding by other prokinetic 
benzamides are available. It is therefore difficult to evaluate the pharmacological 
and therapeutical relevance of the 'R-site' binding. 
Conclusions and unsolved issues 
Though the first generation benzamides, i.e. metoclopramide, bromopride 
and clebopride, are antagonists of peripheral dopamine D2 receptors, the second 
generation benzamides (i.e. cisapride, renzapride) have only moderate or no 
affinity for these sites. Antagonism at D2 receptors is not likely to explain in 
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general the gastrointestinal motility-stimulating action of benzamides. Most 
benzamides share moderate to high affinity for 5-HT3 receptors, acting as antago-
nists. Also this property is very unlikely to account for their prokinetic effects, 
although it might contribute in some species, e.g. the rat. Benzamides have been 
shown to facilitate cholinergic transmission by causing an increase in acetyl-
choline release in the guinea-pig enteric nervous system, though a similar action 
could not be found in the rat. In this species, 5-HT4 receptors on the intestinal 
smooth muscle cells mediate relaxation in contrast to the situation in the 
guinea-pig where 5-HT4 receptors on the enteric nerves mediate (cholinergic) 
contraction. As benzamides are moderate affinity agonists at these receptors, 
facilitation of cholinergic transmission has been shown to be due to agonism at 
the 5-HT4 receptors in the guinea-pig. Despite the above mentioned species 
differences between the rat and guinea-pig, benzamides have been shown to 
stimulate motility in guinea-pigs and also seem to do so in the rat, although in 
the latter species data are scarce. Therefore it is encouraged that more in vivo 
studies in the rat are conducted. 
In the dog, and also in man, benzamides seem to enhance gastric emptying 
and gastroduodenal motility through stimulation of neuronal 5-HT4 receptors 
on cholinergic nerves. It has to date not yet been established whether the increase 
in lower oesophageal sphincter pressure after cisapride is due to neuronal 5-HT4 
receptor stimulation. Although for the dog no data on the effects of benzamides 
on lower gut motility are available, in man cisapride stimulates colonic motility 
and is moderately effective in constipation. However, smooth muscle but no 
neuronal 5-HT4 receptors have been found in the isolated human colon, causing 
inhibition of spontaneous movements and relaxation through an acetylcholine-
independent mechanism. Similar in vitro results have been obtained with other 
benzamides as well. A mechanism additional to 5-HT4 receptor agonism is 
necessary to explain the observations on lower gut motility in patients. 
Facilitation of non-cholinergic transmission, of which only few data exist, 
would be a direction worthwhile to explore. Contractions to exogenous 
neurotransmitter substances, especially to acetylcholine and histamine, have in 
several tissues been found to be amplified by benzamides, although very high 
(non-therapeutic) concentrations were often necessary. Nevertheless, more 
investigation into these phenomena may prove worthwhile. Benzamides inter-
fere with the putative 5-HTip receptors, but a role for these receptors in gastro-
intestinal motility has to be convincingly demonstrated yet. Several lines of 
evidence suggest that the 5-HT4 receptor has separate binding sites for 5-HT and 
related indoles on one hand and benzamides on the other hand. More investiga-
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tion into the exact interrelations between these sites and 5-HTip receptors would 
be interesting. In relation to this, the exact location and alterations in cellular 
function after stimulation of these receptors should be determined. Lastly, direct 
effects on the smooth muscle need clarification. 
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Abstract. It was investigated which 5-hydroxytryptamine (5-HT) receptors mediate the responses 
to 5-HT in the longitudinal muscle layer of the guinea-pig proximal colon, using selective 5-HT 
receptor antagonists and the 5-HT analogues a-methyl-5-HT (a-Me-5-HT), 2-methyl-5-HT (2-Me-
5-HT), and 5-methoxytryptamine (5-MeOT). 
5-HT as well as its analogues induced concentration-related contractions, at low concentrations 
preceded by relaxations. The 5-HT concentration-contractile response curve was biphasic whilst 
the curves to a-Me-5-HT, 2-Me-5-HT, and 5-MeOT were monophasic. Tetrodotoxin (TTX) abolished 
the relaxations, and it inhibited the contractions to all agonists. In the presence of TTX, blockade of 
either 5-HT2 (ketanserin) or 5-HT3 receptors (ondansetron, tropisetron) reduced the contractions to 
5-HT, whereas blockade of both 5-HT receptor types at the same time abolished them. In the 
absence of TTX, the contractions to 5-HT were inhibited by antagonists at 5-HT2 (ketanserin), 5-HT3 
(granisetron, nanomolar concentration of tropisetron) and also 5-HT4 receptors (micromolar 
concentration of tropisetron). Contractions to a-Me-5-HT did not seem to be sensitive to 5-HT2 
receptor blockade with ketanserin, but in the presence of TTX the contractions were abolished by 
the 5-HT2 receptor antagonist. The 5-HT3 receptor antagonist granisetron abolished contractions to 
2-Me-5-HT. In the presence of TTX, the 5-HT2 receptor antagonist ketanserin abolished contractions 
to 5-MeOT, and in the absence of TTX the contractions to 5-MeOT were highly sensitive blockade of 
5-HT4 receptors with tropisetron. Blockade of either 5-HTi (methiothepin), 5-HT2 (ketanserin), 
5-HT3 (ondansetron, granisetron, tropisetron) or 5-HT4 (tropisetron) receptors did not abolish the 
relaxations to 5-HT or 5-MeOT. 
Conclusions: 5-HT induces contractions of the longitudinal muscle of the guinea-pig proximal 
colon, through the stimulation of 5-HT2 receptors on the smooth muscle cells and 5-HT3 receptors 
and putative neuronal 5-HT4 receptors. 5-HT evokes relaxations via an unknown neuronal receptor. 
Introduction 
5-Hydroxytryptamine (5-HT) is stored in high concentrations in the entero-
chromaffin cells of the mucosa, from which it might be released by applying 
pressure to the mucosa. 5-HT is a neurotransmitter in the enteric nervous 
system, and is involved directly and indirectly in the regulation of motility 
(Gershon & Erde, 1981; Furness et al, 1988; Gershon et al, 1989). In the guinea-pig 
proximal colon, the presence of 5-HT has been immunohistochemically demon-
strated in neurons of the myenteric plexus (Legay et al, 1984). In colonic prepara-
tions, 5-HT induces both relaxations and contractions (Costa & Furness, 1979; 
Kojima & Shimo, 1986), but it is not known which receptors mediate these 
responses to 5-HT. Many types of 5-HT receptors have been demonstrated to exist 
in different tissues of several animal species and man. A classification of 5-HT 
receptors into 5-HTi, 5-HT2 and 5-HT3 receptors is established (Bradley et al, 
1986). Recently, Dumuis and co-workers (Dumuis et al, 1988), from their work 
on mouse embryo colliculi neurons, proposed to add yet another, new 5-HT-
receptor type to the 5-HT receptor classification scheme, logically to be designated 
5-HT4 receptor (Bockaert et al, 1992). 
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The aim of this study was to gain more insight into which types of 5-HT 
receptor are involved in the action of 5-HT on the guinea-pig proximal colon. 
We therefore investigated the responses to 5-HT and its analogues, oc-methyl-
5-HT (a-Me-5-HT, 5-HT2 receptor agonist), 2-methyl-5-HT (2-Me-5-HT, 5-HT3 
receptor agonist), and 5-methoxytryptamine (5-MeOT, 5-HT4 receptor agonist), in 
the absence and presence of various selective 5-HT receptor antagonists and/or 
tetrodotoxin (TTX) to eliminate nerve-mediated responses (Gershon, 1967). 
Methods and materials 
Tissue preparation 
Dunkin-Hartley guinea-pigs of either sex, weighing 400-600 g, were killed by 
decapitation. The proximal colon was removed, and the luminal contents were 
washed out with De Jalon's solution (composition in mM: KCl 5.6, CaCl2 0.5, 
NaHCC>3 6.0, NaCl 155, glucose 2.78). Starting at the proximal end, about 1 cm 
distal to the caecum, the colon was divided into 4 segments of 3 cm. These intact 
segments were individually mounted vertically into an organ bath containing 20 
ml De Jalon's solution for isotonic measurement of longitudinal muscle 
responses. This solution was kept at 37 °C and gassed with carbogen (95% O2, 5% 
CO2). The strips were subjected to a preload of 2 g and allowed to stabilize for half 
an hour. After stabilization, the contraction to methacholine (0.3 uM) was 
measured. The measurement was repeated after washing (i.e. replacing the 
bathing fluid twice) and stabilization until the response to methacholine 
remained constant (usually 3 times). The mean of the last two responses was 
taken as 100%. The bathing fluid was replaced after 30 min at most. 
Establishment of concentration-response curves 
Agonists and antagonists were applied directly to the organ baths. Non-cumu-
lative concentration-response curves were constructed with a 15 min dosing 
cycle. Agonist concentration series 10 nM, 30 nM, 0.1 uM, 0.3 uM, etc. were 
applied in ascending order. The preparations were preincubated with antagonists 
for 15 min, thus fitting into the 15 min agonist dosing cycle. The maximum 
amplitude of the contractions was measured, and agonists were washed out as 
soon as the peak responses were reached; contact with the tissue was 2 min at 
most. When biphasic responses occurred (relaxation preceding a contraction), the 
maximal contraction was measured from the base line (before the agonist was 
added) to the highest point of contraction, even if the contraction height was 
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negative as compared to baseline. This manner of quantification of contractions 
was chosen since the relaxatory component in the action of 5-HT was variable 
between different preparations. All measurements were expressed as a percent-
age of the methacholine-induced contractions. For each preparation, only one 
concentration-response curve was established. 
Compounds 
Solutions of ketanserin tartrate, 2-methyl-5-hydroxytryptamine tartrate 
(Janssen Pharmaceutica, Belgium), 5-methoxytryptamine HCl (Janssen Chimica, 
Belgium), a-methyl-5-hydroxytryptamine maleate (Cookson Chemicals Ltd., 
UK), methiothepin maleate (Hoffman-La Roche, Switzerland), methacholine 
HCl (E.Merck, Germany), tropisetron HCl (Sandoz, Switzerland), ondansetron 
(Glaxo, United Kingdom), granisetron HCl (Beecham, United Kingdom), 
5-hydroxytryptamine HCl and tetrodotoxin (Serva, Germany) were added to the 
organ bath solution in volumes less than 1% of the bath volume. All 
compounds were dissolved in distilled water, except for 5-HT (stock containing 
ascorbic acid (0.25 uM). The vehicle had no effect on the tone of the muscle. 
None of the above antagonists had an intrinsic effect, except for TTX (0.3 uM) 
and tropisetron (3 |iM), which caused contractions of about 19 % and 6 % respec-
tively of (0.3 uM) methacholine-induced contractions. None of the antagonists 
inhibited the contractions to methacholine (0.3 (AM), except for tropisetron 
(3 uM), which caused a significant (P < 0.05) inhibition of about 10 %. The stock 
solution of TTX was prepared in advance and kept frozen (-25 °C) in aliquots of 
0.1 mM. 
Statistical analysis 
For graphical representation means ± standard error of the means were calcu-
lated. Differences between mean values were tested with one way analysis of 
variance using the Scheffé F-test (comparison treatment vs. treatment) or 
Dunnett's t-test (treatment vs. control) (Wallenstein et al, 1980). The level of 
significance was set at P < 0.05. 
Results 
5-Hydroxytryptamine 
5-HT concentration-dependently induced both relaxations and contractions 
(10 nM - 30 uM) as exemplified in Figure 2.1. The observed relaxations were 
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variable in magnitude (but always less than 20 % of the methacholine-induced 
contractions), and they were masked by the contractions in the higher 5-HT 
concentration region (Figure 2.1). The concentration-response curve for the 
contractile effect of 5-HT appeared biphasic (Figure 2.2) with a maximum effect of 
112 ± 7 % at 30 uJVI 5-HT (n = 12). 
0.2 cm L 
2 min 
À 
0.01 
1 
A 
0.3 
A 
A 
3 
i 
10 
A 
30 uM 
Figure 2.1 Tracing of responses induced by increasing concentrations of 5-hydroxytryptamine. 
5-Hydroxytryptamine induced contractions as well as relaxations in the lower concentration region, but 
only contractions in the high concentration region. 
TTX (0.3 (J.M) greatly affected the responses to 5-HT (n = 6). In the presence of 
TTX, 5-HT-induced relaxations were abolished (not shown). TTX reduced the 
contractile response to 5-HT from 30 nM onwards (Figure 2.2). TTX 1 \iM and 
TTX 3 |iM reduced the contractions to 5-HT 1 uJVI to a similar extent as did TTX 
0.3 uM (n = 6, results not shown), indicating that 0.3 |xM TTX is sufficient to 
eliminate TTX-sensitive responses. In the presence of TTX (0.3 u,M), 
ondansetron (3 u,M; n = 6) and tropisetron (0.3 uJM; n = 6) reduced the contrac-
tions to 5-HT (> 3 u,M) even more as compared to the inhibition by TTX alone 
(Figure 2.2, left panel). In the presence of TTX, ketanserin (0.3 uM; n = 6) 
inhibited 5-HT-induced contractions completely at concentrations of 5-HT < 
1 |iM. At concentrations of 5-HT > 3 |iM, the 5-HT-induced responses were 
inhibited by ketanserin, as compared to the TTX control curve (Figure 2.2, right 
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panel). In the presence of TTX, ketanserin (0.3 u_M) in combination with 
tropisetron (0.3 u,M; n = 6) (Figure 2.2, right panel) or granisetron (0.3 uJvl; n = 4, 
not shown) abolished the 5-HT-induced responses. 
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Figure 2.2 The concentration-response curve to 5-HT in the absence of antagonists (O), and in the 
presence of TTX (0.3 \iM) (•) , TTX (0.3 |xM) + ondansetron (3 nM) (•), TTX (0.3 uM) + tropisetron 
(0.3 uM) (A), TTX (0.3 uM) + ketanserin (0.3 uM) (O), and a combination of TTX (0.3 uM), ketanserin 
(0.3 uM) and tropisetron (0.3 uM) (A). All data were expressed as mean values ± s.e.m (n = 4-12) rela-
tively to methacholine (0.3 uM)-induced responses. 
Tropisetron and granisetron (both 0.3 uM; n = 6-8) significantly (P < 0.05) 
reduced the contractions to 5-HT > 1 uM (i.e. the second phase of the concentra-
tion-response curve, Figure 2.3, left panel). At a concentration of 3 uM 
tropisetron (n = 6), the contractions to 5-HT were even further reduced (Figure 
2.3, left panel). The inhibition of the 5-HT-induced contractions by tropisetron 
3 uJvI was significantly (P < 0.05) different from that by tropisetron 0.3 u,M up to 
10 u,M 5-HT. Ketanserin (0.3 u,M; n = 6) depressed the concentration-response 
curve of 5-HT at concentrations of 5-HT > 0.1 (i,M (Figure 2.3, right panel). When 
the strips were preincubated with both ketanserin (0.3 u,M) and granisetron 
(0.3 u,M) (n = 6), 5-HT-induced contractions were inhibited at 10 uM 5-HT as 
compared to the contractions in the presence of ketanserin alone. A combination 
of ketanserin (0.3 |iM), granisetron (0.3 |xM) and tropisetron (3 uJvl) (n = 4) 
inhibited 5-HT-induced responses from 30 nM onwards as compared to 5-HT 
control (Figure 2.3, right panel). The inhibition of the contractions to 5-HT in the 
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range 0.1 |iM - 1 uJVI by the combination of ketanserin, granisetron and 
tropisetron differed significantly (P < 0.05) from the inhibition by the combina-
tion of ketanserin and granisetron without tropisetron. Neither one of the anta-
gonists mentioned above, nor methiothepin (0.1 uM; n = 6) abolished the relax-
ations that were induced by 5-HT (not shown). 
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Figure 2.3 The concentration-response curve to 5-HT in the absence of antagonists (O), and in the 
presence of granisetron (0.3 uM) (•), tropisetron (0.3 uM) (A) and (3 uM) (•), ketanserin (0.3 uM) 
(A), ketanserin (0.3 uM) + granisetron (0.3 uM) Iß), and a combination of ketanserin (0.3 \LM), 
granisetron (0.3 uM) and tropisetron (3 uM) (Y). All data were expressed as mean values ± s.e.m 
(n = 4-12) relatively to methacholine (0.3 |xM)-induced responses. 
a-Methyl-5-hydroxytryptamine 
(Figure 2.4) a-Me-5-HT induced both relaxations and contractions from 
0.1 u,M onwards. The concentration-response curve for the contractile effect of 
a-Me-5-HT appeared monophasic (n = 6). Again, TTX (0.3 uM; n = 6) abolished 
the relaxant component of the effect of a-Me-5-HT, but it only significantly 
(P < 0.05) inhibited the contractions to 10 uM a-Me-5-HT. Ketanserin (0.3 uM; 
n = 6) did not significantly (P > 0.05) affect the contractions to oc-Me-5-HT. 
However, in the presence of TTX, ketanserin (n = 6) abolished the responses to 
a-Me-5-HT (significant at 3 uM and 10 |oM as compared to control, significant at 
10 u,M as compared to the contractions in the presence of TTX (P < 0.05). Neither 
one of the antagonists mentioned above abolished the relaxations that were 
induced by oc-Me-5-HT (not shown). 
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2-Methyl-5-hydroxytryptamine 
(Figure 2.5) 2-Me-5-HT induced both relaxations and contractions from 3 \iM 
onwards. The concentration-response curve of the contractile effect of 2-Me-5-HT 
appeared monophasic, with a maximum at 30 uM (n = 4). TTX (n = 4) abolished 
the relaxations, and it inhibited the contractions to 2-Me-5-HT from 10 uM 
onwards. Granisetron (0.3 U.M; n = 4) alone and in the presence of TTX (n = 4), 
abolished the contractions to 2-Me-5-HT (significantly (P < 0.05) as compared to 
control from 10 |iM onwards, as compared to the contractions in the presence of 
TTX at 10 U.M and 30 uM). Neither one of the antagonists mentioned above 
abolished the relaxations that were induced by 2-Me-5-HT (not shown). 
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Figure 2.4 The concentration-response curve to a-Me-5-HT in the absence of 
antagonists (O), and in the presence of ketanserin (0.3 uM) (A), TTX (0.3 u.M) (•) . 
and TTX (0.3 uM) + ketanserin (0.3 uM) (•). All data were expressed as mean values 
± s.e.m (n = 6) relatively to methacholine (0.3 |iM)-induced responses. 
5-Methoxytryptamine 
(Figure 2.6) Like the other tryptamines tested, 5-MeOT induced both 
relaxations and contractions from 30 nM onwards. The concentration-response 
curve for the contractile effect of 5-MeOT appeared monophasic, the maximum 
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response occurred at 3 uM 5-MeOT (47 ± 3 %; n = 12). TTX (0.3 uM; n = 14) 
abolished the relaxations and inhibited the contractions to 5-MeOT. The concen-
tration-response curve to 5-MeOT in the presence of TTX 0.3 |iM coincided with 
that in the presence of TTX 1 uM (n = 6; not shown). In the presence of TTX, 
tropisetron (3 uM; n = 6) did not significantly (P > 0.05) inhibit the contractions to 
5-MeOT any further as compared to the TTX curve (Figure 2.6, left panel). 
However, in the absence of TTX, tropisetron (n = 6) strongly inhibited the 
contractions to 5-MeOT (Figure 2.6, left panel). Ketanserin (0.3 uM; n = 6) 
inhibited the contractions to 5-MeOT in the concentration range 1 - 1 0 uM 
(Figure 2.6, right panel). In the presence of TTX, ketanserin (n = 4) abolished the 
contractions to 5-MeOT (Figure 2.6, right panel). Neither one of the above 
mentioned antagonists, nor methiothepin (0.1 uM), abolished the 5-MeOT-
induced relaxations. 
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Figure 2.5 The concentration-response curve to 2-Me-5-HT in the absence of 
antagonists (O), and in the presence of granisetron (0.3 \M) (•), TTX (0.3 |iM) (•) , 
and TTX (0.3 u.M) + granisetron (0.3 p.M) (A). All data were expressed as mean values 
+ s.e.m (n = 4) relatively to methacholine (0.3 nM)-induced responses. 
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Discussion 
The role and function of 5-HT in the gastrointestinal tract is still poorly 
understood. This study on the action of 5-HT on the guinea-pig proximal colon 
shows that 5-HT displays a complex pattern of action. 
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Figure 2.6 The concentration-response curve to 5-MeOT in the absence of antagonists (O), and in 
the presence of TTX (0.3 nM) (•) , tropisetron (3 jiM) (•), TTX (0.3 uM) + tropisetron (3 uM) (A), 
ketanserin (0.3 u.M) (D), and TTX (0.3 uM) + ketanserin (0.3 (xM) (T). All data were expressed as mean 
values ± s.e.m (n = 4-14) relatively to methacholine (0.3 nM)-induced responses. 
The observed relaxations, elicited by the tryptamine analogues, could not be 
inhibited by the following 5-HT-receptor antagonists at the receptor types: 5-HTi 
(methiothepin), 5-HT2 (ketanserin, methiothepin), 5-HT3 (granisetron, ondanse-
tron, tropisetron 0.3 uM) or 5-HT4 (tropisetron 3 uM [Bockaert et al, 1992]). Other 
investigators observed 5-HT-induced relaxations in their preparation of the 
longitudinal muscle of the guinea-pig proximal and distal colon as well, which 
could not be blocked with the 5-HTi-receptor antagonist methysergide (up to 
2.8 uM) (Costa & Furness, 1979; Onori et al, 1984; Kojima & Shimo, 1986). Other 
workers (Kojima & Shimo, 1986; Kojima, 1991), however, studied the 5-HT-
induced relaxations of the guinea-pig proximal colon in more detail, and 
suggested that the relaxations are mediated through 5-HTi receptors. The exact 
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5-HT-receptor subtype via which the relaxations are evoked, needs further inves-
tigation. 
The neurotoxin tetrodotoxin (TTX) eliminates responses mediated by 
nervous structures, as it blocks Na+ channels involved in the propagation of 
action potentials along the axons. Responses to drugs that act directly on the 
smooth muscle are unaffected by TTX (Gershon, 1967). TTX abolished the relax-
ations that were induced by either of the tryptamines, suggesting neuronal 
involvement, which confirms observations of other investigators (Kojima & 
Shimo, 1986; Kojima, 1991; Elswood & Bunce, 1992). Furthermore, in another 
study we have shown that 5-HT induces relaxations through the release of the 
inhibitory putative transmitter nitric oxide (NO) from the intrinsic nerves 
(Briejer et al, 1992). 
The contractions elicited by 5-HT appear to be mediated by several 5-HT recep-
tor types, illustrated by the fact that the concentration-response curve of 5-HT is 
biphasic. TTX inhibited the 5-HT-induced contractions to a considerable extent, 
corresponding to the observations of other investigators (Costa & Furness, 1979; 
Onori et al., 1984; Kojima & Shimo, 1986). These observations suggest that 5-HT 
acts partly via the enteric neurons, and partly directly on the smooth muscle 
cells. 
Tropisetron, ondansetron and granisetron are established selective 5-HT3 
receptor antagonists (Brittain, 1987; Sanger et al, 1988; Sanger & Nelson, 1989). 
2-Me-5-HT is a selective 5-HT3 receptor agonist without appreciable activity at 
5-HT2 or 5-HT4 receptors (Bradley et al, 1987; Craig et al, 1990; Bockaert et al, 
1992). However, it has activity at the rabbit renal artery 5-HTi-like receptor 
(Tadipatri & Saxena, 1992), and in our preparation it induced relaxations, which 
might also be evoked through 5-HTi receptor stimulation (see above). 
Granisetron abolished the contractile response to 2-Me-5-HT. Granisetron, 
ondansetron and tropisetron (0.3 uM) also antagonized the responses to 5-HT. 
Hence, 5-HT3 receptors are present in the guinea-pig proximal colon, as they are 
in the distal colon (Butler et al, 1990). Since the 5-HT3 receptor-mediated contrac-
tions were in part TTX-sensitive, the 5-HT3 receptors are located, at least in part, 
on neurons. The observed inhibition by 5-HT3 receptor antagonists of the 
contractions to 5-HT and 2-Me-5-HT in the presence of TTX, can be explained in 
several ways: a) Part of the response to 5-HT might be mediated by a neurogenic 
but TTX-insensitive mechanism. Such a mechanism might be true if the 5-HT3 
receptors are present on the nerve terminals, or if action potentials are involved 
that utilize Ca2 + influx instead of Na+ influx. The existence of TTX-resistant 
(Ca2+-mediated) action potentials has bee.n demonstrated in myenteric neurons 
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(Hirst & Spence, 1973; North, 1973). In preparations similar to ours, Costa & 
Furness (1979) observed that, in the presence of TTX (0.63 uM), hyoscine was still 
able to inhibit contractions to 5-HT. Hence, under these conditions, stimulation 
of 5-HT receptors still evoked the release of acetylcholine. This observation 
favours the possibility that these phenomena have a neuronal but TTX-insensi-
tive nature, b) 5-HT3 receptors might be located on non-neuronal tissue, i.e. 
directly on the smooth muscle membranes. To date, however, 5-HT3 receptors 
have been found to be exclusively located on neurons (Richardson & Engel, 1986; 
Kilpatrick et ah, 1990). Therefore, this latter hypothesis does not seem very likely. 
c) The applied TTX concentration was insufficient to block neuronally mediated 
responses. This hypothesis must be rejected since it was demonstrated that the 
inhibitory effect against 5-HT and 5-MeOT of TTX 0.3 uM did not differ from the 
effects of TTX 1 uM or 3 uM. Hence, it is proposed that 5-HT3 receptors are 
present in this preparation, which might be partially located on TTX-sensitive 
nerves and partially on nerve terminals or, possibly, on neurons that utilize 
TTX-insensitive mechanisms. 
Ketanserin is known as a selective 5-HT2 receptor antagonist (Van Nueten et 
ah, 1981; Leysen et ah, 1982). In the absence and presence of TTX, ketanserin 
inhibited the 5-HT-induced responses, suggesting that also 5-HT2 receptors are 
involved in the contractions to 5-HT. The presence of 5-HT2 receptors on the 
smooth muscle cells of the guinea-pig ileum has been demonstrated (Engel et ah, 
1984). Thus, the most likely explanation for the observed inhibition of the 5-HT-
induced contractions by ketanserin in the presence of TTX, is that, in the proxi-
mal colon of the guinea-pig, 5-HT2 receptors are present on the smooth muscle. 
a-Me-5-HT is an agonist at 5-HT2 receptors, though it is not very selective, as it 
has considerable activity at 5-HTic and 5-HT4 receptors as well (Richardson & 
Hoyer, 1990; Bockaert et al, 1992; Tadipatri & Saxena, 1992). The contractions to 
a-Me-5-HT were not significantly antagonized by ketanserin, which might be 
explained by a bias due to the considerable relaxations. In the presence of TTX, i.e. 
when the neuronally mediated relaxations are abolished, ketanserin did abolish 
the contractions to oc-Me-5-HT, thus substantiating the proposal that muscular 
5-HT2 receptors are present in this preparation. 
Ketanserin combined with granisetron or with tropisetron (0.3 uM), in the 
presence of TTX, was sufficient to eliminate responses to 5-HT. Since no response 
could be evoked by 5-HT under these conditions, 5-HT2 and 5-HT3 receptors 
appear to be the only types of 5-HT receptor responsible for the effects to 5-HT in 
the presence of TTX. An effect of 5-HT2 or 5-HT3 receptor antagonists against 
responses to 5-HT in the absence of TTX is to be expected, for it was proposed 
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above that muscular 5-HT2 and 5-HT3 receptors on TTX-insensitive neurons are 
present in this preparation. Indeed, ketanserin, granisetron and tropisetron 
(0.3 uM) inhibited 5-HT-induced responses, confirming these proposals. 
Elswood and co-workers (Elswood et al, 1991) demonstrated that 5-HT4 recep-
tors are present in the guinea-pig proximal colon. The results of our study 
support these findings. Blockade of the 5-HT3 receptors with either granisetron 
or tropisetron 0.3 \iM (equipotent at 5-HT3 receptors [Butler et al, 1990]), inhib-
ited the contractions to 5-HT to an equal extent. When the preparations were 
incubated with tropisetron in a ten-fold higher concentration, i.e. a concentration 
of tropisetron that also blocks 5-HT4 receptor mediated responses (pA2 = 6.0-6.7 
[Bockaert et al, 1992]) the contractile responses were abolished, leaving only 
relaxations to occur. Thus the difference in the inhibition by tropisetron 0.3 |AM 
and 3 uM must be due to the elimination of the 5-HT4 receptor mediated contrac-
tions. This hypothesis is supported by a second set of observations. While the 
putative 5-HT4 receptor was pharmacologically isolated through blockade of 
5-HT2 and 5-HT3 receptors by a combination of ketanserin and granisetron, 
tropisetron 3 \iM again potently inhibited the contractions to 5-HT. Since, in the 
presence of TTX, only 5-HT2 and 5-HT3 receptor-mediated responses could be 
demonstrated, it is proposed that only neuronal 5-HT4 receptors are present. 
5-MeOT is an agonist at some 5-HTi receptor subtypes and at 5-HT2 and 5-HT4 
receptors, but lacks activity at 5-HT3 receptors (Leff & Martin, 1988; Craig et al, 
1990; Bockaert et al, 1992; Tadipatri & Saxena, 1992). In the presence of TTX, the 
contractions to 5-MeOT were abolished by ketanserin, confirming the presence of 
postjunctional 5-HT2 receptors. In the absence of TTX, ketanserin apparently was 
not very effective in inhibiting the contractions to 5-MeOT. This could be caused, 
as with a-Me-5-HT (see above), by a bias of the contractile response by the 
concomitant relaxation. In the presence of TTX, 5-HT4 receptor-mediated 
responses of 5-MeOT could not be shown, since the presence of tropisetron 3 uM 
did not result in enhanced inhibition as compared to TTX. However, in the 
absence of TTX, tropisetron 3 uM strongly inhibited the responses to 5-MeOT. 
Thus, also from the results with 5-MeOT, it can be concluded that the guinea-pig 
proximal colon is endowed with neuronal 5-HT4 receptors. 
With electrophysiological techniques, it has been shown that the enteric 
neurons of both the guinea-pig antrum and small intestine are endowed with 
inhibitory 5 - H T I A receptors and putative 5-HTip receptors (Mawe et al, 1986; 
Tack et al, 1992). It is thus quite possible that one or both of these receptors are 
also present on the enteric neurons of the guinea-pig proximal colon. However, 
no experiments with respect to these receptors were done in this study. 
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Conclusions: 5-HT induces contractions of the longitudinal muscle of the 
guinea-pig proximal colon, through the stimulation of 5-HT2 receptors on the 
smooth muscle cells and 5-HT3 receptors and putative neuronal 5-HT4 receptors. 
5-HT-evoked relaxations are mediated via an unknown neuronal receptor. 
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Abstract. The effects of three tachykinin NKi receptor antagonists and a tachykinin NK2 receptor 
antagonist against substance P-induced contractions of the guinea-pig proximal colon longitudinal 
muscle were investigated. Atropine, tetrodotoxin and phosphoramidon did not affect the concentra-
tion-response curve for substance P (pECso = 7.8). The tachykinin NKj receptor antagonist, 
2s,3s-cis-CP 96345, competitively inhibited the contractions due to substance P (pA2 = 8.5; 
constrained pA2 = 8.9), but at higher concentrations (> 0.3 |iM), 2s,3s-cis-CP 96345 also depressed 
the concentration-response curve for methacholine. The species-selective tachykinin NKi receptor 
antagonists, WIN 51708 and WIN 62577 (both 1 |iM), and the tachykinin NK2 receptor antagonist, 
SR 48968 (0.3 (iM), had no effect. It is concluded that substance P induces contractions through the 
stimulation of tachykinin NKi receptors on the smooth muscle cells. In this preparation, 
tachykinin NK2 receptors do not seem to be involved in the contractile action of substance P. 
Introduction 
The endogenous neuropeptide, substance P, a member of the neurokinin 
family, is considered to be a neurotransmitter in the enteric nervous system (see: 
Barthó & Hölzer, 1985). It is most potent at tachykinin NKi receptors, which 
have been found on both neurons and smooth muscle, but it also has activity at 
smooth muscle tachykinin NK2 receptors and tachykinin NK3 receptors on the 
nerves (Barthó & Holzer, 1985; Maggi et al, 1990; Yau et al, 1992). In preparations 
of guinea-pig ileum, the longitudinal muscle is contracted by substance P 
through the stimulation of tachykinin NKi receptors. In the ileum, tachykinin 
NKi receptors are probably mostly located on the smooth muscle, though few of 
the tachykinin NKi receptors may be located on the nerves, inducing the release 
of acetylcholine (Maggi et al, 1990). In the proximal colon circular muscle, 
tachykinin NKi and NK2 receptors are present on the smooth muscle (Santicioli 
et al, 1993), but the tachykinin receptor(s) that mediates the contraction in 
response to substance P on longitudinal muscle preparations has not been 
characterized yet. In order to do so, we investigated the effects of three potent and 
selective non-peptide tachykinin NKi receptor antagonists, CP 96345 (Snider et 
al, 1991), WIN 51708 and WIN 62577 (Appell et al, 1992), and a tachykinin NK2 
receptor antagonist, SR 48968 (Emonds-Alt et al, 1992; Advenier et al, 1992; 
Maggi et al, 1993), against substance P-induced contractions of a guinea-pig 
proximal colon longitudinal muscle preparation. 
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Materials and methods 
Dunkin Hartley guinea-pigs (400-600 g) were decapitated and the proximal 
colon was removed. Intact segments of about 2.5 cm were suspended under a 2g 
load in 20ml organ baths filled with De Jalon solution at 37 °C and gassed with 95 
% O2, 5 % CO2 for isotonic measurement. After half an hour stabilization, the 
strips were challenged twice with methacholine (0.3 uM). In each preparation, a 
cumulative concentration-response curve was made for substance P in the 
absence, and consecutively, in the presence of an antagonist or vehicle control 
(contact time 15 min) (for details, see: Briejer et al, 1992). 
Data analysis 
Contractions due to substance P were expressed as a percentage of the contrac-
tions with substance P in the absence of an antagonist for each preparation. 
Means and their standard error (S.E.M.) were calculated for graphic representa-
tion. pECso values (± 95 % confidence limits) were determined from the concen-
tration-response curves of the individual strips with the aid of linear regression 
analysis of the values lying within a range of 20-80 % of the maximum response. 
The pA2-value was calculated with Schild regression analysis. Effects of antago-
nists were evaluated by comparing EC50 values and maximum contractions to 
substance P in the absence and presence of antagonists, using the analysis of 
variance in combination with Dunnett's t-test; P < 0.05 was considered signifi-
cant. The number of animals used is denoted by n. 
Drugs 
Substance P, tetrodotoxin (Serva, FRG), methacholine (Merck, FRG), phos-
phoramidon (Sigma, Belgium), atropine (Janssen Chimica, Belgium), SR 48968 
((S)-N-methyl N-[4-(4-acetylamino-4-phenyl-piperidino) 2-(3,4-dichlorophenyl)-
butyl] benzamide) (Sanofi, France), 2S, 3S-cis-CP 96345 ((2S, 3S)-cis-2-(diphenyl-
methyl) N-[(2-methoxyphenyl)-methyl] l-azabicyclo-[2.2.2.]-octan 3-amine) 
(Janssen Research Foundation, Belgium), and were dissolved in distilled water. 
WIN 62577 (17-ß-hydroxy-17-a-ethynyl-A-4-androstanp-[3,2-b]-pyrimido-[l,2-a]-
benzimidazole) and WIN 51708 (17-ß-hydroxy-17-a-ethynyl-5-a-androstano-[3,2-
b]-pyrimido-[l,2-a]-benzimidazole) (Research Biochemicals Inc., USA) were 
dissolved in dimethyl sulfoxide, which in its final bath concentration (1 % v / v ) 
did not affect contractions due to methacholine or substance P. 
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Results 
Substance P induced contractions from 0.1 nM onwards with a fast onset, 
yielding a sigmoidal concentration-response curve (Figure 3.1) (EC50 = 16 nM, 
Table 3.1). The concentration-response curve for substance P was not affected by 
the neuronal blocker, tetrodotoxin (0.3 uM), the muscarinic cholinoceptor anta-
gonist, atropine (0.3 |J.M), or the neutral endopeptidase inhibitor, phosphor-
amidon (1 |oM) (see Table 3.1). 2s,3s-cis-CP 96345 inhibited the contractions due to 
substance P in a surmountable fashion (Figure 3.1). Schild analysis yielded a 
straight line with a slope that was not statistically different from unity (0.8 ± 0.3, 
95 % confidence limits; Figure 3.1) yielding a pA2 value of 8.9 (± 0.5, 95 % confi-
dence limits). When the slope was constrained to 1, a pA2-value of 8.5 (± 0.1, 95 
% confidence limits) was obtained. Up to 0.1 |iM, 2s,3s-cis-CP 96345 did not affect 
the concentration-response curve for methacholine. However, at 0.3 |iM, it 
depressed the concentration-response curve for methacholine (maximum 
contraction depressed by about 20 %; not shown, n = 4). Neither WIN 51708 and 
WIN 62577 (both 1 uM), nor their solvent, dimethyl sulfoxide, affected the 
concentration-response curves for either substance P (Table 3.1) or methacholine 
(n = 4; not shown), nor did SR 48968 (0.3 uM) (Table 3.1). 
Table 3.1 pEC5o-values ± 95% confidence limits of the concentration-response curves for 
substance P in the absence and presence of drugs. 
drug pEC50 95% confidence limits n 
controls (pooled) 
phosphoramidon (1 u.M) 
tetrodotoxin (0.3 u.M) 
atropine (0.3 \iM) 
SR 48968 (0.3 U.M) 
WIN 51708 (1MM) 
WIN 62577 (1 uM) 
None of the mean ECso-values was significantly different from its concomitant control mean EC50-
value. 
7.80 
7.99 
7.74 
7.89 
7.98 
7.78 
7.81 
7.97-7.68 
8.28-7.82 
8.13-7.54 
8.31-7.68 
8.24-7.81 
8.10-7.60 
8.16-7.62 
20 
8 
6 
6 
6 
6 
6 
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Discussion 
Phosphoramidon, a potent inhibitor of neutral endopeptidase, EC.3.4.24.11 
(IC50 ~ 10 nM; Turner et al, 1985), had no effect on substance P-induced contrac-
tions, indicating that inactivation of substance P by neutral endopeptidase did 
not play an important role in our experiments. Neither tetrodotoxin nor 
atropine affected the contractions due to substance P, which suggests that, in our 
preparation, substance P acts solely through the stimulation of receptors on the 
smooth muscle. 
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Figure 3.1 Effects of 2s,3s-cis-CP 96345 against contractions induced by substance P on the 
guinea-pig proximal colon longitudinal muscle: (O) control, or in the presence of 2s,3s-cis-CP 96345 
1 nM (•), 30 nM (•), or 0.1 u.M (•). Mean values ± S.E.M. are shown; n = 6. The contractions were 
expressed as a percentage of the maximum contractions to substance P (0.3 u.M) before 
2s,3s-cis-CP 96345 was added. The inserted figure shows a Schild plot based on the data obtained 
with 2s,3s-cis-CP 96345: fitted line (solid), and fitted line with slope constrained to unity (dotted); r 
represents the concentration ratio. 
The recent development of very potent and selective non-peptide tachykinin 
NKi and NK2 receptor antagonists has led to the finding that there are species 
differences between these receptors. The selective tachykinin NKi receptor 
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antagonist, CP 96345 (Snider et al, 1991), is about 100-fold more potent at guinea-
pig type tachykinin NKi receptors than at rat type tachykinin NKi receptors 
(Sachais et al, 1993; Barr & Watson, 1993). In our guinea-pig colon preparation, 
the substance P-induced contractions were competitively antagonized by 
2s,3s-cis-CP 96345, yielding a pA2 of 8.5, which is in good agreement with litera-
ture affinity values (pKd = 8.3-8.4 at guinea-pig type tachykinin NKi receptors; 
Barr & Watson, 1993; Santicioli et al, 1993). The tachykinin NKi receptor anta-
gonists, WIN 51708 and WIN 62577, which bear no structural resemblance to 
CP 96345, have been reported to be much more potent at rat type tachykinin NKi 
receptors (Kj = 2.1-2.7 nM) than at guinea-pig type tachykinin NKi receptors 
(Ki > 10 uM) (Appell et al, 1992). Hence, the observed lack of effect of both 
compounds at a concentration of 1 uM was to be expected and does not contradict 
the conclusion that tachykinin NKi receptors are involved in the contractile 
action of substance P. The selective tachykinin NK2 receptor antagonist, SR 48968 
(Emonds-Alt et al, 1992; Maggi et al, 1993), has been shown to be most potent at 
guinea-pig type tachykinin NK2 receptors (pA2 = 9.4-10.5) (Emonds-Alt et al, 
1992; Advenier et al, 1992). SR 48968 (0.3 uM) did not affect contractile responses 
to substance P, which implies that tachykinin NK2 receptors are not involved in 
substance P-induced contractions in this preparation. 
It has been reported that CP 96345 has unspecific inhibitory activity on neuro-
transmission, probably due to its Ca2+ channel antagonist properties (Wang & 
Hâkanson, 1992; Schmidt et al, 1992). This might well explain the observed 
antagonism against contractions to methacholine at higher (0.3 |xM) concentra-
tions of CP 96345. These unspecific effects thus limit the use of CP 96345 to 
nanomolar concentrations. 
In conclusion: substance P causes contractions of the guinea-pig proximal 
colon longitudinal muscle by stimulation of muscular tachykinin NKi receptors. 
Tachykinin NK2 receptors do not seem to be involved in the contractile effect of 
substance P. 
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Abstract. The purpose of this study was to investigate whether the effects of cisapride and its close 
structural analogue R 76 186 on the isolated guinea-pig colon ascendens, are mediated through 
5-HT4 receptors. 
Both cisapride and R 76 186 induced contractions in a concentration-dependent fashion, giving 
monophasic concentration-response curves (cisapride: EC50 = 0.12 \iM, maximum effect = 40.3 % of 
methacholine-induced (0.3 nM) contractions; R 76 186: EC50 = 24 nM, maximum effect = 52.1 %). 
Blockade of either 5-HT2 or 5-HT3 receptors did not affect the responses to cisapride. However, 
tropisetron (in 5-HT4 receptor blocking concentrations), and DAU 6285 and SDZ 205-557, two novel 
selective 5-HT4 receptor antagonists, depressed the concentration-response curve to cisapride (to 
about 50 %), and the curve to R 76 186 was shifted to the right. The estimated pA2 values were 6.6 
(tropisetron), 6.3 (DAU 6285), and 7.5 (SDZ 205-557). However, none of these antagonisms was 
purely competitive as higher concentrations of these antagonists depressed the curve to R 76 186. 
Desensitization of the 5-HT4 receptor with 5-methoxytryptamine (5-MeOT) inhibited the 
responses to cisapride, and abolished those to R 76 186. The contractions to cisapride and R 76 186 
were sensitive to mutual antagonism, depressing their concentration-response curves. 
Conclusions: Both cisapride and R 76 186 mediate their contractile effects in the guinea-pig 
colon ascendens through agonism at the 5-HT4 receptor, though cisapride also uses a non-5-HT 
mechanism. R 76 186 is a selective and potent 5-HT4 receptor agonist. 
Introduction 
Cisapride is a 4-amino-5-chloro-2-methoxy-substituted benzamide that is 
clinically effective in the treatment of gastrointestinal motility disorders such as 
non-ulcer dyspepsia, gastro-oesophageal reflux, and constipation (Reyntjens et 
al, 1986; Müller-Lissner, 1985; 1987). In vivo, cisapride has been shown to stimu-
late motility in different animal species, and in gastrointestinal smooth muscle 
preparations of both animal and man, cisapride enhances contractility 
(Schuurkes, 1992). Its mechanism of action is however still unclear. In vitro, 
cisapride has been shown to interact with several 5-hydroxytryptamine (5-HT) 
receptors. It is an antagonist at 5 - H T I A , 5-HT2 and 5-HT3 receptors (Moriarty et 
al, 1987; Van Nueten & Schuurkes, 1989; Leysen, 1990; Taniyama et al, 1991). It 
has been hypothetised that its prokinetic action is related with agonistic activity 
at the recently discovered 5-HT4 receptor (see for review: Bockaert et al., 1992). 
The enhanced cholinergic transmission which is induced by stimulation of this 
5-HT4 receptor (Taniyama et al, 1991; Kilbinger and Wolf, 1992), is proposed to be 
responsible for the prokinetic effects of cisapride and structurally related benza-
mides, such as renzapride, zacopride and metoclopramide (Tonini et al, 1989; 
1991; Bockaert et al, 1992). 
In the guinea-pig proximal colon, cisapride induces tonic contractions 
(Schuurkes et al, 1985; Elswood et al, 1991). The contractile effects in this prepa-
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ration to renzapride and zacopride, two prokinetic benzamides that are structural 
analogues of cisapride, are sensitive to 5-HT4 receptor blocking concentrations of 
tropisetron (ICS 205-930) (Elswood et al, 1991). Besides a potent 5-HT3 receptor 
antagonist, tropisetron is a low potency 5-HT4 receptor antagonist (pA2 = 6.0 - 6.7, 
Bockaert et al, 1992). Recently, two novel, more potent and more selective 5-HT4 
receptor antagonists have been introduced, i.e. SDZ 205-557 (Buchheit et al., 1991; 
1992) and DAU 6285 (Turconi et al, 1991; Dumuis et al, 1992; Schiavone et al, 
1992). A second manner to investigate 5-HT4 receptor mediated responses, is the 
selective desensitization of this receptor with 5-methoxytryptamine (5-MeOT), a 
5-hydroxytryptamine analogue that lacks activity at 5-HT3 receptors (Fozard, 1985; 
Craig et al, 1990; Meulemans & Schuurkes, 1992). 
The aim of our study was to investigate whether cisapride is a 5-HT4 receptor 
agonist on the guinea-pig colon ascendens, utilizing both the established phar-
macological tools (i.e. receptor desensitization with 5-MeOT and antagonism 
with tropisetron) and the two novel antagonists (i.e. SDZ 205-557 and DAU 6285). 
As a benzamide comparator, a structural analogue to cisapride, R 76 186, was also 
incorporated into this study. R 76 186 is the most potent and a highly efficacious 
5-HT4 receptor agonist in the mouse colliculi neurons (Bockaert et al, 1991). 
Materials and methods 
Dunkin-Hartley guinea-pigs of both sexes, weighing 400-600 g, were killed by 
cervical dislocation. The ascending colon was removed, and the luminal 
contents were washed out with De Jalon's solution (mM: KCl 5.6, CaCl2 0.5, 
NaHCC>3 6.0, NaCl 155, glucose 2.8). The mesentery was carefully removed. 
Starting at the proximal end, about 1 cm distal from the caecum, the colon was 
divided into four segments of about 2.5 cm. These intact segments were individ-
ually mounted vertically for isotonic measurement into a tissue bath containing 
20 ml De Jalon's solution. This solution was kept at 37 °C and gassed with 95% 
O2, 5 % CO2. The strips were subjected to a preload of 2 g and allowed to stabilize 
for 20 min. After stabilization, the response of the longitudinal muscle to 0.3 uM 
methacholine (about 60 % of maximum contraction) was measured. The 
measurement was repeated after washing (i.e. replacing the bathing fluid twice) 
and stabilization (10 min) until the response to methacholine remained constant 
(usually 3 times). 
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Protocols 
Strips were incubated with the 5-MeOT (desensitization of 5-HT4 receptors), 
R 76 186, cisapride (for testing mutual antagonism effects), a 5-HT receptor anta-
gonist, or solvent for at least 15 min. Subsequently, one concentration of 
cisapride or R 76 186 was added to the bath. The response was monitored for 
5 min at most. Tropisetron had an intrinsic effect (ranging from about 5 % (of 
methacholine-induced contractions, see below) at 1 uM to about 10 % at 10 uM), 
but the strips always had returned to baseline length before the agonist was 
administered. The applied 5-HT2 and 5-HT3 receptor antagonists, as well as 
DAU 6285 and SDZ 205-557, were without intrinsic effects. The concentration-
response curves of cisapride and R 76 186 either in the absence or presence of an 
antagonist were obtained by single dose administration (one concentration per 
preparation). The fact that repeated benzamide administration results in reduced 
contractions necessitated these single point measurements. A disadvantage of 
these single point measurements is that biological variability gives rise to more 
fluctuation than in the case of multipoint measurements. All responses were 
expressed as a percentage of the mean of the last two contractions induced by 
methacholine 0.3 uM. 
To investigate the specificity of the applied antagonists and 5-MeOT, they 
were tested against methacholine-induced contractions. Methacholine was 
applied cumulatively (0.5 log concentration intervals) to establish concentration-
response curves. First, a concentration-response curve to methacholine in the 
absence of antagonist was established, and subsequently, after 30 min of stabiliza-
tion and repeated washing, a second concentration-response curve was estab-
lished in the presence of either solvent or antagonist. The incubation period was 
at least 15 min in this case as well. The responses of the second curves were 
expressed relatively to the maximum effect to methacholine obtained in the first 
curve, occurring at 10 uM. 
Data analysis 
For graphical representation means ± standard error of the means were calcu-
lated. Mean values were compared with the Scheffé F-test or the Dunnett t-test, 
when appropriate, for multiple comparisons. The level of P < 0.05 was consid-
ered to indicate significant difference. EC50 values and a range of the EC50 values 
± their standard errors were determined with the aid of the computer software 
SAS (version 6, SAS Institute Inc., North Carolina), performing an iterative non-
linear curve-fit according to the method of Marquardt. The pA2 values were 
estimated with the Schild-equation: 
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pA2 = 10log (r -1) - 10log (molar concentration of antagonist) 
in which r represents the concentration ratio. 
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Figure 4.1 Structural formulas of the 4-amino-5-chloro-2-methoxy-substituted 
benzamides cisapride and R 76 186. 
Drugs 
Solutions of R 76 186 (cis-4-amino-5-chloro-N-[l-[4-[4-(dimethylamino)-l-
piperidinyl]-4-oxo-butyl]-3-methoxy-4-piperidinyl] 2-methoxybenzamide) and 
cisapride (cis-4-amino-5-chloro-N-[l-[3-(4-fluorophenoxy) propyl]-3-methoxy-4-
piperidinyl] 2-methoxybenzamide monohydrate), (Figure 4.1), DAU 6285 HCl 
(endo-6-methoxy-8-methyl-8-azabicyclo-[3.2.1]-oct-3-yl 2,3-dihydro-2-oxo-lH-benz-
imidazole-1-carboxylate hydrochloride), ketanserin tartrate ((+)-3-[2-[4-(4-fluoro-
benzoyl)-l-piperidinyl]-ethyl]-2,4-(lH,3H)-quinazoline-di-one monotartrate), SDZ 
205-557 (2-methoxy-4-amino-5-chloro-benzoic acid 2-(diethyl-amino) ethyl ester), 
pirenperone (3-[2-[4-(4-fluorobenzoyl)-l-piperidinyl]-ethyl]-2-methyl-4H-pyrido-
[l,2-a]-pyrimidin-4-one) (Janssen Research Foundation, Belgium), tropisetron 
HCl ((8-methyl-8-azabicyclo-[3.2.1]-oct-3yl) lH-indole 3-carboxylate monohydro-
chloride) (ICS 205-930; Sandoz, Switzerland), granisetron HCl (endo-1-methyl-N-
(9-methyl-9-azabicyclo-[3.3.1]-non-3-yl) lH-indazole-3-carboxamide monohydro-
chloride) (BRL 43694; SmithKline Beecham, United Kingdom), ondansetron 
(l,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-lH-imidazol-l-yl)-methyl] 4H-carbazol-
4-one) (GR 38032F; Glaxo, United Kingdom), 5-methoxytryptamine HCl, (Janssen 
Chimica, Belgium), methacholine HCl (E. Merck, Germany) were added to the 
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organ bath solution in volumes < 1 % of the bath volume. DAU 6285 was a kind 
gift from dr. CA. Rizzi, Boehringer Ingelheim, Italy. Methacholine, tropisetron, 
ondansetron, granisetron, DAU 6285, ketanserin and 5-methoxytryptamine were 
dissolved in distilled water. Cisapride, pirenperone, SDZ 205-557 and R 76 186 
were dissolved in distilled water acidified with tartaric acid in the stock solution 
(pH > 3 in the stock solution). The solvent had no effect on the resting length of 
the preparation and on the methacholine-induced contractions. 
Results 
Cisapride concentration-dependently induced contractions from 10 nM 
onwards. The contractions had a rather slow onset, reaching a maximum after 
2-4 min, and usually had a tonic character. The concentration-response curves to 
cisapride appeared monophasic (Figure 4.2, left panel) with an EC50 of 
0.12 (0.09-0.15) uM and a maximum effect at 1 U.M of 40.3 ± 1.9 % (n = 8-35). 
Table 4.1 Estimated pA2 values of 5-HT4 receptor antagonists against R 76 186 in 
the guinea-pig colon ascendens in comparison to literature pA2 values. 
estimated pA2 literature pA2 
tropisetron 6.6 6.0-6.73 
DAU 6285 6.3 6.4-7.4b 
SDZ 205-557 7J> 7.2-7.70 
aBockaert era/., 1992; bTurconi era/., 1991; Schiavone et ai, 1992; Dumuis er ai, 
1992; cBuchheit et ai, 1992. 
Neither the 5-HT2 receptor antagonists ketanserin (30 nM) and pirenperone 
(30 nM), nor the 5-HT3 receptor antagonists ondansetron (1 uM), granisetron 
(0.1 uM) and tropisetron (0.1 (xM), significantly affected the contractile response 
to cisapride (0.3 uM) (n = 6 -14, results not shown). 
R 76 186 induced contractions from 1 nM onwards in a concentration-depen-
dent fashion. The contractions had a rather fast onset, reaching the maximum 
effect usually within 1 min, and were short-lasting. The concentration-response 
curve to R 76 186 appeared monophasic (Figure 4.2, middle panel) with an EC50 
of 24 (21-27) nM and a maximum effect at 0.1 uM of 52.1 ± 3.0 % (n = 6 - 31). 
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Figure 4.2 Effects of tropisetron on the concentration-response curves to cisapride (left panel), 
R 76 186 (middle panel) and methacholine (right panel). Shown are the control curves (O) and the 
curves in the presence of tropisetron 1u.M ( • ) , 3 |j.M ( • ) , and 1 u.M ( • ) . The contractile responses to 
cisapride and R 76 186 were expressed as a percentage of contractions to methacholine 0.3 u.M. 
However, the contracti le responses to methacholine were expressed as a percentage of the 
maximum effect to methacholine (at 10 u.M). Means ± s.e.m., n = 4 - 35. 
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Figure 4.3 Effects of DAU 6285 on the concentration-response curves to cisapride (left panel), 
R 76 186 (middle panel) and methacholine (right panel). Shown are the control curves (O) and the 
curves in the presence of DAU 6285 1 uM ( • ) , 3 uM (A) , and 10 uM ( • ) . The contractile responses 
to cisapride and R 76 186 were expressed as a percentage of contractions to methacholine 0.3 uM. 
However, the contracti le responses to methacholine were expressed as a percentage of the 
maximum effect to methacholine (at 10 j iM). Means ± s.e.m., n = 6 - 35. 
Tropisetron 
Tropisetron (1 u,M and 3 U.M) significantly inhibited the contractions to 
cisapride (n = 6 - 12) (Figure 4.2, left panel) and R 76 186 (n = 5 - 20) (Figure 4.2, 
middle panel), but in a different way. The responses evoked by cisapride were 
inhibited in a non-surmountable way (Figure 4.2, left panel). The concentration-
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response curve to R 76 186 however was shifted to the right without depression 
of the maximum effect. Schild analysis yielded a slope of 2.2. Though this value 
definitely exceeds unity, significance could not be tested, since only two concen-
trations of tropisetron could be applied. The estimated pA2 (determined with the 
Schild-equation using only tropisetron 1 uM) yielded a value of 6.6 (Table 4.1). 
The inhibition by tropisetron of the responses to cisapride and R 76 186 was not 
fully specific, since at 3 uM, it tended to inhibit the responses to methacholine (a 
significant depression of the methacholine concentration-response curve was 
reached using tropisetron 10 ^M) (Figure 4.2, right panel) though to a much 
lesser extent (n = 4). Because of this non-specific inhibitory action, tropisetron 
was not tested against cisapride and R 76 186 in concentrations exceeding 3 uM. 
DAU 6285 
DAU 6285 significantly inhibited the contractions to cisapride in a non-
surmountable fashion, the inhibition by DAU 6285 10 |iM (n = 6) being not 
different from the inhibition by DAU 6285 1 uM (n = 6 - 8) and 3 uM (n = 6) 
(Figure 4.3, left panel). DAU 6285 also significantly inhibited the contractions to 
R 76 186. The inhibition by DAU 6285 1 (iM (n = 8) was surmountable (maximum 
effect to R 76 186 not significantly different from control), but higher concentra-
tions of DAU 6285 (3 uM, n = 6; 10 uM, n = 6) significantly depressed the maxi-
mum effect to R 76 186 (Figure 4.3, middle panel). The estimated pA2, calculated 
only with the concentration-response curve to R 76 186 in the presence of DAU 
6285 1 |XM, was 6.3 (Table 4.1). The inhibition by DAU 6285 of the effects to 
cisapride and R 76 186 appeared specific, for the concentration-response curve to 
methacholine was not affected by DAU 6285 up to 10 uM (n = 6) (Figure 4.3, right 
panel). 
SDZ 205-557 
SDZ 205-557 inhibited the effects of cisapride (n = 6 - 10), again in a non-
surmountable fashion (Figure 4.4, left panel). SDZ 205-557 significantly inhibited 
the contractile effects to R 76 186 at a concentration as low as 0.1 |iM SDZ 205-557 
(n = 6 - 8) (Figure 4.4, middle panel). At 0.1 uM, the antagonism by SDZ 205-557 
seemed surmountable (maximum effect to R 76 186 not significantly different 
from control; estimated pA2 = 7.5, Table 4.1). Up to 10 |AM, SDZ 205-557 did not 
affect the concentration-response curve to methacholine (n = 4) (Figure 4.4, right 
panel). 
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Figure 4.4 Effects of SDZ 205-557 on the concentration-response curves to cisapride (left panel), 
R 76 186 (middle panel) and methacholine (right panel). Shown are the control curves (O) and the 
curves in the presence of SDZ 205-557 0.1 jiM (•), 0.3 nM (A), 1 uM (•), 3 |j.M (T), and 10 \xM (Q). 
The contractile responses to cisapride and R 76 186 were expressed as a percentage of contractions 
to methacholine 0.3 uM. However, the contractile responses to methacholine were expressed as a 
percentage of the maximum effect to methacholine (at 10 \M). Means ±-s.e.m., n = 4 - 35. 
5-MeOT 
5-MeOT (3 uM: a concentration causing maximum contractions [Briejer et al, 
1993]) induced a quick initial relaxation, followed by a much larger contraction 
(47.2 ± 2.8 %), and subsequently a more sustained relaxation. The effects of 
5-MeOT had disappeared after 15 min, so by the time the second agonist 
(cisapride, R 76 186 or methacholine) was administered, the strips had returned 
to resting length. Preincubation of the strips with 5-MeOT (3 uM) resulted in 
significantly decreased contractions to cisapride as compared to control (n = 7-8) 
(Figure 4.5, left panel). The responses to R 76 186 were abolished by desensitiza-
tion with 5-MeOT (3 uM; n = 4) (Figure 4.5, middle panel). The specificity for 
5-HT receptors is illustrated by the fact that the concentration-response curve to 
methacholine was not affected by preincubation with 5-MeOT (3 uM; n = 4) 
(Figure 4.5, right panel). 
Mutual antagonism 
The responses to cisapride were sensitive to antagonism by R 76 186 0.3 uM 
(n = 6) (Figure 4.6, left panel). The R 76 186 evoked responses were also sensitive 
to antagonism with cisapride 0.3 uM (n = 6) (Figure 4.6, right panel). 
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Figure 4.5 Effects of 5-MeOT on the concentration-response curves to cisapride (left panel), 
R 76 186 {middle panel) and methacholine (right panel). Shown are the control curves (O) and the 
curves in the presence of 5-MeOT 3 uM (•). The contractile responses to cisapride and R 76 186 
were expressed as a percentage of contractions to methacholine 0.3 u.M. However, the contractile 
responses to methacholine were expressed as a percentage of the maximum effect to methacholine 
(at 10 uM). Means + s.e.m., n = 4 - 8. 
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Figure 4.6 Effects of mutual antagonism on the concentration-response curves to 
cisapride (left panel) and R 76 186 (right panel). Shown are the control curves (O) and 
the curves in the presence of 0.3 u.M R 76 186 (left panel, • ) , and cisapride 0.3 uM 
(right panel, • ) . The contractile responses to cisapride and R 76 186 were expressed 
as a percentage of contractions to methacholine 0.3 uM. Means ± s.e.m., n = 6. 
Discussion 
Our study clearly demonstrates that 5-HT4 receptors are involved in the 
contractile action of cisapride on the guinea-pig ascending colon. The lack of 
effect by the selective 5-HT2 receptor antagonists ketanserin and pirenperone 
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(Leysen, 1990), and by the selective 5-HT3 receptor antagonists ondansetron, 
granisetron and the non-selective tropisetron (nanomolar concentrations) 
(Butler et al, 1990; Kilpatrick et al, 1990), is in good agreement with existing data 
that cisapride interacts with these receptor subtypes without intrinsic effect 
(Moriarty et al, 1987; Van Nueten and Schuurkes, 1989; Leysen, 1990). The 5-HT4 
receptor antagonists tropisetron (micromolar concentrations), DAU 6285 and 
SDZ 205-557 (Buchheit et al, 1991; 1992; Turconi et al, 1991; Dumuis et al, 1992; 
Schiavone et al, 1992) all inhibited the responses evoked by cisapride, thus 
showing that at least part of the response to cisapride is mediated through 5-HT4 
receptors. Desensitization of the 5-HT4 receptor with 5-MeOT (Fozard, 1985; Craig 
et al, 1990; Meulemans & Schuurkes, 1992) inhibited the effects to cisapride, thus 
giving extra evidence that this receptor subtype is involved. 
Stimulation of the 5-HT4 receptor, at least in the guinea-pig ileum and proba-
bly also in the colon, induces facilitation of the cholinergic transmission 
(Schuurkes et al, 1985; Taniyama et al, 1991; Kilbinger & Wolf, 1992). Hence, it is 
important to ascertain that a 5-HT4 receptor antagonist does not antagonise 
cholinergic responses. The concentration-response curve to methacholine, an 
agonist at the muscarinic acetylcholine receptor, was not affected by preincuba-
tion of the strips with either DAU 6285, SDZ 205-557 or 5-MeOT, indicating that 
the inhibitory effects against cisapride of these agents were specific. Tropisetron 
(10 uM) however did affect the methacholine-induced contractions. Baxter et al 
(1991) reported competitive antagonism at the muscarinic acetylcholine receptor 
(pA2 = 5.4) by tropisetron in rat oesophageal tunica muscularis. In our prepara-
tion, however, the maximum effect of methacholine was significantly depressed 
by tropisetron 10 uM; tropisetron thus did not seem to antagonize the contrac-
tions to methacholine in a competitive fashion. Scholtysik et al (1988) showed 
that tropisetron blocks cardiac K+, Na+ and Ca2+-channels. Hence, tropisetron 
may inhibit the methacholine-induced responses by affecting the membrane 
potential of the smooth muscle cells in our preparation. Still, the inhibition by 
tropisetron of the methacholine-induced responses was much less pronounced 
than the inhibition against cisapride-induced contractions, thus providing extra 
evidence for the 5-HT4 receptor agonist component in the contractile effect of 
cisapride. 
Blockade with 5-HT4 receptor antagonists and desensitization with 5-MeOT 
all seem to reveal a rest response to cisapride which is not mediated by 5-HT4 
receptors. Stimulation of 5-HTi receptors in this tissue induces relaxations rather 
than contractions (Kojima, 1991; Elswood and Bunce, 1992; Briejer et al, 1992). 
The relaxations induced by 5-MeOT are caused by stimulation of these 5-HTi 
100 Chapter 4 
receptor (Briejer et al, 1992; 1993). Since blockade of 5-HT2 and 5-HT3 receptors 
had no effect on cisapride induced contractions, it seems likely that the second 
component in the contractile action of cisapride is mediated by a non-5-HT 
receptor. The contractions to the 5-HT4 receptor agonist 5-MeOT were fast and 
short-lasting, whereas, in contrast, those to cisapride were developing more 
slowly and had a more tonic character. This may also indicate that cisapride does 
not act solely through a 5-HT4 receptor mechanism. Sanger (1987) suggested that 
metoclopramide (the first clinically applied gastrointestinal prokinetic benza-
mide) increases electrical field stimulation-evoked contractions of guinea-pig 
ileum preparations by at least two different mechanisms, only one of which 
involves activation of enteric 5-HT-like (i.e. 5-HT4) receptors. In isolated guinea-
pig gastric smooth muscle cells, it was suggested that cisapride acts as an agonist 
at muscarinic acetylcholine receptors (Hasler et al, 1991). Schuurkes & Van 
Nueten (1989) showed that, in a preparation identical to ours, the TTX-resistant 
component in the contraction to cisapride was no more sensitive to atropine. 
This suggests that cisapride does not act at (myogenic) muscarinic acetylcholine 
receptors in the guinea-pig colon. Clearly, the non-5-HT component in the action 
of cisapride deserves further investigation. 
Table 4.2. Comparison of EC50 values and efficacies of cisapride and R 76 186, 
obtained in the guinea-pig colon ascendens and in mouse colliculi neurons (Bockaert 
era/., 1991). 
EC50 efficacy 
colliculi neurons 
cisapride 
R 76186 
ratio 
proximal colon 
cisapride 
R 76186 
ratio 
In our experiments, R 76 186, a substituted benzamide that is structurally 
related to cisapride, appeared to be an agonist at the 5-HT4 receptor, since it was 
inhibited by the applied 5-HT4 receptor antagonists (with estimated pA2 values 
that are in good agreement with values from the literature, see Table 4.1) as well 
as by receptor desensitization with 5-MeOT. In fact, the latter procedure abolished 
72 nM 
27 nM 
2.7 
115nM 
24 nM 
4.8 
142 % 
134% 
1.1 
40.3 % 
52.1 % 
0.8 
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the contractions to R 76 186, indicating that R 76 186, at least up to 0.3 |i.M, is a 
selective 5-HT4 receptor agonist. This view is supported by the fact that DAU 6285 
and SDZ 205-557, which are selective 5-HT4 receptor antagonists, also completely 
inhibited the contractions to R 76 186 up to 0.3 uM. In primary cultures of foetal 
mouse colliculi neurons, the system in which 5-HT4 receptors were first identi-
fied by Dumuis and colleagues (1988), R 76 186 was a very potent agonist at 5-HT4 
receptors with a high efficacy (Table 4.2) (Bockaert et al., 1991). In our experi-
ments, R 76 186 was also very effective at the 5-HT4 receptor with a high affinity. 
Both the potency and efficacy ratios of the results of Bockaerts study (collicular 
neurons) and ours correspond well (Table 4.2). This reflects the similarity of 
action of cisapride and R 76 186 in these tissues. The 5-HT4 receptor is subjected 
to rapid desensitization (Craig et al., 1990; Meulemans & Schuurkes, 1992). Since 
cisapride and R 76 186 mutually antagonized their responses, both compounds 
must have at least one site of action in common, supposedly the 5-HT4 receptor 
site. 
The elucidation of the site of action of the benzamides is endowed with a 
number of peculiar observations, to which our study with cisapride and R 76 186 
also adds some. The determination of the kind of antagonism by the applied 
5-HT4 receptor antagonists against cisapride is troubled by the second, non-5-HT 
component in the action of cisapride (see above). From the antagonism against 
R 76 186, it is clear, that none of the antagonists inhibited contractions to R 76 186 
in a competitive fashion, though the inhibition by tropisetron was surmount-
able. In most preparations, tropisetron (in micromolar concentrations) is a 
competitive 5-HT4 receptor antagonist (Bockaert et al., 1992), but in the guinea-
pig colon it antagonised the contractions to 5-HT and 5-MeOT, and also to the 
benzamides zacopride and renzapride, in a non-surmountable fashion (Elswood 
et al, 1991). In the guinea-pig ileum, SDZ 205-557 antagonised responses to 5-HT 
and 5-MeOT competitively, but not those to renzapride (Buchheit et al., 1991; 
1992). DAU 6285 is reported to inhibit both responses to 5-HT and 5-MeOT, as 
well as to cisapride in a competitive fashion (Schiavone et al; 1992; Turconi et al, 
1991; Tonini et al, 1992). In the mouse colliculi neuron system, R76 186 and 
tropisetron could displace [3H]-renzapride binding, whereas 5-HT and 5-MeOT 
could not (Bockaert et al., 1991). They hypothetized that the 5-HT4 receptor might 
contain two different subsites, one for the benzamides, the other for 5-HT and 
indoles. In this model, binding of 5-HT or benzamides at their specific subsites 
would be mutually exclusive (Bockaert et al, 1991). In guinea-pig myenteric 
neurons, a binding site for the benzamides S-zacopride (but not its enantiomer 
R-zacopride) and renzapride was demonstrated, distinct from the binding site for 
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5-HT. It was hypothetized that this benzamide site has a modulatory function in 
5-HT transmission (Wade et al, 1991). From all these observations, it is clear, 
that the interaction of the applied antagonists, the substituted benzamides and 
the 5-HT4 receptor site, is complex and needs further study. 
Conclusions: Cisapride and its analogue R 76 186 are agonists at the 5-HT4 
receptor in the guinea-pig colon ascendens. Cisapride appears to induce contrac-
tions not only through stimulation of the 5-HT4 receptor, but also through a 
second mechanism, probably not involving 5-HT receptors. R 76 186, in contrast, 
appears to be a selective 5-HT4 receptor agonist. 
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Abstract. In the guinea-pig colon ascendens, 5-hydroxytryptamine (5-HT) induces contractions, 
mediated by 5-HT2, 5-HT3 and 5-HT4 receptors, and relaxations, through a 5-HTj receptor subtype, 
that triggers the release of an inhibitory neurotransmitter. Nitric oxide (NO) is one of the main 
candidates of NANC inhibitory neurotransmission in the gut. The aim of this study was to 
establish whether NO is involved in 5-HT-induced relaxations of the guinea-pig colon ascendens. 
Antagonists to block the contractile responses to 5-HT via 5-HT2, 5-HT3 and 5-HT4 receptors 
were present throughout the experiments and methacholine was administered to elevate tone. 
Under these conditions, 5-HT concentration-dependently induced relaxations from 10 nM onwards 
(EC50 = 258 (172-387) nM). The relaxations were inhibited by metergoline (10 nM) and methio-
thepine (0.1 uM) and abolished by TTX (0.3 \iM). Guanethidine (3 uM) did not affect them. 
NG-nitro-L-arginine (L-NNA) inhibited the responses to 5-HT (IC50 = 18.7 (13.3-26.3) uM); at the 
highest 5-HT concentration a maximum inhibition of about 75 % was observed with 0.3 mM 
L-NNA. This inhibition was reversed with L-arginine. Relaxations to glyceryl trinitrate (GTN) 
were not inhibited by L-NNA. Haemoglobin (30 | J M ) inhibited the relaxations to 5-HT and GTN, 
but not those to isoproterenol (ISO). Methylene blue (10 (iM) inhibited the relaxations to 5-HT but 
did not affect those caused by GTN or ISO. 
It is concluded that 5-HT induces relaxations that involve NO. We also confirmed that 5-HT 
induces these relaxations via (a) 5-HTj receptor subtype(s), located on neurons. 
Introduction 
Inhibitory enteric neurons play an important role in gut motility. They are 
involved in reflex relaxation of the lower esophageal and the internal anal 
sphincter, the receptive and adaptive relaxation of the stomach and the descend-
ing inhibition during intestinal peristalsis. The exact mechanisms underlying 
these phenomena remain to be elucidated. 
In isolated colon ascendens preparations of the guinea-pig, 5-hydroxytrypt-
amine (5-HT), a neurotransmitter of the enteric nerves, induces both contrac-
tions and relaxations (Costa & Furness, 1979). It has previously been shown, that 
the contractions are mediated via 5-HT2, 5-HT3 and 5-HT4 receptors (Briejer et al, 
1991; Sato et al, 1991, Eiswood et al, 1991), and the relaxations through a 5-HT-
receptor different from 5-HT2, 5-HT3 or 5-HT4 receptors (Briejer et al., 1991; Sato 
et al., 1991) but sensitive to 5-HTi receptor antagonists (Kojima, 1991; Elswood & 
Bunce, 1992). Since TTX abolished these relaxations, they were presumed to be 
mediated by nerves (Gershon, 1967). In the guinea-pig proximal (Costa & 
Furness, 1979) and distal colon (Onori et al., 1984), 5-HT-evoked relaxations were 
not affected by incubation with guanethidine, which suggests that the relaxations 
are mediated by the intrinsic NANC (non-adrenergic, non-cholinergic) 
inhibitory neurons. Several compounds have been proposed as a neurotrans-
mitter of these NANC inhibitory neurons: ATP (Burnstock, 1972), vasoactive 
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intestinal peptide (VIP) (Makhlouf, 1985) and nitric oxide (NO) (Moncada et al, 
1991). 
Evidence for NO as a transmitter of inhibitory motor neurons in the gastro-
intestinal tract have been obtained by several authors in various tissues: canine 
ileocolonic junction (Bult et al, 1990; Boeckxstaens et al, 1990), canine terminal 
ileum (Bogers et al, 1991), guinea-pig ileum (Osthaus & Galligan, 1992), guinea-
pig stomach (Desai et al, 1991; Meulemans et al, 1993), rat gastric fundus (Li & 
Rand, 1990), rat stomach (Lefebvre et al, 1992), opossum internal anal sphincter 
(Rattan & Chadker, 1992; T0ttrup et al, 1992), human ileum (Maggi et al, 1991), 
human sigmoid colon and internal anal sphincter (Burleigh, 1992). 
Much of this evidence is based on the use of compounds that selectively 
modify the "nitrergic" neurotransmission. NO is formed from L-arginine by NO 
synthase (Palmer et al, 1988), which has been immunohistochemically demon-
strated in the myenteric plexus of the rat (Bredt et al, 1990). NO readily diffuses 
through the presynaptic membrane into the target cell, where it is thought to 
activate the soluble guanylate cyclase, thus giving rise to increased cyclic GMP-
levels (Arnold et al, 1977; Feelish & Noack, 1987a; Moncada et al, 1991; McCall & 
Vallance, 1992). This L-arginine-NO-pathway can be inhibited at several levels. 
Analogues of L-arginine inhibit the synthesis of NO (Moncada et al, 1991; McCall 
& Vallance, 1992). NG-nitro-L-arginine has been shown to be a potent inhibitor of 
the NO-synthesis (Moore et al, 1990; Mülsch & Busse, 1990). Haemoglobin 
captâtes NO after it has diffused out of the neuron, which will prevent it from 
diffusing into the smooth muscle cells (Martin et al, 1985; Keim & Schrader, 
1990). The dye and oxidant methylene blue selectively inhibits the target of NO, 
the soluble guanylate cyclase (Gruetter et al, 1981; Martin et al, 1985) which is 
present in the smooth muscle cells. 
The aim of this study was to establish whether NO is involved in relaxations 
upon 5-HT administration of the guinea-pig colon ascendens. 
Materials and methods 
Tissue preparation 
Dunkin-Hartley guinea-pigs of both sexes, weighing 400-600 g, were killed by 
cervical dislocation. The ascending colon was removed, and the luminal 
contents were washed out with De Jalon solution (mM: KCl 5.6, CaCl2 0.5, 
NaHCOs 6.0, NaCl 155, glucose 2.78). The mesentery was carefully removed. 
Starting at the proximal end, about 1 cm distal from the caecum, the colon was 
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divided into four segments of circa 2.5 cm. These intact segments were individu-
ally mounted vertically for isotonic measurement into an tissue bath containing 
20 ml De Jalon's solution. This solution was kept at 37 °C and gassed with 95% 
O2, 5 % CO2. The strips were subjected to a preload of 2 g and allowed to stabilize 
for half an hour. Ketanserin (0.3 uM) and tropisetron (ICS 205-930, 3 uM) were 
continuously present in the De Jalon's solution during all experiments to block 
contractile responses mediated by 5-HT2, 5-HT3 and 5-HT4 receptors. After stabi-
lization, the response of the longitudinal muscle to 0.3 uM methacholine was 
measured. After washing and 10 min stabilization, the procedure was repeated in 
order to stabilize the response of the tissue. 
Protocols 
For the construction of concentration-response curves, agonists and antago-
nists were applied directly to the tissue bath (added volume < 3 % of tissue bath 
volume). Methacholine (0.3 uM) w a s added to the bath in order to precontract 
the muscle. The mean decrease in length was 5.78 ± 0.24 mm. 
5-Hydroxytryptamine. Since pilot experiments had revealed that relaxations 
to 5-HT are subjected to tachyphylaxis, non-cumulative concentration-response 
curves were established, beginning 10 min after the administration of metha-
choline. The size of the 5-HT-induced relaxation was measured as the maximum 
relaxation induced during an incubation period of approximately 2 min. Then, 
the agonists were washed out by replacing the bathing fluid twice. Stabilization of 
10 min was allowed. This 20 min dosing cycle was repeated applying ascending 
concentrations of 5-HT. The response to repetitive administration of metha-
choline was perfectly stable throughout the experiment. On each segment, first a 
concentration-response curve to 5-HT was constructed in the absence of an anta-
gonist (ketanserin and tropisetron present ) (= first series). Consecutively, the 
measurements were repeated in the presence of an antagonist (= second series). 
Antagonists were added 10 min prior to the methacholine-induced precontrac-
tion, and were re-added directly after each washout. The antagonists had no effect 
on the methacholine-induced contractions, except for methiothepin. When 
L-arginine was tested against NG-nitro-L-arginine, they were added together. Four 
segments were taken per animal; each fourth strip was utilized as a control, i.e. 
vehicle control was added during the second series. In these control strips, the 
concentration-response curve to 5-HT was perfectly reproducible as compared to 
the curves of the first series. All responses were expressed as a percentage of the 
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relaxation induced by 5-HT 10 uM of the first series for each individual segment. 
5-HT (10 uM) induced relaxations of 3.8 ± 0.2 mm (n = 32; mean ± s.e.m.). 
Glyceryl trinitrate and isoproterenol. For the construction of concentration-
response curves to glyceryl trinitrate and isoproterenol, the compounds were 
added in a cumulative fashion, 10 min after precontraction to methacholine-
addition (0.3 uM). After washing and stabilization for 30 min (washing every 
10 min), a second concentration-response curve was established in the presence 
of an antagonist. The responses induced by glyceryl trinitrate or isoproterenol 
were expressed relative to the response to either glyceryl trinitrate 10 uM or iso-
proterenol 3 uM of the first series for each segment. The relaxations induced by 
these concentrations were respectively 7.6 ± 0.5 mm (n = 18) and 10.5 ± 1.0 mm 
(n=12). 
Chemicals 
Methiothepin maleate (Hoffman-La Roche, Switzerland), methacholine HCl 
(E.Merck, Germany), 5-hydroxytryptamine HCl, tetrodotoxin (Serva, Germany), 
bovine haemoglobin (Sigma, Belgium), glyceryl trinitrate (Federa, Belgium), 
metergoline (Gruppo Montedison Farmitalia, Italy), isoproterenol tartrate, 
methylene blue, NG-nitro-L-arginine and L-arginine (Janssen Chimica, Belgium) 
were added to the tissue bath solution in volumes less than 3% of the bath 
volumes. Ketanserin tartrate (Janssen Pharmaceutica, Belgium) and tropisetron 
HCl (ICS 205-930; Sandoz, Switzerland) were continuously present in the De 
Jalon's solution. All compounds were dissolved in distilled water, except for 
5-hydroxytryptamine (stock containing ascorbic acid 0.25 uM). This vehicle had 
no effect on the tone of the strips. Glyceryl trinitrate was further diluted with 
distilled water from a stock solution of 1 % in ethanol. The solution of 
haemoglobin was always freshly prepared, kept on ice during the experiment and 
protected from light. The stock solution of TTX was prepared in advance and 
kept frozen (-25 °C) in aliquots of 100 uM. It was kept on ice during the experi-
ment. 
Statistical analysis 
For graphical representation means ± standard error of the means were calcu-
lated. EC50 and IC50 values were determined by linear regression analysis. 
Differences between mean values were tested using the two-tailed Student's 
f-test for unpaired observations. Values of P<0.05 were considered to be statisti-
cally different. 
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Results 
5-HT induced concentration-dependent relaxations from 10 nM onwards 
(Figure 5.1). The relaxations were fast in onset. In about 1 out of 3 preparations, 
the relaxations induced by 5-HT in the concentration range of 0.3 uM to 3 uM 
were multiphasic, i.e. an initial relaxation followed by a quick small contraction 
and consecutively a larger, more sustained relaxation. 
uM 5-HT 
0.01 0.03 0.1 0.3 1 3 10 
2 min 
4 methacholine 0.3 uM 
Figure 5.1 Tracing of relaxations of the guinea-pig colon ascendens evoked by non-cumulative 
concentrations of 5-HT. The tone of the preparation was elevated by incubation with methacholine, 
and antagonists were continuously present to block contractile responses elicited via 5-HT2, 5-HT3 
and 5-HT4 receptors. 
The concentration-response curve to control 5-HT appeared non-mono-
phasic, starting a second phase at about 1.0 \iM (Figure 5.2). The EC50 value calcu-
lated over the entire concentration-response curve to 5-HT was 258 (172-387) nM. 
TTX (0.3 uM) contracted the strips (18.4 ± 3.8 % (n = 7) of the methacholine-
induced contractions), and it abolished the relaxations to 5-HT 10 uM ( n = 6, not 
shown). The 5-HTi receptor antagonist metergoline (10 nM) inhibited the relaxa-
tions to 5-HT (Figure 5.2). Methiothepin (0.1 uM) also inhibited the relaxations to 
5-HT (by about 45-70 % depending on the applied 5-HT concentration) but it 
inhibited the methacholine-induced contractions as well (by about 25 %). 
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Guanethidine (3 U.M) did not affect the concentration-response curve to 5-HT 
(n = 4, results not shown). 
relaxation 
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-4 log M 
Figure 5.2 Concentration-response curves to 5-HT: control (O), or in the presence 
of metergoline 10 nM (•) or methiothepin 0.1 \iM (A). The tone of the preparation 
was elevated by incubation with methacholine, and antagonists were continuously 
present to block contractile responses elicited via 5-HT2, 5-HT3 and 5-HT4 receptors. 
Values (n = 6) that are significantly different from control values (P<0.05) are marked 
with an asterisk. The relaxations were expressed as a percentage of the relaxations to 
5-HT 10 nM. 
NO-antagonists 
NG-nitro-L-arginine concentration-dependently depressed the concentration-
response curve to 5-HT, the inhibitory effect being statistically significant from 
10 uM NG-nitro-L-arginine onwards (Figure 5.3). The IC50 of the inhibitory effects 
of NG-nitro-L-arginine against 5-HT-induced relaxations was 18.7 (13.3-26.3) uM 
(calculated at 5-HT 0.3 uM). NG-nitro-L-arginine 0.3 mM abolished relaxations to 
5-HT up to 0.3 n.M. However, the relaxations caused by 5-HT > 0.3 |iM were not 
completely blocked: about 25 % of the control response remained (Figure 5.3). 
The high concentrations of NG-nitro-L-arginine elevated the tone of the prepara-
tion slightly (27.2 ± 4.5 % (n = 6) of the methacholine-induced contractions). 
L-Arginine (0.1 mM) did not affect the concentration-response curve to 5-HT 
(n = 3, results not shown). L-Arginine (0.3 mM) did completely reverse the 
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inhibition by NG-nitro-L-arginine (10 uM) against 5-HT (0.1 uM)-induced 
relaxations (n = 6, results not shown). 
log M 
5-HT 
Figure 5.3 Concentration-response curves to 5-HT: control (O), or in the presence 
of NG-nitro-L-arginine 3 nM (A), 10 nM (•), 30 |iM (•), 0.1 mM (•) and 0.3 mM (A). 
The tone of the preparation was elevated by incubation with methacholine, and anta-
gonists were continuously present to block contractile responses elicited via 5-HT2, 
5-HT3 and 5-HT4 receptors. Values (all n = 6; control n = 12) that are significantly 
different from control values (P<0.05) are marked with an asterisk.The relaxations 
were expressed as a percentage of the relaxations to 5-HT 10 uM. 
Glyceryl trinitrate concentration-dependently induced relaxations from 3 nM 
onwards (Figure 5.4) which were fast in onset. TTX (0.3 pM), NG-nitro-L-arginine 
(0.1 mM ) and L-arginine (0.1 mM) did not inhibit the responses to glyceryl tri-
nitrate (Figure 5.4). 
Haemoglobin 10 uM tended to inhibit the 5-HT-induced relaxations, whereas 
haemoglobin 30 uM significantly inhibited them (Figure 5.5, left panel). 
Isoproterenol relaxed the preparations from 1 nM onwards. The relaxations were 
not fast in onset. Haemoglobin 30 |0.M did not affect the concentration-response 
curves to isoproterenol (Figure 5.5, middle panel). In contrast, it depressed the 
concentration-response curve to glyceryl trinitrate (Figure 5.5, right panel). 
Haemoglobin slightly contracted the muscle (4.6 ± 1.6 % of methacholine-
induced contractions (n = 10)). 
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Figure 5.4 Concentration-response curves to glyceryl trinitrate in the absence of an 
antagonist (O) or in the presence of L-arginine 0.1 mM (T), Ne-nitro-L-arginine 0.1 mM 
(•) or TTX 0.3 \iM (•) . The tone of the preparation was elevated by incubation with 
methacholine, and antagonists were continuously present to block contractile 
responses elicited via 5-HT2, 5-HT3 and 5-HT4 receptors. All values n = 6. The relaxa-
tions were expressed as a percentage of the relaxations to glyceryl trinitrate 10 \iM. 
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Figure 5.5 Concentration-response curves to 5-HT {left panel), isoproterenol (middle panel) and 
glyceryl trinitrate (right panel): controls (O), or in the presence of haemoglobin 10 nM (•) and 30 |iM 
(A). The tone of the preparation was elevated by incubation with methacholine, and antagonists were 
continuously present to block contractile responses elicited via 5-HT2, 5-HT3 and 5-HT4 receptors. 
Values (n = 6) that are significantly different from control values (P<0.05) are marked with an asterisk. 
The relaxations to 5-HT, isoproterenol or glyceryl trinitrate were expressed as a percentage of the 
relaxations to 5-HT 10 |iM, isoproterenol 3 nM or glyceryl trinitrate 10 \M respectively. 
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Figure 5.6 Concentration-response curves to 5-HT (left panel), isoproterenol (middle panel) and 
glyceryl trinitrate (right panel): controls (O), or in the presence of methylene blue 10 |iM (•). The tone 
of the preparation was elevated by incubation with methacholine, and antagonists were continuously 
present to block contractile responses elicited via 5-HT2, 5-HT3 and 5-HT4 receptors. Values (n = 6) 
that are significantly different from control values (P<0.05) are marked with an asterisk. The relaxations 
to 5-HT, isoproterenol or glyceryl trinitrate were expressed as a percentage of the relaxations to 5-HT 
10 (iM, isoproterenol 3 |iM or glyceryl trinitrate 10 |iM respectively. 
Methylene blue (10 uM) inhibited the responses to 5-HT from 0.1 uM 
onwards (Figure 5.6, left panel). The concentration-response curves to isoprote-
renol or glyceryl trinitrate however were not affected (Figure 5.6, middle and 
right panels). Methylene blue (10 uM) contracted the muscle slightly (6.2 ± 2.1 % 
of the methacholine-induced contractions (n = 6)). Higher concentrations of 
methylene blue could not be tested because they inhibited the methacholine-
induced contractions seriously. 
Discussion 
The selective 5-HTi receptor antagonists methiothepin and metergoline both 
inhibited the relaxations caused by 5-HT. The selective 5 HT2 receptor antagonist 
ketanserin and the 5-HT3 and 5-HT4 receptor antagonist tropisetron were present 
throughout our experiments. It therefore seems likely that, according to the crite-
ria for 5-HT receptor classification as proposed by Bradley et al. (1986), the relaxa-
tions to 5-HT are mediated via 5-HTi receptors. Kojima (1991) and Elswood & 
Bunce (1992) also found a 5-HTi receptor to be involved in 5-HT-induced relaxa-
tions in the guinea-pig colon. It was however not established which 5-HTi recep-
tor subtype is concerned. In intestinal tissues of the guinea-pig, rat and rabbit, 
receptors with 5 - H T I A (Fozard & Kilbinger, 1985; Matsuyama et al., 1990; Wade 
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et al, 1991; Galligan, 1992), putative 5 - H T I P (Mawe et al, 1986; Branchek et al, 
1988; Wade et al, 1991), 5-HTiC and 5-HTiD (Baez et al, 1991; Kalkman & Fozard, 
1991) characteristics have been demonstrated. Further studies are required to 
elucidate which 5-HTi receptor subtype is involved in the 5-HT-induced relaxa-
tions of the guinea-pig colon. 
TTX abolished relaxant responses to 5-HT, which confirms that nerves are 
involved. Since guanethidine did not affect the 5-HT-induced relaxations (Costa 
& Furness, 1979; present results), it is not likely that noradrenaline is the 
inhibitory neurotransmitter involved. In the canine terminal ileum and ileo-
colonic junction, it has been demonstrated that 5-HT-induced relaxations are 
mediated by NO (Bogers et al, 1991). In our study, evidence is obtained which 
strongly suggests that NO is involved in 5-HT-induced relaxations in the guinea-
pig colon ascendens as well. This evidence consists of three sets of observations. 
Firstly, the L-arginine analogue NG-nitro-L-arginine, which is known to be a 
potent inhibitor of NO-synthase (Moore et al, 1990; Mülsch & Busse, 1990), 
inhibited the relaxations to 5-HT but not those to glyceryl trinitrate. Further-
more, the inhibition could be reversed by L-arginine. These data suggest that NO 
is involved in the 5-HT-induced relaxations. 
Secondly, both the relaxations to glyceryl trinitrate and 5-HT but not those to 
isoproterenol were inhibited by haemoglobin. Although the exact mechanism of 
action is still under debate, glyceryl trinitrate is thought to react with thiol groups 
of co-factors (cysteine) of the soluble guanylate cyclase, which yields the genera-
tion of NO (Ignarro et al, 1981; Feelish et al, 1988). NO in turn activates the 
soluble guanylate cyclase to increase the intracellular cyclic GMP content (Feelish 
& Noack, 1987a; b). Haemoglobin is a scavenger of NO (Martin et al, 1985; Keim 
& Schrader, 1990). It has been shown that haemoglobin does not bind or inacti-
vate glyceryl trinitrate and that it does not affect the reaction between glyceryl 
trinitrate and the thiols (Martin et al, 1986; Feelish & Noack, 1987b). In our 
experiments, neither TTX nor NG-nitro-L-arginine or L-arginine inhibited the 
relaxations to glyceryl trinitrate, which is in good agreement with the above 
mechanism of action. Due to its large size, haemoglobin is likely to be confined 
to the extracellular space. Since NO readily crosses cell membranes, haemoglobin 
might avidly bind the extracellular NO which will lower its extracellular concen-
tration, thus increasing the net rate of diffusion of NO out of the cell (Martin et 
al, 1985; 1986). This might explain the observed inhibition by haemoglobin 
against the relaxations to glyceryl trinitrate. Other authors have also found 
haemoglobin to inhibit relaxations to glyceryl trinitrate: Martin et al. (1985, 1986; 
rabbit aorta), Boeckxstaens et al (1990; canine ileocolonic junction), Bogers et al 
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(1991; canine terminal ileum and ileocolonic junction). Isoproterenol, on the 
other hand, induces relaxations through an increase of intracellular cyclic AMP-
content (Martin et al., 1985). Hence, the inhibition by haemoglobin of the relaxa-
tions to 5-HT and glyceryl trinitrate, but not isoproterenol, strongly suggests that 
NO is involved in the action of 5-HT. 
Thirdly, the relaxations to 5-HT were inhibited by the oxidant methylene 
blue, whereas the responses to glyceryl trinitrate and isoproterenol were not. 
Methylene blue is a selective inhibitor of the target of NO, the soluble guanylate 
cyclase. (Gruetter et al, 1981; Martin et al, 1985). Hence, it would be expected that 
the responses to glyceryl trinitrate would also be inhibited, as it does so in other 
tissues (Gruetter et al, 1981; Martin et al, 1985; Desai et al, 1991). We do not have 
an explanation for this observation. The inhibition of the responses to 5-HT but 
not to isoproterenol however provides additional proof for the involvement of 
NO. 
Methylene blue, NG-nitro-L-arginine, hemoglobine and also the neurotoxin 
TTX all contracted the strips. This might indicate that NO constantly leaks from 
enteric inhibitory nerves in small quantities. 
The concentration-response curve to 5-HT does not seem to be monophasic. 
Furthermore, NG-nitro-L-arginine was not able to abolish the responses to 5-HT. 
Both these findings suggest that, at higher concentrations of 5-HT, inhibitory 
endogenous substances might be co-released with NO. Whether other candidates 
for inhibitory NANC-neurotransmission, which implicates VIP and ATP, are 
involved, needs further investigation. 
It is concluded that in the guinea-pig colon ascendens NO is involved in the 
relaxation that is induced by 5-HT. Our studies confirm that the relaxations are 
mediated by 5-HTi receptor subtype. The involvement of VIP and/or ATP can 
not be excluded. 
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5-HT-induced neurogenic relaxations 
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Abstract. In the guinea-pig proximal colon, 5-hydroxytryptamine (5-HT) relaxes the longitudinal 
muscle by stimulating neuronal 5-HT receptors, which induces the release of nitric oxide (NO). It 
was investigated whether the inhibitory neurotransmitters adenosine 5'-triphosphate (ATP) 
and/or vasoactive intestinal polypeptide (VIP) could be involved as well. 
Antagonists to block the contractile responses to 5-HT via 5-HT2, 5-HT3 or 5-HT4 receptors were 
present throughout the experiments and methacholine was administered to precontract the strips. 
ATP, VIP and 5-HT induced concentration-dependent relaxations, in case of 5-HT yielding a non-
monophasic concentration-response curve. Tetrodotoxin (TTX; 300 nM), NG-nitro-L-arginine 
(L-NNA; 100 |iM) and the combination treatment did not inhibit the relaxations induced by VIP (up 
to 0.3 uM) or 0.3-3 p.M ATP but reduced those by 10 uM ATP. Suramin (300 uM) strongly inhibited 
the relaxations to ATP and VIP. L-NNA and suramin also inhibited the relaxations to 5-HT. In 
the presence of L-NNA (100 \iM), suramin did not significantly inhibit the relaxations to 5-HT. 
Suramin did not affect the relaxations to isoprenaline, nitroglycerin or exogenous NO (1 |xM), 
demonstrating its specificity. Apamin (30 nM) inhibited both the relaxations to ATP (by 70-100 %) 
and to 5-HT; relaxations to isoprenaline were partially inhibited, indicating a non-specific compo-
nent in the inhibitory action of apamin. However, relaxations to exogenous VIP (up to 0.3 |iM), NO 
(1 nM) and to nitroglycerin were not inhibited. In the presence of L-NNA (100 |iM), apamin inhib-
ited the relaxations to 5-HT only at 30 |iM. a,ß-methylene-ATP (a,ß-Me-ATP; 100 |iM) did not 
desensitize the responses to ATP. Reactive blue 2 affected the relaxations to isoprenaline at concen-
trations necessary to significantly inhibit the relaxations to ATP (i.e. from 10 |xM onwards). Thus, 
it was not possible to test either a,ß-Me-ATP or reactive blue 2 against the relaxations to 5-HT. 
a-Chymotrypsin (0.015 mg.ml*1) and trypsin (0.005 mg.ml"1) almost abolished the relaxations to 
VIP, but did not affect those to isoprenaline and 5-HT. The VIP receptor antagonists [p-Cl-D-
Phe6,Leu17]VIP (1 |iM) and VIP10-28 (1 and 3 |iM) did not affect the concentration-response curve to 
VIP and were hence not tested against 5-HT. Phosphoramidon (1 |xM) had no effect on the relaxa-
tions to VIP or 5-HT. 
It can be concluded that on the guinea-pig colon longitudinal muscle, VIP and ATP induce 
relaxation via a direct effect of the smooth muscle, not involving NO. 5-HT-induced relaxations are 
mediated by NO as well as by a substance which is sensitive to inhibition by suramin and apamin. 
It is suggested that this substance is ATP and not a peptide. 
Introduction 
5-Hydroxytryptamine (5-HT; serotonin), a neurotransmitter in the enteric 
nervous system, causes a complex response of the longitudinal muscle of the 
proximal guinea-pig colon. 5-HT induces contractions through the stimulation 
of 5-HT2, 5-HT3 and 5-HT4 receptors (Briejer et al., 1993), as well as relaxations. 
These relaxations are abolished by tetrodotoxin (TTX), a blocker of neuronal 
conductance, and are inhibited by 5-HTi receptor antagonists (Briejer et al, 1992; 
Briejer et ah, 1994b). Furthermore it was shown, that the recently identified 
inhibitory neurotransmitter nitric oxide (NO) (for review, see Stark & 
Szurszewski 1992) is involved in the 5-HT-induced relaxations (Briejer et ah, 
1992). However, the relaxations to 5-HT are only partially sensitive to NG-nitro-
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L-arginine (L-NNA), an inhibitor of the NO synthesis. Furthermore, 5-HT could 
release a transmitter which in turn causes the generation of NO. Though it is 
now generally accepted that NO is an important and widespread inhibitory 
neurotransmitter in the gut (Stark & Szurszewski, 1992), vasoactive intestinal 
polypeptide (VIP) and adenosine 5'-triphosphate (ATP) are also still on the list of 
candidates (Burnstock, 1972; Goyal et al, 1980; Kennedy, 1990; Crist et al, 1992). 
In the guinea-pig taenia caeci, which is located anatomically proximal to the 
proximal colon, a role for ATP as an inhibitory neurotransmitter has been 
suggested (Burnstock, 1972; Maas et al, 1980). ATP generally causes relaxation of 
gastrointestinal smooth muscle through stimulation of postsynaptic P2y 
purinoceptors (see: Kennedy, 1990). Several pharmacological tools are available 
to inhibit these purinoceptor-mediated responses. The trypanocide suramin and 
the anthraquinone-sulphonic acid derivative dye reactive blue 2 have been used 
as specific purinoceptor antagonists (Burnstock & Warland, 1987; Den Hartog et 
al, 1989; Hoyle et al, 1990; see for review: Kennedy, 1990). a,ß-methylene-ATP 
(oc,ß-Me-ATP), an ATP analogue that is resistant to enzymatic degradation, is 
generally used to desensitize the P2x purinoceptors, mediating contraction in 
smooth muscle preparations; still, desensitization of P2y purinoceptors inducing 
relaxation has been obtained with oc,ß-Me-ATP in some parts of the gastro-intes-
tinal tract (Kennedy, 1990). The polypeptide bee venom apamin has been used in 
several guinea-pig intestinal preparations as an effective antagonist of inhibitory 
responses to externally applied ATP (Shuba & Vladimirova, 1980; Maas et al, 
1980; Costa et al, 1986). 
Vasoactive intestinal (poly)peptide (VIP) is a neurotransmitter of the enteric 
nervous system (Goyal et al, 1980; Grider et al, 1985). Its presence in enteric 
neurones of the guinea-pig has been demonstrated with immunohistochemical 
methods (Costa & Furness, 1983; Probert et al, 1983). In most gastrointestinal 
smooth muscle preparations, VIP causes relaxations (Goyal et al, 1980; Grider et 
al, 1985) through a direct action on the smooth muscle, though in a minority of 
tissues neurogenic contractions to VIP have been observed, e.g. in the guinea-pig 
ileum (Katsoulis et al, 1993). 
The objectives of the current study were, to assess whether ATP and/or VIP, 
either as an intermediate or end transmitter, could also be involved in the 5-HT-
induced relaxations of the guinea-pig colon. 
124 Chapter 6 
Materials and methods 
Dunkin-Hartley guinea-pigs of both sexes, weighing 400-600 g, were killed by 
decapitation. The proximal colon was removed, and the luminal contents were 
washed out with De Jalon solution (mM: KCl 5.6, CaCl2 0.5, NaHC0 3 6.0, NaCl 
155, glucose 2.78). The mesentery was carefully removed. Starting at the proximal 
end, about 1 cm distal from the caecum, the colon was divided into four 
segments of circa 2.5 cm. These intact segments were individually mounted 
vertically for isotonic measurement into a tissue bath containing 20 ml De Jalon 
solution. This solution was kept at 37.5 °C and gassed with 95% O2, 5 % CO2. The 
strips were subjected to a preload of 2 g and allowed to stabilize for half an hour. 
Ketanserin (0.3 uM) and tropisetron (ICS 205-930, 3 uM) were continuously 
present in the De Jalon solution during all experiments to block contractile 
responses mediated by 5-HT2, 5-HT3 and 5-HT4 receptors. After stabilization, the 
longitudinal muscle was challenged with 0.3 uM methacholine. After washing 
and 10 min stabilization, the procedure was repeated in order to stabilize the 
response of the tissue. 
Protocols 
For the construction of concentration-response curves, agonists and antago-
nists were applied directly to the tissue bath (added volume < 3 % of tissue bath 
volume). Methacholine (0.3 uM) was added to the bath in order to precontract 
the muscle. 
5-HT. Since pilot experiments had revealed that relaxations to 5-HT are 
subjected to tachyphylaxis, non-cumulative concentration-response curves were 
established, beginning 10 min after the administration of methacholine. The size 
of the relaxation was measured as the maximum relaxation that was induced 
during an incubation period of approximately 2 min (at high concentrations in 
some cases up to 4 min). Then, 5-HT and MeCh were washed out by replacing the 
bathing fluid twice. Stabilization of 10 min was allowed. This 20 min dosing cycle 
was repeated applying the next concentration of 5-HT. The response to repetitive 
administration of methacholine was stable throughout the experiment. Each 
segment was first challenged with 10 \iM 5-HT in the absence of an antagonist 
(ketanserin and tropisetron present). After washout this cycle was repeated, 
applying again 10 uM 5-HT. The relaxation to this latter administration of 5-HT 
was taken as 100 % relaxation. Consecutively, antagonists were administered 
(and their intrinsic effects, if any, were assessed), and were left with the prépara-
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tions for 15 min. Then, non-cumulative concentration-response curves were 
established, applying the above described 20 min dosing cycle. Antagonists were 
re-added directly after each washout. Of 4 segments that were taken from each 
animal, one strip was utilized as a control. The antagonists had no effect on the 
methacholine-induced contractions. The concentrations of 5-HT were applied in 
ascending order. However, when a-chymotrypsin and trypsin were tested against 
5-HT-induced relaxations, 5-HT was applied in descending order, for the pepti-
dases tended to increase the basal length of some of the preparations after several 
hours. When an ascending concentration administration order is applied, the 
largest relaxations are in the end of the experiment. It is likely that these large 
relaxations are more affected by the increase in length of the strips due to the 
proteases than would be small relaxations. To avoid this, a descending order was 
chosen. 
ATP. A protocol identical to that of 5-HT was applied for ATP. The only 
difference was, that prior to the establishment of the concentration-response 
curves, a relaxation to 5-HT 10 nM was established. All consecutive relaxations 
were expressed as a percentage of this relaxation to 5-HT. The optimum 
antagonist concentration of suramin to inhibit ATP 3 (iM-induced relaxations 
was determined, by preincubation of the strips with increasing concentrations of 
suramin or solvent, in a similar protocol as described above. 
NO. In an identical 20 min dosing cycle as described for 5-HT, a relaxation to 
1 uM NO was induced twice; for each strip, the relaxation to this second relaxa-
tion was taken as 100 %. Then, after washout and a 10 min stabilization period, 
antagonists or vehicle (= control) were added, and a 10 min incubation period 
was allowed. Consecutively, methacholine was administered to induce a contrac-
tion, and after another 10 min, NO (1 |iM) was administered as well. 
Nitroglycerin, isoprenaline and VIP. For the construction of concentration-
response curves to nitroglycerin, isoprenaline and VIP, the compounds were 
added in a cumulative fashion, 10 min after precontraction to methacholine-
addition (0.3 uM). After washing and stabilization for 30 min (washing every 
10 min), a second concentration-response curve was established in the presence 
of an antagonist. The relaxations to nitroglycerin, isoprenaline and VIP were 
reproducible in time. The responses induced by nitroglycerin, isoprenaline and 
VIP were expressed relative to the response to respectively nitroglycerin 10 uM, 
isoprenaline 3 uM or VIP 0.3 uM of the first series for each segment. 
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Desensitization to a,ß-Me-ATP. First, the strips were precontracted with 
methacholine 0.3 uM, and after 10 min, the relaxation to 5-HT 10 uM was estab-
lished. All further relaxations in this experiment were expressed as a percentage 
of this relaxation to 5-HT. Consecutively, after washout and 10 min stabilization, 
the strips were again precontracted with methacholine, and after 10 min a 
relaxation to ATP, was established. After washout and 10 min stabilization, a,ß-
Me-ATP 100 uM was administered. Again 10 min later, the precontraction and 
relaxation cycle with ATP was repeated. 
Chemicals 
Methacholine HCl (E. Merck, Germany), nitroglycerin (Federa, Belgium), 
suramin sodium (Rhone-Poulenc, France), 5-HT creatinine sulphate, 
tetrodotoxin, apamin, vasoactive intestinal polypeptide (VIP) (Serva, Germany), 
isoprenaline tartrate, NG-nitro-L-arginine, reactive blue 2 (procion blue HB, 
Cibacron blue F3GA), ATP disodium salt (Janssen Chimica, Belgium), phosphor-
amidon, bovine trypsin (type III; specific activity: 10700 BAEE units.mg-1), bovine 
a-chymotrypsin (type II; specific activity: 40-60 BTEE units.mg"1), VIPio-28 (acetate 
salt), [p-Cl-D-Phe6,Leu17]VIP, a,ß-methylene-ATP lithium salt (Sigma, Belgium) 
were added to the tissue bath solution in volumes < 3% of the bath volumes. 
Ketanserin tartrate and tropisetron HCl (ICS 205-930; Janssen Research 
Foundation, Belgium) were continuously present in the De Jalon solution. All 
compounds were dissolved in distilled water. The stock solution for isoprenaline 
and 5-HT contained 0.25 uM ascorbic acid. This vehicle had no effect on the 
strips. Glyceryl trinitrate was further diluted with distilled water from a stock 
solution of 1 % in ethanol. The stock solutions of apamin, TTX, VIP, VIPio-28/ 
[p-Cl-D-Phe6,Leu17]VIP and phosphoramidon were prepared in advance and kept 
frozen (-30 °C). The solutions of the peptides mentioned above, as well as those 
of phosphoramidon, TTX and a,ß-Me-ATP were kept on ice during the experi-
ments. Phosphoramidon and trypsin had no effect on the length of the strips; 
NG-nitro-L-arginine, apamin, suramin and tetrodotoxin induced a transient 
shortening of the strips, but the level of precontraction by methacholine was 
unaffected. NO solution was kindly provided by Drs. J. De Man and G. 
Boeckxstaens. The solution was prepared as described elsewhere (Boeckxstaens et 
al., 1991), which yields a saturated solution of about 2 mM (Feelish, 1991). The 
NO solution was protected from air and kept on ice during the experiment. 
Addition of trypsin immediately caused complex effects on the strips (relaxations 
as well as contractions) which tended to fade within several min, but the level of 
precontraction was not affected. As stated before, trypsin and a-chymotrypsin 
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tended to increase the length of some strips after several hours, probably caused 
by their digestive action on the integrity of the tissue. 
Statistical analysis 
For graphical representation means ± standard error of the means (S.E.) were 
calculated. Differences between mean values were tested with one way analysis 
of variance using the Scheffé F-test (comparison treatment vs. treatment) or 
Dunnett/s f-test (treatment vs. control) (Wallenstein et al, 1980). The level of 
significance was set at P < 0.05. 
Results 
5-HT induced concentration-dependent relaxations (Figure 6.1, upper panel) 
that were fast in onset. Maximum relaxations were observed at 30 |iM 5-HT. In 
about 1 out of 3 preparations, the relaxations to higher concentrations of 5-HT 
were multiphasic, i.e. an initial quick relaxation followed by a small contraction 
and consecutively a more sustained relaxation (Figure 6.1, middle panel). The 
concentration-response curve to 5-HT appeared non-sigmoidal (Figure 6.2). ATP 
induced concentration-dependent relaxations (Figure 6.1, middle panel) that 
were fast in onset. The ATP-induced relaxations were short lasting, and were 
mostly followed by a second, more sustained relaxation. At higher concentra-
tions of ATP, this slow, more sustained second relaxation exceeded the first, fast 
relaxation (Figure 6.1, middle panel). The concentration-response curve to ATP 
is shown in Figure 6.2. As relaxations to 10 nM ATP approximately equalled 
maximum relaxations to 5-HT (Figure 6.2), higher concentrations of ATP were 
not tested for the construction of the ATP concentration-relaxation curve. Both 
in case of 5-HT and ATP, the maximum relaxation to each agonist concentration 
was measured for quantification of the responses, irrespective to whether this 
maximum relaxation occurred in the first, fast relaxation or the second, more 
sustained relaxation. VIP induced slowly developing concentration-dependent 
relaxations from 3 nM onwards, which did not fade (Figure 6.1, lower panel). 
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Figure 6.1 Representative tracings of the relaxations to 5-hydroxytryptamine (5-HT; 
upper tracing), adenosine triphosphate (ATP; middle tracing) and vasoactive intesti-
nal polypeptide (VIP; lower tracing). The preparations were precontracted with 
methacholine, whereafter 5-HT, ATP or VIP were added. Antagonists were continu-
ously present to block contractile responses elicited via 5-HT2, 5-HT3 and 5-HT4 
receptors. 
At low concentrations (3 nM), some strips responded after a short lag time 
(maximally about 0.5 min), but at higher concentrations no lag time was 
observed. The concentration-response curve of the relaxations to VIP was 
sigmoidal, with a near maximum effect at 0.3 uM VIP. Maximum relaxations to 
5-HT were on average only about half in magnitude of that caused by VIP. VIP 
inhibited the spontaneous movements of the strips. Isoprenaline induced slowly 
developing relaxations, whereas those to nitroglycerin were fast in onset. The 
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maximum relaxations to isoprenaline and nitroglycerin were on average about 
twice as large as those to 5-HT. 
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Figure 6.2 The concentration-response curves to ATP (Q) and 5-HT (O) (n = 14 -
29; means ± S.E.). The relaxations to ATP and 5-HT were expressed as a percentage 
of relaxations induced by 5-HT 10 (iM. 
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Figure 6.3 Concentration-response curves to adenosine triphosphate (ATP) in the 
absence of drugs (O) or in the presence of tetrodotoxin 0.3 \LM ( • ) , NG-nitro-
L-arginine too nM (• ) , or both tetrodotoxin and Ne-nitro-L-arginine (A). Values 
(means ± S.E.; n = 6) that are significantly different from control (P < 0.05) are 
marked with an asterisk. The relaxations to ATP were expressed as a percentage of 
relaxations to 5-hydroxytryptamine (5-HT) 10 |j.M. 
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Tetrodotoxin (TTX) and NG-nitro-L-arginine (L-NNA) 
The neuronal conductance blocker TTX (0.3 uM) did not affect the responses 
to ATP up to 3 uM, but at 10 n_M ATP, it significantly inhibited the relaxations 
due to ATP (Figure 6.3). The NO synthase inhibitor L-NNA (100 uM) had a 
similar effect on the relaxations to ATP, as did the combination treatment with 
TTX and L-NNA (Figure 6.3). TTX (0.3 uM) did not significantly affect the concen-
tration-response curve to VIP (n = 4), nor did L-NNA (100 uM; n = 4) (not 
shown). 
Suramin 
The putative P2-purinoceptor antagonist suramin, at a concentration > 30 uM, 
inhibited relaxations to ATP 3 |iM significantly, while the inhibition was maxi-
mal at 300 uM suramin (n = 8; not shown). Suramin (300 uM) induced transient 
contractions (11.0 ± 3.8 % of 5-HT-induced relaxations; n = 6) and it had no signi-
ficant effect on the magnitude of the methacholine-induced precontractions. 
Suramin strongly inhibited the relaxations to ATP up to 3 uM (Figure 6.4, upper 
panel). Surprisingly, the concentration-relaxation curve to VIP was also strongly 
depressed (Figure 6.4, middle panel). Suramin (300 |iM) did not significantly 
influence the concentration-relaxation curves to isoprenaline and nitroglycerin 
(n = 4; not shown). Relaxations to exogenous NO (ca. 1 uM) were also not signifi-
cantly inhibited by suramin (300 uM; n = 8, not shown). Suramin inhibited the 
relaxations to 5-HT in the low concentration range (up to 3 uM), but the relaxa-
tions to higher concentrations of 5-HT were more strongly inhibited, rendering a 
monophasic sigmoidal concentration-response curve (Figure 6.3, lower panel; 
n = 8). As observed before (Briejer et al, 1992), L-NNA (100 uM) strongly 
inhibited the relaxations to 5-HT. In the presence of L-NNA (100 |i.M), suramin 
(300 uM) could not significantly inhibit the relaxations to 5-HT any further 
(Figure 6.4, lower panel; n = 8). 
Apamin 
The Ca2+-dependent K+-channel blocker apamin (30 and 600 nM) induced 
short-lasting contractions (resp. 33.7 ± 5.4 % and 51.7 ± 6.8 % of 5-HT-induced 
relaxations, n = 6), and it had no effect on the magnitude of the methacholine-
induced precontractions. Apamin 30 nM strongly inhibited the relaxations to 
ATP (Figure 6.5, upper panel; n = 4); at 600 nM, apamin could not inhibit the 
relaxations to ATP any further (n = 4; not shown), which indicates that 30 nM is a 
fully effective concentration. Up to 3 uM ATP (i.e. relaxations which are in 
magnitude comparable to maximum relaxations to 5-HT), apamin inhibited the 
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ATP relaxations by 70-100 % (Figure 6.4, upper panel). Apamin (30 nM) inhibited 
relaxations to VIP only significantly at 30 nM VIP (Figure 6.5, middle panel), 
while it depressed the concentration-response curve to isoprenaline by about 
10-20 % (n - 4; not shown). The relaxations to nitroglycerin were not significantly 
affected by the presence of apamin 30 nM (n = 4; not shown). Apamin 600 nM did 
not significantly inhibit the relaxations to NO (1 uM; n = 8, not shown; apamin 
30 nM was not tested against NO). Apamin (30 nM) inhibited the relaxations to 
5-HT, the inhibition being more prominent at higher concentrations of 5-HT 
(Figure 6.4, lower panel). In the presence of L-NNA (100 uM), apamin (30 nM) 
only significantly inhibited relaxations to 5-HT 30 uM. 
Miscellaneous substances 
The neutral endopeptidase inhibitor phosphoramidon (1 uM) had no signifi-
cant effect on the relaxations to VIP (n = 6; not shown), nor did it affect the 
concentration-response curve to 5-HT (n = 6; not shown). The putative VIP 
receptor antagonists [p-Cl-D-Phe6,Leu17]VIP (1 uM) and VIPio-28 (1 and 3 |J.M) 
induced a transient contraction of respectively 13.5 ± 6.3 %, 29.8 ± 3.3 % and 
58.7 ± 8.9 % of VIP (0.3 uM)-induced relaxations (n = 4). By the time that VIP was 
administered, the effects of the VIP receptor antagonists had disappeared. 
Neither of these putative VIP receptor antagonists affected the relaxations to exo-
genously applied VIP, yielding concentration-response curves that coincided 
with controls (n = 4; not shown). The peptidases a-chymotrypsin and trypsin had 
no effect against isoprenaline-induced relaxations at a concentration of respec-
tively 0.015 mg.ml"1 and 0.005 mg.ml"1 (n = 5; not shown). However, higher 
concentrations of the peptidases (0.010 mg.ml"1 and 0.030 mg.ml"1 respectively) 
caused a significant decrease of both the methacholine-induced precontractions 
and the relaxations to isoprenaline, and therefore the former concentrations 
were used to test against VIP. a-Chymotrypsin (0.015 mg.ml"1) as well as trypsin 
(0.005 mg.ml"1) abolished the relaxations to VIP up to 0.03 uM, and strongly 
inhibited them up to 0.3 uM VIP (n = 4; Figure 6.6). Neither a-chymotrypsin 
(0.015 mg.ml"1), nor trypsin (0.005 mg.ml"1) significantly (P > 0.05) affected the 
concentration-response curve to 5-HT (n = 6; not shown). 
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Figure 6.4 The upper panel shows a 
concentration-response curve to adeno-
sine triphosphate (ATP) in the absence 
(O) and presence (•) of suramin 300 u.M. 
Suramin 300 \iM ( • ) also strongly inhib-
ited the relaxations to vasoactive intesti-
nal polypeptide (VIP) (O = control; middle 
panel}. The lower panel shows concen-
tration-response curves to 5-hydroxy-
tryptamine (5-HT): control (O) or in the 
presence of suramin 300 u,M ( • ) , 
NG-nitro-L-arginine (L-NNA) 100 u,M (•) , 
or both suramin and L-NNA (A). Values 
(means ± S.E.; n = 4 - 8) that are signifi-
cantly different from control (P < 0.05) 
are marked with an asterisk. The relaxa-
tions to ATP were expressed as a per-
centage of relaxations to 10 u.M 5-HT, 
whereas the relaxations to VIP were ex-
pressed as a percentage of the relaxa-
tions to 0.3 uM VIP. 
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Figure 6.5 The upper panel shows a 
concentration-response curve to adeno-
sine triphosphate (ATP) in the absence 
(O) and presence (•) of apamin 30 nM. 
Apamin 30 nM (•) inhibited the relaxa-
tions to vasoactive intestinal peptide (VIP) 
(O = control) only at 30 nM VIP (middle 
panel). The lower panel shows concentra-
tion-response curves to 5-hydroxytrypt-
amine (5-HT): control (O) or in the 
presence of apamin 30 nM (•), NG-nitro-
L-arginine (L-NNA) 100 p.M (•), or both 
apamin and L-NNA (•). Values (means ± 
S.E.; n = 4-6) that are significantly differ-
ent from control (P < 0.05) are marked 
with an asterisk; significant difference 
from treatment with L-NNA is denoted with 
t . The relaxations to ATP were ex-
pressed as a percentage of relaxations to 
10 \iM 5-HT, whereas the relaxations to 
VIP were expressed as a percentage of 
the relaxations to 0.3 \M VIP. 
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a,ß-Me-ATP 
The metabolic degradation-resistant ATP analogue a,ß-Me-ATP 100 uM 
induced a lasting relaxation (139 ± 17 % of 5-HT-induced relaxations, 8 strips), 
without any sign of fading. When methacholine 0.3 uM was subsequently added 
to precontract the muscle, it induced a transient contraction (normally a tonic 
contraction), followed by phasic contractions in 7 out of 8 strips (normally a stable 
line). When after 10 min ATP 3 |iM was added as well, it still induced relaxations 
(64 ± 6 % of the ATP-induced relaxations before treatment, n = 4). Another exper-
iment revealed, that even after 2 h and a second administration of a,ß-Me-ATP 
after 1 h, consecutive relaxations to ATP were not at all desensitized by use of 
cc,ß-Me-ATP (n = 4, not shown). From these results it is clear, that under the 
present experimental conditions, it is not possible to desensitize the inhibitory 
responses to ATP. Therefore, no further experiments were performed with this 
compound. 
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Figure 6.6 Concentration-response curves to vasoactive intestinal polypeptide 
(VIP): control (O), or in the presence of a-chymotrypsin (•) (0.015 mg.ml"1) or trypsin 
( • ) (0.005 mg.ml"1). The relaxations to VIP were expressed as a percentage of 
relaxations to VIP (0.3 |iM) in the absence of a peptidase. Values represent the 
means ± SE of 4 experiments. 
Reactive blue 2 
The putative P2y-purinoceptor antagonist reactive blue 2, in concentrations 
from 10 (iM onwards, significantly inhibited the relaxations to isoprenaline, 
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depressing the concentration-response curve (10 uM: 30 % depression of 
maximum; 30 uM: 45 % depression). Reactive blue 3 uM did not affect the relaxa-
tions to ATP. The contractions to methacholine were also inhibited (up to 30 %) 
by reactive blue 2 in the tested concentrations; these effects seemed to increase 
with time. Hence, in our preparation, reactive blue 2 could not be used as an 
antagonist to study ATP-mediated responses. 
Discussion 
The results of the current study suggest that, in association with NO (Briejer 
et al, 1992; current results) ATP might be involved in the mediation of 5-HT-
induced relaxations in the guinea-pig proximal colon longitudinal muscle. 
Evidence for the involvement of VIP or another peptide was not obtained. 
ATP caused the preparations to relax, a concentration of 3 uM being about as 
effective as 5-HT 10 uM. A slightly higher concentration of ATP induced relaxa-
tions that were partially sensitive to the blocker of NO synthase, L-NNA, and the 
neurotoxin TTX; the combined treatment caused no additional inhibition. VIP-
induced relaxations were not inhibited by either TTX or L-NNA, suggesting an 
action directly on the smooth muscle. These observations suggest that VIP and 
ATP at lower concentrations act mainly directly on the smooth muscle, although 
at higher concentrations ATP may also release some NO from a neuronal source. 
Suramin inhibited the relaxations to exogenously applied ATP. In contrast, it 
did not affect the relaxations to either isoprenaline, which acts by stimulation of 
post-junctional ß-adrenoceptors (Broadly & Grassby 1985), or nitroglycerin, which 
generates NO (NO-synthase independent) (Feelish, 1991). Relaxations induced by 
exogenous NO were also not affected by suramin. Many other studies have 
demonstrated the antagonist specificity of suramin for P2 purinoceptor-mediated 
responses (Den Hertog et al, 1989; Hoyle et al, 1990; see also: Kennedy, 1990). 
Relaxations to ATP, that were in magnitude comparable to submaximal 
relaxations to 5-HT, were virtually abolished by suramin. Thus, if 5-HT were to 
act solely through the release of ATP, its relaxations should be potently inhibited 
by suramin which is not the case. It has been shown previously, that the greater 
part of the relaxations to 5-HT is mediated by NO as a final transmitter (Briejer et 
al, 1992). Exogenous NO mimicked the relaxations to 5-HT, and the relaxations 
to 5-HT, but not NO, were sensitive to inhibition by L-NNA. Hence, the observa-
tions with L-NNA in this study confirm this conclusion. Both NO and ATP relax 
the smooth muscle mainly by a direct action (Briejer et al, 1992; current results). 
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As L-NNA inhibits most of the relaxation to 5-HT, if ATP is involved as well as 
NO, the concentration of endogenously released ATP is likely to be low. 
Therefore, relaxations to endogenous concentrations of ATP should be abolished 
by suramin. Indeed, suramin did partially inhibit the relaxations to 5-HT, 
especially at higher concentrations of 5-HT. At these higher concentrations, 
L-NNA could not completely block the relaxations to 5-HT. However, in the 
presence of L-NNA, suramin did not significantly further inhibit the relaxations. 
This might indicate that the endogenously released NO acts synergistically with 
ATP in relaxing the smooth muscle. 
Surprisingly, it was found that suramin is also an effective inhibitor of VIP-
induced relaxations in this preparation. This observation undermines the 
contention that suramin is a specific purinoceptor antagonist. Furthermore, the 
observed inhibition by suramin against 5-HT-induced relaxations, could also 
suggest that VIP instead of or next to ATP is involved. 
A second set of observations strengthens the ATP hypothesis. The ATP-
induced relaxations, but not those to VIP, were potently inhibited by apamin. 
Shuba and Vladimirova (1980) discovered that apamin abolishes the hyperpolar-
izing action of externally applied ATP in guinea-pig intestinal preparations. 
Apamin was also found to inhibit the relaxation and the inhibitory junction 
potentials that are evoked when non-adrenergic non-cholinergic nerves are 
electrically stimulated and which have been associated with the facilitation of 
purinergic transmission (Shuba & Vladimirova 1980). These observations might 
well be explained by the Ca2+-dependent K+-channel blocking properties of 
apamin (Banks et al, 1979; Maas et al, 1980). However, the specificity of apamin 
has been discussed, for it has been shown that it does not only inhibit hyper-
polarizations and inhibitory junction potentials to ATP. NO and noradrenaline 
or noradrenergic nerve stimulation also evoke similar inhibitory responses, that 
in some tissues are inhibited by apamin (Banks et al, 1979; Ward et al, 1992). We 
have previously shown, that noradrenaline is not involved in the 5-HT-induced 
relaxations (Briejer et al, 1992). Furthermore, it is known that not all Ca2 +-
dependent K+-channels are sensitive to apamin (Jury et al, 1985; Ward et al, 
1992), which suggests the existence of several subtypes of these K+-channels. In 
our preparation, apamin only slightly inhibited the relaxations to isoprenaline, 
but not those to nitroglycerin, NO or VIP. In other studies it was also reported 
that, in similar preparations, apamin (0.5 uM) slightly inhibited the relaxations 
to isoprenaline and VIP (Costa et al, 1986). Since, in contrast, apamin potently 
inhibited relaxations induced by ATP (current results) and cc,ß-Me-ATP (Costa et 
al, 1986), it seems that apamin is, in this preparation, a relatively specific antago-
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nist of the relaxations to ATP. We therefore tested it against the relaxations to 
5-HT, and found that apamin caused marked inhibition, especially in the higher 
5-HT concentration range. These observations confirm the above results, sugges-
ting a role for ATP, but not VIP, in the 5-HT-induced relaxations. 
To further strengthen our hypothesis, we attempted to seek for more 
pharmacological tools. Reactive blue 2, previously described as a P2 purinoceptor 
antagonist (slightly selective for the P2y purinoceptor) (Burnstock & Warland, 
1987; Crist et al., 1992), caused many non-specific effects in our preparation. At 
concentrations necessary to inhibit ATP-induced relaxations (in gastrointestinal 
preparations > 30 uM: Lefebvre & Burnstock 1990), it inhibited relaxations to 
isoprenaline as well. It was therefore not possible to test reactive blue 2 against 
5-HT-induced relaxations. Other workers have also observed these non-specific 
(time-dependent) effects, and it has been suggested, that the impurity of commer-
cially available reactive blue 2 (60 % pure) may well cause these problems 
(Burnstock & Warland, 1987). 
It was also investigated whether it was possible to desensitize the purino-
ceptor responsible for the relaxations to ATP. Since ATP is a metabolically and 
chemically rather unstable agent, a,ß-Me-ATP, resistant to metabolic degrada-
tion, was used. a,ß-Me-ATP is usually more effective than ATP as a desensitizing 
agent (Kennedy, 1990). However, a,ß-Me-ATP induced non-fading relaxations, 
and the relaxations to exogenous ATP applied subsequently did not appear 
inhibited. From the above discussed observations it thus seems that the 
P2-purinoceptors under the applied experimental conditions are not prone to 
desensitization. It is known, though not understood, that in some parts of the 
gastrointestinal tract, repeated administration of ATP or a,ß-Me-ATP does not 
lead to desensitization of the inhibitory (P2y purinoceptor-mediated) responses, 
whereas in other parts it does (Kennedy, 1990). Based on the observations 
discussed above, no further experiments with a,ß-Me-ATP were therefore under-
taken. 
Neural endopeptidase EC 3.4.24.11 (NEP), an enzyme which degrades endo-
genous peptide transmitters, has been shown to be present in the guinea-pig 
gastrointestinal tract (Nau et al, 1986; Gu et al, 1993). Phosphoramidon, a potent 
inhibitor of NEP (IC50 ~ 5 nM; Gu et al 1993), has been reported to potentiate the 
inhibitory response to exogenous VIP in guinea-pig trachea (Rhoden & Barnes 
1989). In our preparation, phosphoramidon did not affect the relaxations to 
exogenous VIP or to 5-HT. These results either suggest that NEP is not present in 
a concentration that is high enough to significantly influence the concentration 
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of VIP at its site of action, or that VIP (or another NEP-degradable peptide) is not 
involved in the relaxations to 5-HT. 
To date, a potent and selective VIP receptor antagonist is still not available. 
The antagonists that have been claimed to possess VIP antagonistic activity are 
analogues of VIP or GRF (which structurally is a member of the VIP peptide 
family), and need to be applied at micromolar concentrations (see for review: 
Presti & Gardner, 1993). [p-Cl-D-Phe6,Leu17]VIP (IC50 at VIP receptor ~ 3 uM, 
Pandol et al, 1986) was tested at a concentration of 1 \iM and the VIP fragment 
VIPio-28 (IC50 ~ 1 uM, Turner et al, 1986) at 1 uM and also at 3 uM. At the tested 
concentrations, however, they did not have any effect on the relaxations to 
exogenous VIP. Other studies have also reported on the ineffectiveness of these 
putative VIP receptor antagonists against responses to VIP, even up to a concen-
tration of 30 |iM (D'Amato et al, 1988; De Beurme & Lefebvre, 1988; Ellis & 
Farmer, 1989a). Thus, if these antagonists were to have any antagonistic effect in 
our tissues, some inhibition was to be expected at the applied concentractions. 
For example, in guinea-pig airway tissue, 1 uM [p-Cl-D-Phe6,Leu17]VIP signifi-
cantly inhibited relaxations to exogenous VIP (Venugopalan et al, 1990). 
Interestingly, both [p-Cl-D-Phe6,Leu17]VIP and VIPio-28 induced a contraction in 
our preparation. In a guinea-pig ileum preparation, it has been shown that VIP 
and pituitary adenylate cyclase-activating polypeptide (PACAP) evoke a neuro-
genic contraction (Katsoulis et al, 1993). These observations and the ineffective-
ness of the antagonists to inhibit VIP-induced relaxations in our preparation 
might be explained in terms of regional differences of VIP receptors and different 
subtypes of VIP/PACAP receptors. Since the putative VIP antagonists were 
ineffective against VIP itself in our preparations, they were not tested against 
5-HT-induced relaxations to investigate the involvement of VIP. 
Peptidases like trypsin and oc-chymotrypsin have been successfully applied to 
investigate peptidergic involvement in relaxatory responses in guinea-pig, 
human and rat tissues (De Beurme & Lefebvre, 1987; Ellis & Farmer 1989b; 
Belvisi et al, 1993). It cannot be excluded that the peptidases did not reach the site 
of action of VIP because of their large molecular size. However, the specific 
inhibition by oc-chymotrypsin and trypsin of electrical field stimulation-induced 
peptidergic responses, suggests that the peptidases do penetrate tissues (De 
Beurme & Lefebvre, 1987; D'Amato et al, 1988; Ellis & Farmer, 1989b; Belvisi et 
al, 1993). In our preparation, trypsin and a-chymotrypsin almost abolished 
relaxations to externally applied VIP, while leaving the relaxations to 
isoprenaline unaffected. Hence, trypsin and a-chymotrypsin are suitable to 
investigate the involvement of VIP in 5-HT-induced relaxations in our prépara-
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tion. However, neither trypsin nor oc-chymotrypsin affected the relaxations to 
5-HT in any respect. These results suggest that VIP is not involved in the 5-HT-
induced relaxations The action of trypsin and cc-chymotrypsin against relaxatory 
peptides other than VIP has not been investigated in our preparation. 
Summarizing, the results as presented here favour the involvement of a 
second transmitter next to NO in 5-HT-induced relaxations of the guinea-pig 
colon. Suramin inhibited the relaxations to 5-HT, ATP and VIP, but apamin was 
only effective against 5-HT and ATP, which suggest ATP is involved. Further-
more, the lack of effect of oc-chymotrypsin and trypsin against 5-HT-induced 
relaxations argues against involvement of a peptide. As relaxations to ATP (and 
to VIP and NO: current results and Briejer et al. 1992) were shown to be (largely) 
caused via a direct effect on the smooth muscle, not involving NO synthesis, it is 
suggested that NO and ATP are both released in parallel and act in a synergistic 
way. The biphasic concentration-response curve to 5-HT could suggest that even 
two 5-HT receptor types are involved, a high affinity 5-HT receptor mediating 
NO generation and a low affinity 5-HT receptor mediating ATP release. Direct 
and indirect evidence for a two receptor system has also been obtained with the 
use of several 5-HT receptor antagonists (Briejer et al, 1994a; b). 
It can be concluded that on the guinea-pig colon longitudinal muscle, VIP and 
ATP induce relaxation via a direct effect of the smooth muscle, not involving 
NO. 5-HT-induced relaxations are mediated by NO as well as by a substance 
which is sensitive to inhibition by suramin and apamin. It is suggested that this 
substance is ATP and not a peptide. 
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Abstract 5-hydroxytryptamine (5-HT) contracts the guinea-pig proximal colon via 5-HT2A, 5-HT3 
and 5-HT4 receptors, and causes relaxation via unknown neurogenic 5-HT receptors. The aim of the 
current investigation was to characterize these 5-HT receptors. 
Ketanserin 0.3 |iM and tropisetron 3 |iM were continuously present to prevent contractions to 
5-HT, and the strips were precontracted with methacholine 0.3 (iM. Under these circumstances, 
5-HT induced relaxations from 10 nM onwards, yielding a biphasic concentration-response curve. 
Other tryptamines were also agonists with the following rank order of potency: 5-HT > 
5-carboxamidotryptamine (5-CT) = 5-methoxytryptamine (5-MeOT) > a-methyl-5-HT (a-Me-
5-HT; partial agonist) > tryptamine (partial agonist). 5-Hydroxytryptophan, 2-methyl-5-HT 
(2-Me-5-HT) and N-methyl-tryptamine were virtually inactive as agonists. The concentration-
response curve to 5-HT was not affected by pargyline (MAO inhibitor), Citalopram (5-HT uptake 
inhibitor), phentolamine (ct-adrenoceptor antagonist), a tenfold increase of the ketanserin 
concentration, or by the 5-HT4 receptor antagonists 2-methoxy-4-amino-5-chloro-benzoic acid 
2-(diethylamino)-ethyl ester (SDZ 205-557) and (l-butyl-4-piperidinylmethyl)-8-amino-
7-chloro-l,4-benzodioxan-5-carboxylate (SB 204070). 8-hydroxy-2-(di-n-propylamino)-tetralin 
(8-OH-DPAT), (5-methoxy-3[l,2,3,6-tetrahydroxypyridin-4-yl]-lH-indole (RU 24969), 2-(2,6-di-
methoxyphenoxyethyl)-aminomethyl-l,4-benzodioxane (WB 4101), l-(3-chlorophenyl)-piper-
azine (mCPP), l-(m-trifluoromethylphenyl)-piperazine (TFMPP), flesinoxan, sumatriptan and 
6-chloro-2-(piperazinyl)-pyrazine (MK212) were inactive as 5-HT receptor agonists; some were 
found to antagonize methacholine-induced contractions. The first phase of the concentration-
relaxation curve to 5-HT was inhibited by the following drugs: metergoline (pA2 = 8.8 ± 0.3, against 
5-MeOT 9.3 ± 0.3), methysergide (non-surmountable; NS), methiothepin (NS), spiroxatrine (NS), 
MK212 (NS), mesulergine (7.8 + 0.3), mCPP (7.1 ± 0.1), mianserin (7.0 ± 0.4), ritanserin (8.9 ± 0.2), 
rauwolscine (7.0 ± 0.2), yohimbine (6.2 + 0.2), l-(l-naphtyl)-piperazine (1-NAP; 7.7 ± 0.2) and 
RU 24969 (6.4 ± 0.1), but not by l-(2-methoxyphenyl)-4-[4-(2-phtalimidobtyl] -piperazine (NAN-
190), spiperone, sumatriptan, 8-OH-DPAT and flesinoxan. When compared with pharmacological 
affinity and efficacy profiles at the currently recognized 5-HT receptor subtypes, the guinea-pig 
colon high affinity 5-HT receptor correlated only with receptors of the 5-HT2 group (significantly 
with 5-HT2C and near-significantly with 5-HT2A)- The receptor under study however also 
displayed pronounced pharmacological differences with these receptors. 
It is therefore suggested that the 5-HT receptor under study could be considered a 5-HT2-like 
receptor. 
Introduction 
In the guinea-pig gastrointestinal tract, several receptors for serotonin 
(5-hydroxytryptamine; 5-HT) have been identified that are involved in motor 
responses: classical 5-HT2 receptors mediating smooth muscle contraction (this 
receptor is currently designated 5-HT2A/ Humphrey et al, 1993), and 5-HT3 and 
5-HT4 receptors on the enteric nerves, which cause an increase in acetylcholine 
release upon stimulation (Engel et al., 1984; Eiswood et ah, 1991; Briejer et al., 
1993). Furthermore, acetylcholine release-inhibiting prejunctional 5 - H T I A 
receptors have been identified on the myenteric nerves (Fozard & Kilbinger, 
1985; Galligan, 1992). However, several studies have appeared, presenting data 
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on 5-HT receptors in guinea-pig gastrointestinal tissues that cannot be classified 
according to the 5-HT receptor classification scheme as proposed by Humphrey et 
al. (1993). In the stomach fundus and in the ileum, 5-HT receptors have been 
identified on the smooth muscle with 5-HTi-like properties (Feniuk et al, 1983; 
Kalkman et al, 1986; Kojima et al, 1992). In the proximal colon, neuronal 5-HT 
receptors were found to mediate relaxation involving nitric oxide (Kojima et al, 
1991; Eiswood & Bunce, 1992; Briejer et al, 1992; 1995). Classically, responses to 
5-HT that are inhibited by the 5-HTi/5-HT2 receptor antagonists methiothepin 
and methysergide, but not by the 5-HT2 receptor antagonist ketanserin and a 
5-HT3 receptor antagonist like tropisetron, would be designated as mediated by 
5-HTi receptors (Bradley et al, 1986). Based on these criteria, Kojima (1991) and 
Elswood & Bunce (1992) suggested that the 5-HT receptor that mediates 
relaxation in the guinea-pig colon was a 5-HTi receptor subtype. As in the mean 
time many new receptor subtypes were characterized, the 5-HT receptor 
classification scheme was extended, and new criteria for classification were 
proposed (Humphrey et al, 1993). According to these novel guidelines, some of 
the above described "orphan" receptors would probably not be designated 5-HTi-
like. 
The aim of the current study was to try and characterize the high affinity 5-HT 
receptor mediating relaxation of the guinea-pig proximal colon longitudinal 
muscle. We therefore tested both 5-HT receptor agonists and antagonists and 
compared observed activity and affinity to literature data, in the view of the 
novel 5-HT receptor classification scheme. 
Materials and methods 
Preparation 
Dunkin-Hartley guinea pigs of both sexes, weighing 400-600 g, were killed by 
stunning and decapitation. The proximal colon was removed, and the luminal 
contents were washed out with De Jalon solution (mM: KCl 5.6, CaCl2 0.5, 
NaHCC»3 6.0, NaCl 155, D-(+)-glucose 2.8). The mesentery was carefully removed. 
Starting at the proximal end, about 1 cm distal from the caecum, the colon was 
divided into four segments of circa 2.5 cm. These intact segments were 
individually mounted vertically for isotonic measurement into a tissue bath 
containing 20 ml De Jalon solution. This solution was kept at 37 °C and gassed 
with 95% O2, 5 % CO2. The tissues were subjected to a load of 2 g and allowed to 
stabilize for half an hour. Ketanserin (0.3 uM) and tropisetron (3 uM) were 
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continuously present in the De Jalon solution during all experiments to block 
contractile responses mediated by 5-HT2A/ 5-HT3 and 5-HT4 receptors. After 
stabilization, the longitudinal muscle was challenged with 0.3 uM methacholine. 
After washing and 10 min stabilization, the procedure was repeated in order to 
stabilize the response of the tissue. 
Protocols 
For the construction of concentration-response curves, drugs were applied 
directly to the tissue bath (added volume < 1 % of tissue bath volume). 
Methacholine (0.3 uM) was added to the bath in order to precontract the muscle. 
As the relaxations to 5-HT were previously shown to be prone to 
desensitization (Briejer et al, 1992), non-cumulative concentration-response 
curves to the agonists were established, beginning 10 min after the 
administration of methacholine. As soon as a maximum relaxation to a 
concentration of agonist occurred (after 2 to 4 min), methacholine and the 
agonist were washed out by replacing the bathing fluid twice and stabilization of 
10 min was allowed. This 20 min dosing cycle was repeated applying the next 
concentration of agonist (ascending order). The response to repetitive 
administration of methacholine was stable throughout the experiment. Each 
segment was first challenged with 10 |oM 5-HT in the absence of an antagonist 
(ketanserin and tropisetron present). After washout, this cycle was repeated, 
applying again 10 uM 5-HT. The relaxation to this latter administration of 5-HT 
was taken as 100 % relaxation. Consecutively, drugs that might interfere with the 
agonist under study, were administered, and were left with the preparations for 
15 min. Then, non-cumulative concentration-response curves were established, 
applying the above described 20 min dosing cycle. Drugs were re-added directly 
after each washout. Of 4 segments that were taken from each animal, one strip 
was utilized as a control (i.e. one curve per preparation). 
For the construction of concentration-response curves to methacholine, a 
similar protocol was used, but the concentrations were added cumulatively 
instead of non-cumulatively. Hence, first a curve was established in the absence 
of the drug to be tested, and then, after washout, drug addition and 15 min 
stabilization the curve was repeated (2 curves per preparation). Concentration-
response curves to methacholine were reproducible. 
Data analysis 
Means ± standard error of the mean (S.E.) were calculated. Differences 
between control and treated segments were evaluated with one way analysis of 
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variance and subsequently Dunnett 's t-test for multiple comparisons 
(Wallenstein et al, 1980). The level of significance was set at P < 0.05. EC50 values 
were determined with linear regression analysis. Only the first phase of the 
concentration-response curves to 5-HT (0.01-1 uM) and 5-MeOT (0.1-10 |oM) were 
considered for the calculation of affinity parameters. The maximum effects of the 
first phases were estimated with a Lineweaver-Burk plot followed by linear 
regression analysis (Tallarida & Murray, 1981). pA2 values and their standard 
errors were estimated with the Schild-Gaddum equation, or were determined 
with a Schild plot, according to the methods described by Tallarida & Murray 
(1981). In some cases of non-surmountable antagonism, a pD'2 value 
(-log (concentration) of antagonist that causes 50 % depression) was calculated 
according to Van Rossum (1963). 
Chemicals 
The following drugs were used: ketanserin tartrate, tropisetron, SB 204070, 
SDZ 205-557, NAN-190 HCl, spiperone, mCPP, TFMPP cyclohexanesulfamate, 
2-methyl-5-hydroxytryptamine, 8-OH-DPAT HBr, phentolamine HCl, 
sumatriptan, mesulergine HCL, ritanserin, spiroxatrine (Janssen Research 
Foundation, Belgium), metergoline (Gruppo Montedison, Italy), methiothepin 
maleate (Hoffman-La Roche, Switzerland), dopamine HCl, 5-hydroxytryptophan, 
N-methyltryptamine, tryptamine HCl, 5-methoxytryptamine HCl (Janssen 
Chimica , Belg ium) , me thacho l ine HCl (E. Merck, G e r m a n y ) , 
5-hydroxytryptamine creatinine sulphate (Serva, Germany), paroxetine HCl 
(Ferrosan, Denmark), Citalopram HBr (Lundbeck, Denmark), pargyline HCl 
(Abbott, USA), 5-carboxamidotryptamine maleate, a -methyl -5-hydroxy-
tryptamine maleate (Cookson Chemicals, UK), l-(l-naphtyl)piperazine HCl 
(Lilly, UK), flesinoxan HCl (Duphar, The Netherlands), mianserin HCl 
(Organon, The Netherlands), methysergide maleate (Sandoz, Switzerland), 
MK212 HCl (MSD, USA), rauwolscine HCl (Carlrooth, UK), RU 24969 -1/2 
tartrate (Roussel-Uclaf, France), yohimbine HCl (Sigma, Belgium), WB4101 
(Amersham, UK). All compounds were dissolved in distilled water, except for 
the bases, which were dissolved in distilled water acidified with tartaric acid in 
the stock solution (pH > 3). The stock solution for 5-HT contained 0.25 |xM 
ascorbic acid. This vehicle had no effect on the strips. 
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Results 
5-HT and analogues 
As previously described (Briejer et al, 1992; 1995), 5-hydroxytryptamine 
induced relaxations from 10 nM onwards, yielding a biphasic concentration-
response curve (Figure 7.1). The relaxations reached a maximum effect in 1-2 
min, and then decayed in the course of minutes. The first phase ranged from 
10 nM to 1 uM (maximum 83 %; pECso = 7.00 ± 0.04; n = 79), and the second 
phase ranged from 1 uM to 100 uM. 5-MeOT and 5-CT induced relaxations, 
yielding a biphasic and a monophasic concentration-response curve, respectively 
(pEC50 values 6.16 ± 0.03 and 6.10 ± 0.02 respectively; n = 22 and 10) (Figure 7.1). 
oc-Me-5-HT and tryptamine also induced relaxations, but with a lower potency 
and efficacy (Figure 7.1). 5-Hydroxytryptophan, 2-Me-5-HT and N-methyl-
tryptamine were virtually inactive (Figure 7.1). 
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Figure 7.1 Concentration-response curves to 5-hydroxytryptamine (5-HT) 
(O; n = 79) and its analogues 5-carboxamidotryptamine (• , n = 10), 5-methoxy-
tryptamine ( • , n = 22), a-methyl-5-HT (T, n = 4), tryptamine ( • , n = 8), 2-methyl-
5-HT (D, n = 4), N-methyltryptamine (A, n = 6) and 5-hydroxytryptophan (V, n = 4). All 
experiments were done in the presence of ketanserin 0.3 uM and tropisetron 3 uM, 
and the strips were precontracted with methacholine 0.3 fiM. Relaxations were 
expressed as a percentage of relaxations induced by 5-HT 10 |iM. Points represent 
the mean + S.E. 
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Table 7.1 Intrinsic effects of drugs and effects against 5-HT- and methacholine-induced responses 
on the guinea-pig colon. All experiments were performed in the presence of ketanserin (0.3 |xM) and 
tropisetron (3 uM). 
drug 
induces 
relaxations 
exceeding 
inhibition of 
contractions3 
to methacholine 
inhibition of 
relaxations 
to 5-HT 
relaxation 
sensitive to 
methysergide L-NNA 
8-OH-DPAT 
dopamine 
flesinoxan 
mCPP 
TFMPP 
MK212 
WB4101 
sumatriptan 
RU 24969 
1uM 
100uM 
100 uM 
30 uM 
10 uM 
3uM 
10 uM 
30 uM 
30 uM 
pA2 = 5.2b; 40 % 
depression (100 uM) 
NT 
depression 60 % 
no shift (100 jiM) 
pA2 ~ 4.5; 30 % 
depression (100 uM) 
pA2 - 5; 20 % 
depression (30 uM) 
pA2 - 5.5 
NT 
100 uM no effect 
pA2 - 4.5; 20 % 
depression (100 uM) 
1 uM no effect 
NT 
1 uM no effect 
NT 
NT 
pD2' = 5.6 
NT 
1 uM no effect 
pA2 =6.4±0.1 
NT 
no 
no 
no 
NT 
no 
NT 
no 
NT 
NT 
NT 
NT 
no 
noc 
no 
a
 a pA2 value was estimated with the Schild equation, if possible; b pA2 value of 8-OH-DPAT 10 u.M 
and 30 uM respectively 5.20 ± 0.01 and 5.20 ± 0.09; c relaxations to 5-HT, but not to sumatriptan, 
were abolished by TTX 0.3 uM; NT = not tested. 
Other putative 5-HT receptor agonists 
Relaxations to 5-HT are highly sensitive to the NO synthase inhibitor 
NG-nitro-L-arginine (L-NNA; 100 uM) (Briejer et al, 1992; 1995) as well as to 
methysergide (1 |iM) (see below). All compounds mentioned in Table 7.1 
induced relaxations only at micromolar concentrations, though these relaxations 
were not sensitive to L-NNA and/or to methysergide. Thus, a mechanism other 
than 5-HT receptors was suspected to account for the relaxations to these 
compounds. Therefore, these compounds (except for WB4101) were tested 
against contractions to methacholine, and it was found that they shifted and/or 
depressed the concentration-response curve to methacholine (see Table 7.1). 
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Sumatriptan (100 |iM) did not affect the concentration-response curve to 
methacholine, suggesting even a different mode of action (n = 4; not shown). 
Various drugs 
Relaxations to 5-HT were not affected by the oc-adrenoceptor antagonist 
phentolamine (1 uM; n = 4) (not shown). The MAO-inhibitor pargyline 
(1-10 uM) depressed the concentration-response curves to 5-HT, 5-CT and 
5-MeOT slightly, but no shift to the left (potentiation) was observed (n = 4; not 
shown). Incubation with the 5-HT uptake blocker Citalopram (1 uM) had no 
effect (n = 4; not shown) on 5-HT-induced relaxations. Hence, in further 
experiments no a-adrenoceptor antagonist, MAO-inhibitor or uptake blocker 
was present. 
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Figure 7.2 Concentration-response curves to 5-HT in the absence (O; n = 6-10) and presence of: 
(left pane!) methysergide 0.3 nM (•, n = 4), 3 nM (•, n = 4), 30 nM (A, n = 6) and 300 nM (A, n = 6); 
(right panel) methiothepin 3 nM (•, n = 6) and 30 nM (•, n = 6). All experiments were done in the 
presence of ketanserin 0.3 uM and tropisetron 3 uM, and the strips were precontracted with 
methacholine 0.3 \M. Relaxations were expressed as a percentage of relaxations induced by 5-HT 
10 u.M. Points represent the mean ± S.E. Mean values that are significantly different from control 
(P < 0.05) are marked with an asterisk. 
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Table 7.2 Estimated pECso and pA2 values of 5-HT receptor ligands against the high affinity phase 
of the concentration-relaxation curve to 5-HT, as compared to literature PEC50 values and pA2 
values/binding affinities (pK,). 
agonist 
5-HT 
5-CT 
5-MeOT 
a-Me-5-HT 
tryptamine 
2-Me-5-HT 
antagonist 
ritanserin 
metergoline 
mesulergine 
1-NAP 
mCPP 
mianserin 
rauwolscine 
RU 24969 
yohimbine 
NAN-190 
sumatriptan 
8-OH-DPAT 
flesinoxan 
spiperone 
ketanserin 
spiroxatrine 
MK212 
methysergide 
methiothepin 
pEC50±S.E. 
7.00 ± 0.04 
6.10 ±0.02 
6.16 ±0.03 
-5.7 
-5.5 
i 
pA2 ± S.E. 
8.9 ± 0.2 
8.8 ± 0.3b 
7.8 ± 0.39 
7.7 ± 0.2 
7.1 ±0.1 
7.0 ± 0.4 
7.0 ± 0.2 
6.4 ±0.1 
6.2 ± 0.2 
0.3 uM i 
1uMi 
1uMi 
1 |xMi 
l u M F 
3 (AM i 
nd 
5.66 
9.0e 
7.8e 
n 
79 
10 
22 
4 
6 
6 
n 
6 
6 
6 
6 
6 
6 
8 
5 
8 
6 
4 
4 
3 
6 
4 
6 
3 
4 
6 
5-HT1A 
7.6 
8.6 
8.0a 
-
6.8a 
5.8a 
5-HT1A 
5.2-6.1 
8.1 
6.2-6.8 
7.2 
6.5 
6.0 
6.9 
8.1 
6.9 
8.9 
6.1-6.6 
8.6-8.7 
8.8 
7.2d 
< 5-5.9 
8.1-8.4 
5.3 
7.6 
7.1 
5-HT1B 
7.8 
7.9 
6.4a 
-
5.0a 
6.1a 
5-HT1B 
4.0-5.8 
7.4 
4.9-5.9 
6.6 
6.6 
6.0d 
5.3 
8.2-8.4 
5.5 
6.2 
6.4-6.8 
4.2-5.8 
6.1 
4.4d 
< 5-5.7 
3.6-3.9 
5.0 
5.8 
7.3 
5-HT,D 
7.6 
8.1 
8.4a 
-
7.1a 
5.8a 
5-HT1D 
5.8-6.4 
9.1 
5.2-5.4 
-
5.8 
6.5d 
7.7 
7.3-7.4 
7.1 
6.7 
7.2-7.5 
5.9-6.0 
6.8 
4.8d 
5.7-6.0 
5.1 
-
8.4 
6.3 
5-HT1E 
7.3 
4.7 
5.3 
6.9a 
5.6-6.5a 
6.1a 
5-HT,
 E 
-
6.0 
-
6.7 
5.5 
7.0 
5.4 
7.2 
5.9-6.4 
-
5.6-5.7 
5.5-6.1 
-
5.0-5.3 
4.1 
-
4.3 
6.5-7.2 
6.7-6.9 
5-HT, F 
8.1 
6.0 
5.9a 
6.7a 
5.6a 
6.4a 
5-HT,
 F 
-
6.5 
<5 
7.3 
-
-
6.0 
-
7.0 
6.7 
7.6 
5.8 
-
<5 
<5 
-
-
7.5 
6.2 
5-HT2A 
7.6 
3.5 
5.5a 
7.3 
6.0a 
<5a 
5-HT2A 
8.5-9.3 
8.5d 
9.1d 
7.2 
6.7 
10.1d 
6.1 
5.8-6.0 
6.0 
6.7 
3.7 
< 5-5.0 
5.4 
8.8-9.4 
9.3d 
6.2-6.9 
4.8 
8.6 
8.8 
5-HT2B 
8.0-8.4 
6.9-7.6 
7.8 
8.0 
6.7-7.2 
6.2-7.0 
5-HT2B 
8.3 
8.5-9.0d 
7.4 
8.9-9.0d 
7.9d 
6.7-7.3 
8.5d 
7.5d 
7.9-8.2d 
-
<5 
5.1-5.4 
-
< 4-5.5 
5.4 
<5« 
< 4-6.4 
7.1-8.2' 
-
5-HT2C 
6.5 
5.7 
7.6a 
7.3 
7.3 
6.3a 
5-HT2C 
8.6-9.3 
10.6d 
9.1d 
8.2 
7.7 
8.0d 
5.8 
6.5-7.3 
4.4 
6.2 
4.1-5.1 
5.1-5.2 
<5 
5.9 
6.6d 
5.1 
6.2 
8.6 
7.6 
i = inactive, nd = not determined; a pKj binding affinity; b pA 2 against 5-MeOT 9.3 ± 0.3 (n = 6), 
estimated with metergoline 3 nM; c depression of second phase of concentration-relaxation curve to 
5 -HT; d pA2 value instead of pK, binding affinity; e pD'2 values; f p lC 5 0 = 8.7; 9 pA2 estimated with 30 nM 
mesulergine, estimation with 100 nM mesulergine yields a pA2 of 7.9 ± 0.1 (n = 3). Literature affinity 
data inferred from: Clineschmidt et al., 1985; Nelson & Taylor, 1986; Cohen & Fludzinski, 1987; 
Hoyer, 1988; Leonhardt e ra / . , 1989; Van Wijngaarden e ra / . , 1990; Hoyer & Schoeffter, 1991; 
Kalkman & Fozard, 1991; Foguet et ai, 1992; Kursar etat., 1992; Zgombick etat., 1992; Adham etat., 
1993; Beer etat., 1993; Gudermann etat., 1993; Wainscott er ai, 1993. 
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5-HT receptor antagonists 
Increasing the concentration of ketanserin (a selective 5-HT2A receptor 
antagonist, Table 7.2) 10-fold to 3 uM, had no significant effect on the 
concentration-response curve to 5-HT, as compared to the "standard" 
concentration of 0.3 uM (n = 8; not shown). The 5-HT4 receptor antagonists 
SDZ 205-557 (1 uM) or SB 204070 (10 nM) had also no effect (n = 6-7, not shown). 
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Figure 7.3 Concentration-response curves to 5-HT in the absence (O; n = 6) and 
presence of: spiroxatrine 0.3 u.M ( • , n = 6) and spiperone 1 |iM ( • , n = 6). All 
experiments were done in the presence of ketanserin 0.3 jiM and tropisetron 3 p.M, 
and the strips were precontracted with methacholine 0.3 \iM. Relaxations were 
expressed as a percentage of relaxations induced by 5-HT 10 |iM. Points represent 
the mean ± S.E. Mean values that are significantly different from control (P < 0.05) are 
marked with an asterisk. 
The 5-HTi/5-HT2 receptor antagonist methysergide (Table 7.2) inhibited both 
the first and second phase of the concentration-response curve to 5-HT, though 
to a different extent (Figure 7.2, left panel). At 0.3 nM, the first phase was 
depressed relatively more than the second phase (n = 4), while at 3 nM (n = 4), 
the first phase was almost blocked. Increasing the concentration methysergide to 
30 nM and 300 nM (n = 6), also depressed the second phase to an increasing 
extent (Figure 7.2, left panel). For inhibition of the first phase, a pD'2 value of 9.0 
was estimated. The 5-HT1/5-HT2 receptor antagonist methiothepin (Table 7.2) 
(3 and 30 nM; n = 6) preferentially depressed the second phase of the 
concentration-response curve to 5-HT, though the first phase was also depressed 
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(Figure 7.2, right panel). The 5 - H T I A / 5 - H T 2 A receptor antagonist spiperone 
(Table 7.2) (1 u,M) only depressed the second phase of the curve to 5-HT (n = 6), 
leaving the first phase unaffected (Figure 7.3). The 5 - H T I A receptor antagonist 
spiroxatrine (Table 7.2) (0.3 uM) virtually blocked the first phase of the 
concentration-response curve to 5-HT (n = 6), but at a concentration of 3 nM, it 
had no effect. Only in the concentration-range coinciding with the second phase, 
relaxations were not fully blocked by spiroxatrine (0.3 uM) (Figure 7.3). 
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Figure 7.4 Concentration-response curves to 5-HT {left panel) and 5-MeOT (right panel) in the 
absence (O; n = 6) and presence of metergoline 3 nM (•, n = 6), 10 nM (•, n = 6) and 30 nM (A, 
n = 6). All experiments were done in the presence of ketanserin 0.3 |iM and tropisetron 3 u.M. and the 
strips were precontracted with methacholine 0.3 u.M. Relaxations were expressed as a percentage of 
relaxations induced by 5-HT 10 u.M. Points represent the mean±S.E. The inserted figure on the 
left represents a Schild-piot (dr = dose ratio). The line was fitted with the least squares method, and 
did not significantly differ from unity. All concentrations caused a significant shift of the EC50 of the 
high affinity phase of the concentration-response curve to 5-HT and 5-MeOT (P < 0.05), except for 
3 nM against 5-HT (P < 0.10). 
Neither the selective 5 - H T I A receptor antagonists NAN-190 (0.3 U.M), 
flesinoxan (1 u,M) and the 5 - H T I A receptor agonist 8-OH-DPAT (1 uM), nor the 
moderately selective 5 - H T I D receptor agonist sumatriptan (1 uM) (see for 
selectivities Table 7.2) did affect the relaxations to 5-HT (n = 3-6). Metergoline 
( 5 - H T I / 5 - H T 2 receptor antagonist, Table 7.2) (3,10 and 30 nM, n = 6) inhibited the 
relaxations to 5-HT and 5-MeOT in a surmountable fashion. As can be seen from 
Figure 7.4 (left panel), metergoline preferentially shifted the first phase of the 
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concentration-response curves to 5-HT. Schild analysis of the inhibition against 
5-HT yielded a slope of 1.01 ± 0.21 (Figure 7.4, left panel) and a pA2 of 8.8 ± 0.3 
(constrained at unity: pKd = 8.9 ± 0.1). Schild analysis of the antagonism against 
5-MeOT however (Figure 7.4, right panel) yielded a slope (0.58 ± 0.26) that 
differed from unity. The pA2 was estimated by using only the shift caused by 
3 nM metergoline, and was calculated to be 9.3 ± 0.3. 
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Figure 7.5 Concentration-response curves to 5-HT in the absence (O; n = 5-8) and presence of: 
(upper left panel) yohimbine 1 uM ( • , n = 8), rauwolscine 1 nM (• . n = 8); (upper middle panel) 
1-NAP 0.3 |xM (A, n = 6); (upper right panel) MK212 1 \iM (A, n = 3), mCPP 1 p.M (•, n = 6); (lower 
left panel) mianserin 0.3 nM ( • , n = 6), ritanserin 0.1 \iM (V, n = 6); (lower middle panel) RU 24969 
1 \iM ( • , n = 5); (lower right panel) mesulergine 0.03 u.M ( • , n = 6) and 0.1 uM ( • , n = 3). All 
experiments were done in the presence of ketanserin 0.3 (xM and tropisetron 3 nM, and the strips 
were precontracted with methacholine 0.3 nM. Relaxations were expressed as a percentage of 
relaxations induced by 5-HT 10 uM. Points represent the mean ± S.E. All antagonists caused a 
significant shift of the EC5o of the high affinity phase of the concentration-response curve to 5-HT 
(P < 0.05). 
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Figure 7.6 Correlations of affinity values of antagonists for 5 -HT2A,5 -HT2B, 5 -HT 2 C and 5-ht7 
receptors on one hand, and for the relaxation-mediating 5-HT receptor in the guinea-pig colon on the 
other hand. pA2 values (± S.E.) in the colon of 8-9 compounds (X-axis) are plotted against pA2 values 
or, if not available, pKj binding values inferred from the literature (see also Table 7.2) on the Y-axis. In 
case more than 2 values were found in literature, the value in between the extremes was used (the 
error bar represents the extreme values found in literature). The lines were fitted with the least 
squares method (r represents the correlation coefficient) and analysed statistically with ANOVA 
followed by the F-test for significance of correlation, denoted with p. Data were obtained from the 
following compounds: yohimbine (1), RU 24969 (2), rauwolscine (3), mianserin (4), mCPP (5), 1-NAP 
(6), mesulergine (7), metergoline (8) and ritanserin (9). The upper left panel shows the correlation with 
5 - H T 2 A receptor affinity values, the upper right panel with 5-HT 2 B receptors, lower left panel with 
5-HT2c receptors and the lower right panel wWh 5-M7 receptors. 
Yohimbine (1 U.M), rauwolscine (1 \iM), 1-NAP (0.3 U.M), mianserin (0.3 uM), 
ritanserin (0.1 uM), RU 24969 (1 uM), mesulergine (0.03 and 0.1 U.M) and mCPP 
(1 U.M) (compounds that all interfere with 5-HTi and/or 5-HT2 receptors with 
variable selectivities: see Table 7.2 for affinities) (n = 5-8) inhibited the relaxations 
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to 5-HT surmountably, causing a shift of the first phase of the concentration-
response curve to 5-HT (Figure 7.5; for estimated pA2 values see Table 7.2). 
MK212 (1 uM) caused a depression (rather than a shift to the right) of the first but 
not the second phase of the concentration-response curve to 5-HT (n = 3; 
Figure 7.5, upper right panel). 
Of the antagonists tested, 9 allowed estimation of a pA2 value. These values 
correlated near significantly with literature affinity values for 5-HT2A receptors 
(r = 0.599; P = 0.0883; slope = 0.983; n = 9) and significantly for 5-HT2c receptors 
(r = 0.851; P = 0.0036; slope = 1.648; n = 9), as shown in Figure 7.6 {left panels). No 
significant correlation was found with affinity values for 5 - H T I A , 5 - H T I B , 
5 - H T I D , 5 - H T I E , 5 - H T I F , 5-HT2B receptors (see Figure 7.6, upper right panel). 
Comparison of the affinities of antagonists in the colon with those for the 
recently cloned 5-ht5A, 5-ht5B, 5-ht6 and 5-ht7 receptors yielded only a significant 
correlation with affinity values for 5-ht7 receptors (r = 0.769; P = 0.0256; slope = 
0.647; n = 8) (Figure 7.6, lower right panel). 
Discussion 
The concentration-response curve to 5-HT in the guinea-pig colon 
preparation was biphasic, suggesting that two receptors are involved. Though 
the author did not make special reference, the concentration-relaxation curve to 
5-HT in the similar preparation as used by Kojima (1991) also was biphasic, with 
an inflection at a similar concentration of 5-HT. As compared to our 
experimental circumstances (intact segments, 5-HT2, 5-HT3 and 5-HT4 receptors 
blocked), Kojima used strips of which the mucosa was removed, atropine was 
present in the bath solution to prevent cholinergic contractions via 5-HT3 and 
5-HT4 receptors and ketanserin (10 uM) to block 5-HT2 receptors, and the strips 
were not precontracted (Kojima, 1991). The observed differential inhibition of 
these two phases, notably by methysergide, methiothepin, spiroxatrine, 
spiperone, but also by other compounds, also suggests a two receptor system. As 
the low affinity receptor, which mediates the second phase, is much more 
difficult to quantatively analyze, the receptor characterization as described below 
focussed only on the 5-HT receptor that accounts for the first, high affinity phase 
of the concentration-response curve to 5-HT. 
In the guinea-pig gut, 5 - H T I A receptors are known to be present on the 
enteric neurons (Fozard & Kilbinger, 1985; Galligan, 1992). For 5 - H T I A receptors, 
some selective compounds are available (see Table 7.2), e.g. 8-OH-DPAT and 
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flesinoxan, which are agonists (Fozard & Kilbinger, 1985; Schipper et ah, 1990), 
and NAN-190, spiperone and spiroxatrine, which are antagonists (though in 
some systems they behave as partial agonists) (Nelson & Taylor, 1986; Pauwels et 
ah, 1993). At relevant concentrations (see Table 7.2), however, these compounds 
showed no consistent effects, and spiperone could only inhibit the second phase 
of the concentration-response curve to 5-HT. These results suggest that 5 - H T I A 
receptors do not play a role in the 5-HT-induced relaxations. 5 - H T I B and 5 - H T I D 
receptors have not (yet) been shown to be present in the gastrointestinal tract. 
The current results do also not provide evidence for their presence. Compounds 
that are known to interact with 5 -HTIB and/or 5 - H T I D receptor subtypes, such as 
RU 24969, yohimbine, rauwolscine, sumatriptan, metergoline, methysergide and 
methiothepin (Schoeffter & Hoyer, 1989; Hoyer & Schoeffter, 1991; Miller et ah, 
1992), had no effects that were consistent with the affinities reported in literature 
(see Table 7.2). Functional correlates of the more recently discovered 5 - H T I E and 
5-HTip receptors have not been encountered yet, and no selective antagonists at 
5 - H T I E and 5-HTip receptors (Leonhardt et al., 1989; Zgombick et al., 1992; 
Adham et al., 1993; Gudermann et ah, 1993) are available. The affinities as 
available from the literature are too scarce to provide decisive evidence as to 
whether either 5-HTi receptor subtype is involved. However, 5-CT is more than 
100 times less potent than 5-HT at 5 -HTIE or 5 - H T I F receptors, which was not the 
case in our model, rendering involvement of these 5-HTi receptor subtypes 
rather unlikely (see also Table 7.2). At classical 5-HTi receptors, 5-CT is more 
potent than 5-HT, which was one of the criteria for designating a 5-HT receptor 
5-HTi (Bradley et ah, 1986; Table 7.2). In the colon, however, 5-CT was less potent 
than 5-HT. Hence, taken together, the above described results do not provide 
evidence that the relaxations to 5-HT in the guinea-pig colon are mediated by a 
known 5-HTi receptor subtype. 
Ritanserin and metergoline were potent antagonists of the 5-HT-induced 
relaxations, and mesulergine, yohimbine, rauwolscine, mCPP and mianserin 
were moderately potent antagonists. Comparing these data with literature 
receptor affinity values suggests that a 5-HT2 receptor subtype could be involved 
(see Table 7.2). The affinities of 9 antagonists that were tested showed a near 
significant correlation with literature affinities for 5-HT2A receptors, suggesting 
some resemblance with this receptor subtype. The potent 5-HT2A receptor 
antagonists ketanserin and spiperone did however not affect the concentration-
response curve to 5-HT. Hence the receptor under study is not identical to the 
5-HT2A receptor subtype. The 5-HT2B and 5-HT2C receptors are rather insensitive 
to inhibition by spiperone and ketanserin (Cohen & Wittenauer, 1985; Hoyer & 
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Schoeffter, 1991; Foguet et al, 1992; Growcott et al, 1993; Wainscott et al, 1993) as 
are the relaxations described here in the guinea-pig colon (see Table 7.2; Kojima, 
1991; Elswood & Bunce, 1992). In the rat fundus, the 5-HT2B receptor is located on 
the smooth muscle and mediates contraction. In the guinea-pig colon, on the 
other hand, 5-HT acts on the nerves, as the relaxations are readily blocked by the 
neurotoxin tetrodotoxin (Briejer et al, 1992). This is not an argument to exclude 
that the receptors are similar, as, for example, smooth muscle 5-HT4 receptors in 
the rat gastrointestinal tract cause relaxation, while in the guinea-pig they are 
neurogenic and mediate contraction (Elswood et al, 1991; Reeves et al, 1991; 
Baxter et al, 1991; Briejer et al, 1993). Though there are some antagonists that 
have similar affinities both for the colon receptor and the 5-HT2B receptor (see 
Table 7.2: ritanserin, metergoline, mesulergine), there are however also great 
differences (see Table 7.2: 1-NAP, rauwolscine, yohimbine). Spiroxatrine has 
been reported to have no effect on rat fundus contractions to 5-HT up to a 
concentration of respectively 1 |iM (Cohen & Fludzinski, 1987), while in our 
preparation it strongly inhibited the 5-HT-induced relaxations at 0.3 uM. These 
authors also found that mianserin up to 0.3 uM did not affect contractions in the 
rat fundus to 5-HT (Cohen & Fludzinski, 1987), though it was active in our 
preparation, with a pA2 value estimated to be 7.0, which is in agreement with 
receptor binding data (see Table 7.2). a-Me-5-HT was a poor agonist in the colon, 
while in the rat fundus it is a full and potent agonist (Kalkman & Fozard, 1991; 
Growcott et al, 1993). Methysergide seemed to have a higher affinity for the 
colon receptor than for the 5-HT2B receptor (Table 7.2), but in the colon it 
behaved as a non-competitive antagonist, which makes it difficult to calculate a 
reliable affinity parameter. Comparison of antagonist affinities at the rat fundus 
receptor (5-HT2B) and the guinea-pig colon receptor showed no significant 
correlation. There was however a significant correlation with 5-HT2C receptor 
affinities, but also here some differences with the colon receptor were apparent. 
The rank order of potency at 5-HT2C receptors is a-Me-5-HT > 5-HT > 5-CT 
(Hoyer & Schoeffter, 1991), while in the colon the potency order was 5-HT > 5-CT 
= a-Me-5-HT, demonstrating especially the difference with respect to a-Me-5-HT. 
Yohimbine and rauwolscine have only low affinity for 5-HT2C receptors, but in 
our model however, yohimbine and rauwolscine showed moderate affinity. The 
affinities of metergoline and mesulergine do also not quite correspond for the 
colon receptor and for 5-HT2C receptors. These differences are reflected in the 
steep slope of the fitted line in Figure 7.6. Hence, the 5-HT receptor under study 
resembles most the 5-HT2C receptor, but its characteristics are not identical. 
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RU 24969, 8-OH-DPAT, sumatriptan and MK212 (and others: Table 7.1) 
induced methysergide- and/or L-NNA-insensitive relaxations in our prepara-
tion, while those to 5-HT are blocked by methysergide or L-NNA (this paper; 
Briejer et al, 1992). Relaxations to RU 24969, 8-OH-DPAT and MK212 were 
shown to be caused by antagonism of the methacholine-induced precontraction. 
Galligan (1992) also showed that in the guinea-pig ileum, 8-OH-DPAT blocks 
histamine and muscarinic (pA2 = 5.5; in our preparation pA2 = 5.2) receptors. 
Though the compounds might also induce part of the relaxation via the 5-HT 
receptor under study, the non-specific effects would mask them. Affinity 
estimates could however be assessed by using them as an antagonist at a 
concentration that would induce no non-specific effects (see Table 7.1 and 7.2). 
Recently, a number of novel 5-HT receptors have been cloned, provisionally 
designated 5-ht5A (REC17, 5-ht5a), 5-ht5B (MR22, 5-ht5p), 5-ht6 and 5-ht7 (PCT65, 
REC20, 5-htx) (Plassat et al, 1992, 1993; Matthes et al, 1993; Erlander et al, 1993; 
Monsma et al, 1993; Ruât et al, 1993a, b; Shen et al, 1993; Lovenberg et al, 1993; 
Bard et al, 1993). Comparison of receptor binding affinities and pECso values in 
cells in which such receptors were expressed showed a significant correlation 
with the 5-ht7 receptor. Northern blot analysis revealed the presence of 5-ht7 
receptor gene transcripts in mouse and human, but not rat, gut (Ruât et al, 
1993a, b; Plassat et al, 1993; Shen et al, 1993; Lovenberg et al, 1993; Bard et al, 
1993). No functional correlates have yet been found of the putative 5-htz receptor 
and relevant pharmacological data is too scarce to allow any thorough 
comparison of the putative 5-ht7 receptor and the receptor currently under 
study. 
In the guinea-pig ileum, a smooth muscle receptor mediates relaxations to 
5-HT. These responses could be inhibited by metergoline, spiperone and 
methysergide, but with quite different pA2 values as compared to the current 
results (Feniuk et al, 1983, 1984; Kalkman et al, 1986), which suggests that the 
receptor involved is of another subtype. Also in the guinea-pig stomach fundus 
circular muscle, 5-HT induces relaxations via a smooth muscle receptor (Kojima 
et al, 1992). Here, the rank order of potency was 5-CT » 5-HT = 5-MeOT > 
5-Me-5-HT; TFMPP and 8-OH-DPAT were partial agonists, and oc-Me-5-HT, 
2-Me-5-HT and sumatriptan were virtually inactive. The relaxations to 5-HT in 
this preparation were inhibited by methiothepin and mianserin, but also by 
ketanserin and spiperone. These data indicate that the 5-HT receptor in the 
guinea-pig stomach fundus is also different from the 5-HT receptor in the colon. 
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It is concluded that the neuronal 5-HT receptor that mediates the first phase 
of the concentration-response curve to 5-HT (NO-mediated part) is not a known 
5-HT receptor, and could be considered a 5-HT2 -like receptor. 
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Cisapride and structural analogs selectively 
enhance 5-hydroxytryptamine (5-HT)-induced 
purinergic neurotransmission in the 
guinea pig proximal colon 
M.R. Briejer, G.J. Veen, L.M.A. Akkermans, 
R.A. Lefebvre and J.A.J. Schuurkes 
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Abstract. In the guinea pig proximal colon, 5-HT stimulates neuronal 5-HTi-like receptors to induce 
relaxations that are mediated by nitric oxide (NO) and adenosine 5'-triphosphate (ATP). In the 
current study, the effects of cisapride and structural analogs on these 5-HT-induced relaxations 
were investigated. 
In the continuous presence of ketanserin (0.3 uM) and tropisetron (3 |oM) to block contractions via 
5-HT2A, 5-HT3 and 5-HT4 receptors, 5-HT induced relaxations yielding a biphasic concentration-
response curve. Cisapride (0.1-1 (iM) enhanced the second phase of the concentration-response curve 
to 5-HT by about 20-40 %, while, from 0.3 (iM onwards it inhibited the first phase. Also in the 
presence of cisapride (0.3 |iM), tetrodotoxin (TTX; 0.3 |iM) abolished the relaxations to 5-HT. 
Cisapride (0.3 uM) did not affect the concentration-response curves to isoprenaline, nitroglycerin, 
nitroprusside or exogenous ATP, demonstrating its specificity. The 5-HT-relaxation enhancing 
effects of cisapride were not mimicked by phentolamine (1 uM), NAN-190 (0.03 |JM), spiperone 
(1 uM), Citalopram (0.3 uM), paroxetine (0.3 uM), pargyline (100 uM) or SDZ 205-557 (0.3 uM). In 
the presence of the inhibitor of NO synthesis, NG-nitro-L-arginine (L-NNA; 100 |JM), cisapride 
(0.3 fiM) still enhanced the remaining relaxations to 5-HT (2-3 fold). However, in the presence of 
the P2-purinoceptor antagonist suramin (300 pM), cisapride could not enhance the relaxations to 
5-HT. In the presence of L-NNA, the cisapride-enhanced relaxations to 5-HT could be inhibited by 
about 90 % by suramin. 
Conclusion: In the guinea pig colon, cisapride selectively facilitates the suramin-sensitive, 
ATP-mediated, part of the relaxation to 5-HT ma an unidentified effect on intramural nerves. 
Introduction 
The 2-methoxy-4-amino-5-chloro-substituted benzamides are used in the 
treatment of impaired gastrointestinal motility, which manifests in disorders 
like gastroesophageal reflux, gastroparesis, functional dyspepsia and constipa-
tion (Reyntjens et al, 1986; Müller-Lissner, 1987; Reynolds & Putnam, 1992). 
These prokinetics are represented by cisapride, metoclopramide, clebopride and 
cinitapride (which is a 2-ethoxy-4-amino-5-nitro-substituted benzamide) (Pinder 
et al, 1976; Massingham et al, 1985; Reynolds & Putnam, 1992). Renzapride, 
dazopride and zacopride are not used in the clinic, but have similar gastro-
intestinal motility stimulating properties (Reynolds & Putnam, 1992; Gullikson 
et al, 1992). The mechanism of prokinetic action is however still not completely 
understood. A common feature of the prokinetic benzamides is their agonist 
action at 5-hydroxytryptamine4 (5-HT4) receptors (see: Bockaert et al, 1992; Ford 
& Clarke, 1993), which is thought to cause facilitation of cholinergic (and possibly 
also non-cholinergic) excitatory neurotransmission (Taniyama et al, 1991; 
Kilbinger & Wolf, 1992; Bingham & Andrews, 1992). This has been put forward 
as the mechanism by which motility is enhanced (see: Tonini et al, 1991). 
However, in a number of tissues, this mechanism does not seem to apply. For 
example, in the canine gastric antrum, cisapride enhanced field stimulation-
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induced cholinergic contractions via a mechanism that was not sensitive to 
5-HT4 receptor blockade (De Ridder & Schuurkes, 1993), and in human colon, 
cisapride did even not enhance the release of acetylcholine (Burleigh & Trout, 
1985). In electrophysiological experiments with guinea pig AH/type 2 myenteric 
neurons, cisapride has been shown to enhance EPSPs via 5-HT4 receptors (see 
Tonini et ah, 1991), but direct 5-HT4 receptor-mediated responses could not be 
demonstrated (Nemeth et al, 1985; Mawe et al, 1989; Wade et al, 1991). On such 
neurons, 5-HT stimulates, next to 5 - H T I A and 5-HT3 receptors, putative 5-HTip 
receptors which mediate the slow prolonged depolarization. Some of the above 
prokinetic benzamides interfere with this 5-HTip receptor-mediated response, 
either as agonist (S-zacopride) or antagonist (cisapride, R-zacopride, renzapride) 
(Nemeth et al, 1985; Mawe et al, 1989; Wade et al, 1991). Enhancement of gastric 
emptying in mice has been associated with antagonism of 5-HTip receptors on 
inhibitory neurons (Mawe et al, 1989). 
Previously, it has been shown that 5-HT induces relaxations of the guinea pig 
colon through the stimulation of a neuronal 5-HTi-like receptor (Kojima, 1991; 
Elswood & Bunce, 1992; Briejer et al, 1992). These relaxations were highly sensi-
tive to inhibition of nitric oxide synthesis (Briejer et al, 1992) and were moder-
ately inhibited by suramin and apamin, which were shown to selectively inhibit 
relaxations to ATP (Briejer et al, 1995). Here we report on the facilitating effects 
of cisapride and some other prokinetic benzamides on the suramin-sensitive, but 
not the NO-mediated, part of the relaxation to 5-HT on the guinea pig colon. The 
mechanism by which this is accomplished was investigated. 
Materials and methods 
Tissue preparation 
Dunkin-Hartley guinea pigs of both sexes, weighing 400-600 g, were killed by 
stunning and decapitation. The proximal colon was removed, and the luminal 
contents were washed out with De Jalon solution (mM: KCl 5.6, CaCl2 0.5, 
NaHCC>3 6.0, NaCl 155, glucose 2.8). The mesentery was carefully removed. 
Starting at the proximal end, about 1 cm distal from the caecum, the colon was 
divided into four segments of circa 2.5 cm. These intact segments were individu-
ally mounted vertically for isotonic measurement into a tissue bath containing 
20 ml De Jalon solution. This solution was kept at 37 °C and gassed with 95% O2, 
5 % CO2. The strips were subjected to a load of 2 g and allowed to stabilize for half 
an hour. Ketanserin (0.3 uM) and tropisetron (3 |iM) were continuously present 
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in the De Jalon solution during all experiments to block contractile responses 
mediated by 5-HT2A/ 5-HT3 and 5-HT4 receptors. After stabilization, the longitu-
dinal muscle was challenged with 0.3 uM methacholine. After washing and 
10 min stabilization, the procedure was repeated in order to stabilize the response 
of the tissue. 
Protocols 
For the construction of concentration-response curves, drugs were applied 
directly to the tissue bath (added volume < 1 % of bath volume). Methacholine 
(0.3 uM) was added to the bath in order to precontract the muscle. 
5-HT. 10 Min after the addition of methacholine, the strips were first 
challenged with 0.3 uM 5-HT in the absence of an antagonist (ketanserin and 
tropisetron present). Then, 5-HT and methacholine were washed out by 
replacing the bathing fluid twice and stabilization of 10 min was allowed. After 
washout, this 20 min dosing cycle was repeated, applying 10 uM 5-HT. The 
relaxation to this latter administration of 5-HT was taken as 100 % relaxation. 
The size of the relaxation was measured as the maximum relaxation that was 
induced during an incubation period of approximately 2 min (at high concentra-
tions in some cases up to 4 min). The compounds were washed out and again 
10 min stabilization was allowed. Consecutively, drugs were administered, and 
were left with the preparations for 15 min. Then, non-cumulative concentration-
response curves to 5-HT were established, applying the above described 20 min 
dosing cycle. Drugs, that were investigated for their possible effects against 5-HT-
induced relaxations, were re-added directly after each washout. Of 4 segments 
that were taken from each animal, one strip was utilized as a control. The 
response to repetitive administration of methacholine was stable throughout the 
experiment. 5-HT (10 uM) induced relaxations of 5.2 ± 0.2 mm (n = 45). 
ATP. The concentration-response curve to ATP was established in a similar 
non-cumulative dosing scheme as applied for 5-HT. Relaxations to ATP were 
expressed as a percentage of relaxations to ATP 3 uM, which induced relaxations 
of 3.3 ± 0.4 mm (n = 4). 
Nitroprusside, nitroglycerin and isoprenaline. For the construction of concen-
tration-response curves to nitroprusside, nitroglycerin and isoprenaline, the 
compounds were added in a cumulative fashion, 10 min after precontraction to 
methacholine-addition (0.3 uM). After washing and stabilization for 30 min 
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(washing every 10 min), a second concentration-response curve was established 
in the presence of cisapride. The responses induced by these agonists were 
expressed relatively to their maximal response during the first concentration-
response curve for each segment. These maximal relaxations were respectively 
12.4 ± 1.2 mm (nitroprusside 30 uM; n = 4), 6.1 ± 0.5 mm (nitroglycerin 10 uM; 
n = 4), and 11.1 ± 0.8 mm (isoprenaline 3 uM; n = 4). 
Statistical analysis 
For graphical representation means ± standard error of the mean (S.E.) were 
calculated. Differences between mean values were tested with one way analysis 
of variance using Dunnett's t-test (control versus treatment) or the Scheffé F-test 
(treatment versus treatment), when appropriate (Wallenstein et al., 1980). The 
level of significance was set at P < 0.05. 
Drugs 
Cinitapride tartrate, clebopride tartrate (Almirall, Spain), dazopride fumarate, 
zacopride HCl (Robins Co., USA), renzapride (Beecham, Great Britain), metoclo-
pramide HCl (Delagrange, France), cisapride, R 76 186 (cis-4-amino-5-chloro-
N-[l-[4-[4-(dimethylamino)-l-piperidinyl]-4-oxobutyl]-3-methoxy-4-piperidinyl]-2-
methoxybenzamide) (see Figure 8.1), SDZ 205-557 (2-methoxy-4-amino-5-chloro-
benzoic acid 2-(diethylamino) ethyl ester), NAN-190 HCl (l-(2-methoxyphenyl)-4-
[4-(2-phthalimido)-butyl] piperazine), spiperone, phentolamine HCl (Janssen 
Research Foundation, Belgium), methacholine HCl (E. Merck, Germany), 
suramin sodium (Rhone-Poulenc, France), 5-hydroxytryptamine creatinine 
sulphate, TTX (tetrodotoxin) (Serva, Germany), isoproterenol tartrate, L-NNA 
(NG-nitro-L-arginine), disodium ATP (adenosine 5'-triphosphate), sodium nitro-
prusside (Janssen Chimica, Belgium), nitroglycerin (Federa, Belgium), paroxetine 
HCl (Ferrosan, Denmark), Citalopram HBr (Lundbeck, Denmark), pargyline HCl 
(Abbott, USA), N-hexanoyl-5-hydroxytryptophyl-5-hydroxytryptophan amide 
(hex-5-HTP-DP) and 5-hydroxyindalpine (5-OHIP) maleate (gift M.D. Gershon) 
were added to the tissue bath solution in volumes < 1% of the bath volume. 
Ketanserin tartrate and tropisetron (Janssen Research Foundation, Belgium) 
were continuously present in the De Jalon solution. All compounds were 
dissolved in distilled water, except for cisapride, SDZ 205-557, R 76 186, metoclo-
pramide, spiperone and tropisetron, which were dissolved in distilled water acid-
ified with tartaric acid in the stock solution (pH > 3). The stock solution for 
isoproterenol and 5-HT contained 0.25 uM ascorbic acid. This vehicle had no 
effect on the strips. The stock solution of TTX was prepared in advance and kept 
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frozen (-30 °C). The benzamides induced small contractions per se, but this effect 
had disappeared by the time methacholine was added. 
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Figure 8.1 Structural formulas of the prokinetic benzamides that were tested. 
Results 
General 
Over a concentration range of 0.03 uM to 100 uM, 5-HT induced relaxations in 
a concentration-dependent fashion (Figure 8.2, upper panel). The concentration-
response curve to 5-HT was non-monophasic, with a first phase ranging from 
0.03 uM to 1 uM, and a second phase from 1 uM to 30 uM, where the maximum 
effect to 5-HT was observed at 30 uM (Figure 8.2, lower panel). 
Effects of cisapride and other substituted benzamides 
From 0.1 uM onwards, cisapride significantly (P < 0.05) affected the concentra-
tion-response curve to 5-HT (Figure 8.2, lower panel). At a concentration of 
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0.1 U.M, cisapride significantly enhanced the 5-HT-induced relaxations from 1 uM 
5-HT onwards (i.e. the second phase of the concentration-response curve to 
5-HT) by ca. 20-30 % (Figure 8.2, lower panel). At 0.3 and 1 uM, cisapride even 
further enhanced the relaxations to 5-HT (up to ca. 40 % amplification; Figure 8.2 
lower panel). At these concentrations, cisapride also significantly inhibited the 
relaxations to 5-HT 0.1 uM. As can be seen from Figure 8.2 (middle panel), 
cisapride changed the time-relaxation profile, rendering it into a more 
pronounced and less tonic relaxation. At 3 uM cisapride merely inhibited the 
relaxations to 5-HT (up to 3 uM 5-HT) (Figure 8.2, lower panel). 
uNI 5-HT 
Figure 8.2 5-HT, administered in 
a non-cumulative fashion, induces 
relaxations on the methacholine-
precontracted guinea pig proximal 
colon segments {upper panel). The 
experiments were done in the 
presence of ketanserin (0.3 |j.M) 
and tropisetron (3 u.M) to block con-
tractile responses to 5-HT mediated 
by 5-HT2A, 5-HT3 and 5-HT4 recep-
tors. The middle panel shows a 
recorder tracing of the effect of cis-
apride 0.3 M.M on the 5-HT-induced 
relaxations. The vertical bars left to 
the tracing of the methacholine-in-
duced precontraction represent 
the magnitude of the relaxation to 
5-HT (10 uM) of that particular strip 
prior to the establishment of the 
concentration-response curve. In 
the lower panel, concentration-re-
sponse curves to 5-HT in the ab-
sence (O) (n = 12), or presence of 
cisapride is shown: (•) 0.1 |iM, (•) 
0.3 u.M. (A) 1 uM, (A) 3 uM (all n = 
6); means ± S.E. Relaxations were 
expressed as a percentage of a re-
laxation to 5-HT 10 uM in the ab-
sence of cisapride. Statistically sig-
nificant difference from control is 
denoted with an asterisk. 
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Several other structural analogs of cisapride were tested against the 5-HT-
induced relaxations (all at a concentration of 1 uM). Cinitapride, clebopride and 
dazopride showed effects that were very similar to those induced by cisapride: 
relaxations to lower concentrations (< 3 uM) of 5-HT were inhibited, while 
relaxations to higher concentrations (> 30 uM) of 5-HT were enhanced (up to ca. 
40 %) (Figure 8.3, left panel). In contrast, renzapride only caused a slight 
enhancement of 5-HT-induced relaxations from 1 uM 5-HT onwards (up to ca. 
20 %) (Figure 8.3, right panel). Zacopride only significantly (P < 0.05) enhanced 
the relaxations to 5—HT from 1 uM to 10 uM, while metoclopramide had no 
significant effect (Figure 8.3, right panel). R 76 186 did not significantly affect the 
concentration-response curve to 5-HT (n = 5; not shown). 
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Figure 8.3 Concentration-response curves to 5-HT in the absence (O) or presence of several 
structural analogs (1 |iM) of cisapride are shown: left panel cinitapride (•), clebopride (•) and dazo-
pride (A); right panel renzapride (•), zacopride (•) and metoclopramide (A). All experiments n = 6; 
means + S.E. The experiments were done in the presence of ketanserin (0.3 |iM) and tropisetron 
(3 uM) to block contractile responses to 5-HT mediated by 5-HT2A. 5-HT3 and 5-HT4 receptors. 
Relaxations were expressed as a percentage of a relaxation to 5-HT 10 (iM in the absence of benza-
mide. Statistically significant difference from control is denoted with an asterisk. 
In order to investigate the specificity of the cisapride-induced enhancement of 
5-HT-induced relaxations, cisapride (0.3 uM) was tested against relaxations 
induced by ATP and isoproterenol, and by the NO donors nitroglycerin and 
nitroprusside. Cisapride did not significantly affect the concentration-response 
curves to either of these agonists (Figure 8.4). 
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Figure 8.4 Concentration-response curves to ATP (upper left panel), isoproterenol (upper right 
panel), nitroglycerin (lower left panel) and sodium nitroprusside (lower right panel) in the absence (O) 
or presence (•) of cisapride (0.3 |iM). All experiments n = 4; means ± S.E. The experiments were 
done in the presence of ketanserin (0.3 p.M) and tropisetron (3 |j.M) to block contractile responses to 
5-HT mediated by 5-HT2A, 5-HT3 and 5-HT4 receptors. Relaxations were expressed as a percentage of 
a relaxation to respectively ATP (3 p.M), isoproterenol (3 p.M), nitroglycerin (10 |iM) or nitroprusside 
(30 u.M) in the absence of cisapride. 
Effects of cisapride on nitrergic and purinergic neurotransmission 
TTX (0.3 |iM) abolished the relaxations to 5-HT in the presence of cisapride 
(1 U.M) (n = 4; not shown). The NO synthase inhibitor L-NNA (100 u,M) strongly 
inhibited the relaxations to 5-HT (Figure 8.5, upper panel), showing that the 
greater part of the relaxation to 5-HT is due to NO. In the presence of L-NNA, 
cisapride (0.3 |iM) induced a 2-3 fold amplification of the remaining relaxation to 
5-HT (Figure 8.5, upper panel). The purinoceptor antagonist suramin (300 |iM) 
depressed the second, but not the first, phase of the curve to 5-HT (significant 
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from 10 uM 5-HT onwards) (Figure 8.5, middle panel). In the presence of 
suramin, cisapride (0.3 uM) did not have a significant effect on the curve to 5-HT, 
except for a small inhibition at 0.1 and 0.3 uM 5-HT (Figure 8.5, middle panel). In 
the presence of both cisapride and L-NNA, the remaining relaxations to 5-HT 
were virtually abolished by suramin (Figure 8.5, lower panel). 
Figure 8.5 Concentration-response curves 
to 5-HT in the absence (O) or presence of 
several drugs: upper panel cisapride (0.3 fiM; 
• ) , L-NNA (100 uM; A) and the combination 
of cisapride and L-NNA (• ) (n = 6); middle 
panel cisapride (0.3 uM; • ) , suramin (300 
uM; • ) , and the combination of cisapride and 
suramin (•) (n = 10); lower panel the combi-
nation of cisapride and L-NNA with ( • ) or 
without (V) suramin (n = 4); means + S.E. The 
experiments were done in the presence of 
ketanserin (0.3 u,M) and tropisetron (3 u,M) to 
block contractile responses to 5-HT mediated 
by 5-HT2A, 5-HT3 and 5-HT4 receptors. 
Relaxations were expressed as a percentage 
of a relaxation to 5-HT 10 u.M in the absence 
of antagonist. Statistically significant differ-
ence from control is denoted with an asterisk. 
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Possible mechanisms 
The 5 - H T I P receptor antagonist hex-5-HTP-DP (1 uM) had no intrinsic effect, 
nor did it affect the concentration-response curve to 5-HT (n = 4; not shown). The 
5-HTip receptor agonist 5-OHIP (1 uM) also had no intrinsic effect, but it inhib-
ited the first phase of the concentration-response curve to 5-HT (up to 1 uM), 
while the second phase was unaffected (n = 4; not shown). In the presence of 
5-OHIP (1 uM), cisapride (0.3 uM) still enhanced the relaxations to 5-HT (10-100 
(AM) by about 25 %. 
Cisapride might cause enhancement of the 5-HT-induced relaxations by 
inhibition of 5-HT uptake or 5-HT degradation by mono amine oxidase (MAO). 
The amplifying effects of cisapride on the concentration-response curve to 5-HT 
were however not mimicked by the specific 5-HT uptake inhibitors Citalopram 
and paroxetine (0.3 uM; n = 5) (not shown), or by the MAO inhibitor pargyline 
(100 uM; n = 4) (not shown). As cisapride has moderate affinity for 
oc-adrenoceptors, it was investigated whether blockade of a-adrenoceptors could 
explain the effects of cisapride. The non-selective a-adrenoceptor antagonist 
phentolamine (1 uM) did not significantly affect the relaxations to 5-HT (n = 5; 
not shown). Antagonism of transmitter release-inhibiting 5 - H T I A receptors 
might account for the effects of cisapride. The 5 - H T I A receptor antagonists 
NAN-190 (0.03 (xM) and spiperone (1 \iM) did not amplify the relaxations to 
5-HT, but spiperone inhibited them from 10 uM 5-HT onwards (n = 6; not 
shown). It is conceivable that the presence of 3 uM tropisetron in the antagonist 
cocktail is insufficient to block all of the 5-HT4 receptor-mediated contraction, 
and that desensitization of these receptors by cisapride explains the enhancing 
effects of cisapride on the 5-HT-induced relaxations (i.e. elimination of func-
tional antagonism). However, the 5-HT4 receptor antagonist SDZ 205-557 
(0.3 uM) did not mimiek the effects of cisapride (n = 4; not shown). 
Discussion 
Previously, we have shown that the 5-HT-induced relaxations on the guinea 
pig colon are mediated by nitric oxide (Briejer et al, 1992) and ATP (Briejer et ah, 
1995). It was shown, that suramin (and apamin) strongly inhibited relaxations to 
exogenous ATP, but did not affect those induced by nitroglycerin, exogenous NO 
and isoproterenol (Briejer et al, 1995). However, both in the previous and 
current study, suramin selectively depressed the second, but not the first, phase 
of the concentration-response curve to 5-HT. ATP is an established (co-)trans-
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mitter, and suramin is known to be a selective antagonist of ATP-induced P2-
purinoceptor mediated responses (Burnstock, 1972; Burnstock & Kennedy, 1985; 
Kennedy, 1990). Hence, it was concluded that ATP might be a mediator of 5-HT-
induced relaxations in this preparation. This second phase is selectively 
amplified by cisapride and some structural analogs, and these amplified relaxa-
tions can be inhibited by suramin, but not by the NO synthase inhibitor L-NNA. 
Furthermore, both in the absence and presence of cisapride, relaxations were 
abolished by the neurotoxin TTX (Briejer et al, 1992; this study), and cisapride did 
not affect relaxations evoked by exogenous ATP or the NO donors nitroglycerin 
or nitroprusside. These observations suggest, that cisapride selectively enhances 
purinergic neurotransmission through a prejunctional mode of action. 
As the effects of cisapride on relaxations to 5-HT were mimicked by its struc-
tural analogs cinitapride, dazopride, clebopride and to a lesser extent renzapride 
and zacopride (see Figure 8.1), it is suggested that these benzamides have a 
similar mode of action. The 5-HT4 receptor agonist R 76 186 (Briejer et al, 1993) 
and metoclopramide did not significantly affect the concentration-response 
curve to 5-HT. Apparently, the 2-methoxy-4-amino-5-chloro-substituted benza-
mide moiety is not sufficient to elicit the amplification effect, as it is present in 
all benzamides that were tested. Cinitapride, containing a 2-ethoxy-4-amino-5-
chloro-substituted benzamide moiety instead (see Figure 8.1), was about equally 
effective to cisapride in affecting the relaxations to 5-HT. Hence, a qualitative 
structure-activity relationship is not obvious. 
The concentration-response curve to 5-HT is non-monophasic, which 
suggests that two different 5-HT receptors are involved. The first phase is 
completely inhibited by the NO synthase inhibitor L-NNA (Briejer et al., 1992; 
current results), and the second phase is inhibited by suramin (Briejer et ah, 1995; 
current results). Hence, it is proposed that the guinea pig colon is endowed with 
a high affinity receptor ( 5 -HTH) , causing the generation of nitric oxide, and a low 
affinity receptor ( 5 - H T L ) whose stimulation induces the release of ATP. In 
another study, we have also found several lines of evidence for such a two-
receptor system (Briejer et al, submitted). The selective inhibition of spiperone 
of only the second phase of the concentration-response curve to 5-HT is in good 
agreement with the assumption that two 5-HT receptors are involved. 
In previous studies, the 5-HT-induced relaxations were shown to be inhib-
ited by 5-HTi receptor antagonists, but did not resemble one of the currently 
known 5-HTj receptor subtypes (Kojima, 1991; Elswood & Bunce, 1992; Briejer et 
al., 1992). As cisapride, and some of the other benzamides tested, shifted the first 
phase of the concentration-response curve to 5-HT to the right, it is likely that 
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these drugs are antagonists of the 5 - H T H receptor. This shift of the curve to the 
right probably explaines the apparent lack of enhancement of the 5-HT-induced 
relaxations at 3 nM cisapride. Cisapride is known to have affinity for 5 - H T I A , 
5-HT2A, 5-HT3 and 5-HT4 receptors (Van Nueten & Schuurkes, 1989; Leysen, 
1990; Taniyama et al, 1991; Briejer et al, 1993), and interferes with putative 
5-HTip receptor-mediated responses (Nemeth et al, 1985). Our data suggest that it 
also interacts with the putative 5 - H T H receptor. 
Several mechanisms can be proposed by which cisapride (and some of the 
other above described benzamides) could enhance relaxations to 5-HT. As 
cisapride seems to act prejunctionally, and the purinoceptor-mediated part of the 
response to 5-HT is selectively amplified, it is likely that the amount of released 
ATP is increased by cisapride, though only direct measurement of the amount of 
released ATP would allow a definite conclusion on this. 
Prejunctional 012-adrenoceptors and 5 - H T I A receptors are known to exist in 
the enteric nervous system, and both receptor types are known to inhibit trans-
mitter release after stimulation (Kojima et al, 1988; Galligan, 1993). Leakage of 
noradrenaline from enteric neurons might continuously stimulate the prejunc-
tional 012-adrenoceptors, thus inhibiting ATP release. In binding experiments, 
however, cisapride has moderate affinity for ai-adrenoceptors, but not for 
(X2-adrenoceptors (J.E. Leysen, personal communication). Furthermore, the non-
selective a-adrenoceptor antagonist phentolamine did not mimiek the effects of 
cisapride. Hence, an action at 0C2-adrenoceptors cannot account for the amplifying 
effects of cisapride. 
In electrophysiological experiments with guinea pig enteric neurons, 5-HT 
and cisapride are known to induce hyperpolarizations in some neurons, which 
are thought to be caused by stimulation of 5 - H T I A receptors (Nemeth et al, 1985). 
In functional experiments with preparations of the guinea-pig ileum, 5-HT and 
its analog 5-carboxamidotryptamine have been shown to inhibit field stimula-
tion-induced acetylcholine release (Galligan, 1992). These effects could be 
inhibited by NAN-190, a novel selective 5 - H T I A receptor antagonist, and 
spiperone. From similar experiments, other investigators have reported that 
cisapride inhibited 5 - H T I A receptor-mediated inhibition of acetylcholine release 
(Taniyama et al, 1991). In binding experiments, the affinity of cisapride for 
5 - H T I A receptors (cloned human 5 - H T I A Ha-7 cells, 8-hydroxy-2-(di-
N-propylamino) tetralin displacement) was 6.1 (J.E. Leysen, personal communi-
cation). It is known that partial agonists behave as antagonists, when applied 
together with a full agonist at a common receptor, for the partial agonist 
prevents maximal stimulation of the common receptor by the full agonist (see: 
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Hoyer & Boddeke, 1993). If it is supposed that 5 - H T I A receptors are also present 
on the inhibitory purinergic neurons and that cisapride is a partial agonist of 
5 - H T I A receptors, apparent antagonist effects of cisapride would thus explain the 
enhancement of the ATP release. However, spiperone and NAN-190, at concen-
trations that inhibited 5 - H T I A receptor-mediated effects in the guinea pig ileum 
(see above; Galligan, 1992), failed to mimiek the effects of cisapride. Furthermore, 
to date 5 - H T I A receptors have been found to be present exclusively on excitatory 
neurons (seen above). Hence, a 5 - H T I A receptor mechanism is also not likely to 
account for the amplifying effects of cisapride. 
In electrophysiological experiments with a subset of type 2/AH myenteric 
neurons of the guinea pig, slow prolonged depolarizations can be elicited by 
5-HT, that are not sensitive to classical 5-HT receptor antagonists (Nemeth et al, 
1985; Takaki et al., 1985). The receptor that mediates this effect, has provisionally 
been named 5-HTip, though it does not belong to the 5-HTi-like group of recep-
tors as defined by Humphrey et al. (1993). The 5-HT-induced depolarizations can 
be mimicked by 5-OHIP and the S-enantiomer of zacopride (Mawe et al., 1986; 
Wade et al., 1991), and inhibited by a dipeptide of 5-hydroxytryptophan, i.e. hex-
5-HTP-DP (Takaki et al., 1985), and the benzamides R-zacopride, renzapride and 
cisapride (Nemeth et al., 1985; Mawe et al, 1989; Wade et al., 1991). If cisapride 
would slightly depolarize the ATP-containing neurons, it is conceivable that the 
generation of action potentials is facilitated, and thus more ATP is released. 
However, cisapride is an antagonist of 5-HTip receptor-mediated depolarizations, 
and therefore it is difficult to explain the amplifying effects of cisapride and some 
of the other benzamides tested in terms of interactions with 5-HTip receptors. 
Furthermore, the 5 - H T I P receptor antagonists hex-5-HTP-DP and renzapride had 
no effect on the relaxations to 5-HT, and the agonist 5-OHIP merely depressed the 
first phase of the concentration-response curve to 5-HT, while leaving the second 
phase unaffected. The structural formula of 5-OHIP resembles that of 5-HT, and 
therefore, it is not surprising that 5-OHIP acts as an antagonist at 5 - H T H 
receptors. From these observations it can be concluded that 5-HTip receptors are 
not likely to be involved in the 5-HT-relaxation-enhancing effects of cisapride. 
Inhibition of 5-HT degradation by MAO, or inhibition of 5-HT uptake by the 
neurons, might cause enhancement of the effects of 5-HT. However, inhibition 
of MAO or 5-HT uptake did not mimiek the effects of cisapride. Furthermore, 
inhibition of either removal system would be expected to cause a shift of the 
concentration-response curve to the left, and not, as in our experiments, a 
selective enhancement of the responses. Hence, also inhibition of 5-HT uptake or 
MAO do not explain the effects of cisapride. 
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The substituted benzamides are agonists at the 5-HT4 receptor, whose 
stimulation causes contraction of the guinea-pig gut. These contractions are 
prone to desensitization (Bockaert et al, 1992; Briejer et al, 1993; Ford & Clarke, 
1993). The 5-HT4 receptors might be incompletely blocked by tropisetron (pA2 = 
6.0-6.7; see Bockaert et al, 1992; Ford & Clarke, 1993) in our experiments. 
Desensitization of a part of the relaxation-counteracting 5-HT4 receptors that is 
not blocked by tropisetron, could therefore result in an apparent enhancement of 
the relaxations to 5-HT. Therefore, the selective 5-HT4 receptor antagonist 
SDZ 205-557 (Buchheit et al, 1992; see: Ford & Clarke, 1993) was tested in addition 
to tropisetron, but it did not mimiek the effects of cisapride. Furthermore, if 
5-HT4 receptor desensitization were the mechanism of action, 5-HT4 receptor 
agonists like R 76 186 (Briejer et al, 1993), renzapride and zacopride (Bockaert et 
al, 1992) would also enhance the relaxations to 5-HT, but these compounds had 
no or only a weak effect. Hence, 5-HT4 receptors do not seem to be involved. 
Propulsion of gut contents is established by a coordinated pattern of 
contractions and relaxations of both the longitudinal and circular smooth muscle 
coat in the gut wall. The stimulation (prokinetic) effects of cisapride in both 
animal and man has been explained in terms of facilitation of cholinergic and 
non-cholinergic neurotransmission which favours contraction during peristalsis 
(Schuurkes et al, 1985; Tonini et al, 1991; Taniyama et al, 1991; Kilbinger & 
Wolf, 1992; Bingham & Andrews, 1992). The current results suggest that cisapride 
(and some other prokinetic benzamides) can also facilitate inhibitory 
neurotransmission, which could favour relaxation during peristalsis and could 
thus contribute to its prokinetic effects. Future research will be needed to 
evaluate whether these findings are relevant for the clinical efficacy of cisapride. 
Conclusions: cisapride, and some of its structural analogues, seem to 
selectively enhance the suramin-sensitive, purinoceptor-mediated, part of the 
neurogenic relaxations to 5-HT. Though it was shown that cisapride acts 
presynaptically, it is not known by what mechanism it amplifies the relaxations 
to 5-HT. 
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Chapter 9 
A novel in vivo method for the assessment of 
peristalsis in the distal colon of the guinea-pig 
M.R. Briejer, M. Tonini, L.M.A. Akkermans & J.A.J. Schuurkes 
submitted for publication 
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Abstract. A novel method for the study of colonic peristalsis in the anaesthetized guinea-pig was 
developed. After laparotomy, a rubber balloon was inserted into the lumen of the distal colon and 
inflated with 0.05-0.2 ml of water to mimic faecal pellet size. Thus, movement of the balloon and 
change in length of the longitudinal muscle could be assessed by isotonic recording. 
Inflation of the balloon per se did not induce propulsion of the balloon. Treatment with the 
a-adrenoceptor antagonist phentolamine (2 m g / k g i.v.) induced peristalsis and balloon displace-
ment. This suggests that sympathetic nerve over-activity, probably due to anaesthesia and surgery, 
exerts a tonic inhibitory influence on the colon, which prevents coordinated motor activity. The 
opioid antagonist naloxone (1 m g / k g i.v.) did not promote peristalsis when given alone. However, 
when naloxone was administered in addition to phentolamine, a decrease in the maximum, but not 
the average velocity of propulsion was observed compared to treatment with phentolamine alone. 
Treatment with the NO synthase inhibitor NG-nitro-L-arginine (25 m g / k g i.v.) in addition to 
phentolamine increased the average, but not the maximum, pellet propulsion velocity as compared 
to treatment with phentolamine alone. Irrespective of the treatment schedule employed, the velo-
city of propulsion was not dependent upon the inflation volume of the balloon. 
This model provides the first in vivo method for the investigation of drugs to induce or affect 
colonic propulsion. 
Introduction 
The intrinsic enteric nervous system of the gut, which controls its motility, is 
considered the third part of the autonomic nervous system (see: Gershon & Erde, 
1981). Sympathetic (inhibitory) and parasympathetic (both excitatory and 
inhibitory) inputs from extrinsic nerves merely modulate the intestinal motor 
activity. Many functional in vitro models have been described to investigate the 
pharmacological modulation of gastrointestinal motility. Such models usually 
comprise isolated parts of the guinea-pig gastrointestinal tract, in which para-
meters like force, pressure, electrical properties or pellet propulsion are assessed 
in response to distension, pressure, or electrical or pharmacological stimulation 
(for example: Trendelenburg, 1917; Frigo & Lecchini, 1970; Costa & Furness, 1976). 
In such preparations, extrinsic parasympathetic and sympathetic nerve input 
(and output, feedback loops), as well as blood supply, have usually been cut off 
together with the mesentery. In vivo models differ in this respect, though in 
anaesthetized animals, anaesthesics and abdominal surgery influence sympa-
thetic and parasympathetic tone (and possibly also other neurotransmitter 
balances, e.g. opioid peptides), and thus affect gastrointestinal motility (see: 
Dubois, 1988; Galligan et al, 1986). Here we describe a novel in vivo model in the 
anaesthetized guinea-pig, which allows measurement of the velocity of propul-
sion of an inflated balloon in the distal colon, and the effects of drugs thereon. 
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Methods 
Preparation of the animals 
Dunkin-Hartley guinea-pigs of both sexes, weighing 700-800 g, were used that 
had access to food and water ad libitum. The guinea-pigs (12 in total) were anaes-
thetized with a mixture of N2O : O2 in a ratio of 2 : 1 and halothane (Fluothane®, 
3-3.5 % induction, 1-1.5 % maintenance). The animals breathed the gas mixture 
spontaneously by means of a cap positioned over the head. The abdomen and 
throat were shaved, and the animals were mounted upon a heating pad main-
tained at 38 °C. The left carotid artery and the right external jugular vein were 
cannulated for monitoring blood pressure and to allow the i.v. administration of 
drugs, respectively. Heart rate was also monitored by means of 4 electrodes that 
were attached subcutaneously. 
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Figure 9.1 Schematic drawing of the experimental set-up. After laparotomy of the anaesthetized 
guinea-pig, the distal part of the colon was cut and fixed in a lifted position by insertion of a small plastic 
cylinder, that was attached to an isotonic transducer (transducer A, 4 g load) via a pulley. A second 
isotonic transducer (transducer B, 125 mg load) was connected to a small balloon, that could be 
inserted into the lumen of the distal colon, and that could be inflated by means of a syringe filled with 
water via a thin polyethylene tubing (see also magnified insert in the left lower corner for details). After 
inflation, length changes and propulsion velocity could thus be assessed simultaneously. 
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The abdominal cavity was exposed by a midline incision. The abdominal wall 
was lifted by means of stitches that were attached to two metal rods above the 
animal. These rods and stitches were positioned in such a manner, that the 
wound attenuated to a rectangular shape and an enlarged abdominal cavity. In 
case the caecum was very large due to faecal contents and/or gas, it was removed 
(8 guinea-pigs). In female animals, the intact uterus was fixated in a lifted 
position to avoid interference with the balloon movement. The distal part of the 
colon was lifted, and at about 10 cm proximal to the anus the colon was ligated, 
occluding the lumen. Under normal conditions, the distal colon serves to 
transport faecal pellets into the anal direction. About 10 cm of colon proximal to 
this ligature was removed after ligation of the supplying blood vessels, to avoid 
sterical hindrance. A few mm distal to the ligature, a small hole was made, and 
the luminal contents were washed out through the anus by gentle injection of 
prewarmed (38 °C) saline into the distal part of the colon. Then, a small plastic 
cylinder (approximately 1.3 cm long, outer diameter ca. 5 mm) was inserted 
through the hole and fixated. This plastic cylinder was attached to an isotonic 
transducer (load 4 g) via a pulley to detect changes in length. It was positioned 
just equally high to the wound borders with the aid of the pulley. A small 
balloon was prepared from a piece of condom by folding it over a thin polyethy-
lene tubing and tiing it down with a thread. This thread was attached to a second 
isotonic transducer (load 125 mg) via a pulley, and the empty balloon was 
inserted through the plastic cylinder into the lumen. The balloon could be 
inflated by injecting water through the polyethylene tubing by means of a 
syringe. Movement of the balloon at different diameters and change in length of 
the colon could thus be assessed simultaneously. The set-up as described here is 
schematically represented in Figure 9.1. During the experiments, care was taken 
that the abdominal cavity and its contents were kept moist, by regular spraying of 
prewarmed saline into the wound. To help maintain a constant temperature at 
the ventral side, the animals were placed under an infrared heating lamp, but 
the abdominal cavity was protected from radiation with a moist cotton wool 
swab. 
Experimental protocol 
The deflated balloon was inserted about 3 to 4 cm from the plastic cannula, 
and inflated to a volume of 0.05, 0.1, 0.15 or 0.2 ml, in a random order. 
Phentolamine and/or naloxone were injected through the venous cannula, 
about 3-5 min after the balloon had been inserted and inflated for the first time. 
After peristaltic propulsion had occurred, the balloon was deflated and gently 
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pulled back into the plastic cannula. After a resting period of 0.5-1 min, the 
balloon was reinserted and inflated, again to a randomly chosen volume, and the 
velocity of propulsion was determined. The number of peristaltic propulsion 
movements that were thus assessed, ranged from 4 to 18 per animal. 
Simultaneously, changes in length of the longitudinal coat were monitored. 
Statistics and graphical representation 
The average and maximum velocities were determined graphically. The 
average velocity during a peristaltic movement was defined as the distance of 
travelling divided by the time, whereby a peristaltic movement consisted of a 
period of continuous movement with no stop (< 1 mm movement in 5 s). The 
maximum velocity was determined from the maximum slope of the tracing. 
Velocities were averaged per animal for each of the volumes tested. N denotes 
the number of animals. Differences in mean values were compared with 
ANOVA and the Scheffé F-test for multiple comparisons. The level at which a 
difference was considered statistically significant was set at P < 0.05. For graphical 
representation, the mean ± standard error of the mean was calculated. 
Drugs 
The following drugs were used: naloxone HCl, phentolamine HCl 
(Regitine®), guanethidine, NG-nitro-L-arginine (Janssen Chimica, Belgium). The 
drugs were dissolved in saline. 
Giuliani et al. (1993) reported that treatment with the a-adrenoceptor anta-
gonist phentolamine and the opioid receptor antagonist naloxone of anaes-
thetized guinea-pigs resulted in a higher reproducibility in the assessment of 
colonic motor reflexes. We therefore evaluated the effects of these drugs. 
Results 
No drug treatment 
In most cases, the longitudinal coat showed only little activity as reflected by 
the constant base line (Figure 9.2), though in others, rithmic activity was 
recorded. Insertion and subsequent inflation of the balloon induced in some 
cases a small contraction of the longitudinal coat, and sometimes the rhythmic 
activity of the longitudinal coat increased, but neither of these effects was consis-
tently observed. The balloon was not propelled under these circumstances, or 
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only over a small distance (< 1 cm). In the absence of any drug treatment, 
continuous peristaltic movements were never observed. 
insertion 
deflation 
withdrawal 
30 sec 
balloon 
displacement 
—// 
colon length 
0.1 ml 
inflation 
phentolamine 
2 mg/kg iv 
0.05 ml 
inflation 
0.2 ml 
inflation 
0.15 ml 
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Figure 9.2 Recorder tracing of a typical experiment. In the upper tracing, displacement of the 
balloon is shown, while the lower tracing represents longitudinal length changes of the colon. As can 
be seen from this tracing, spontaneous movements were usually small in amplitude, though this 
varied in the different animals studied. Insertion of the balloon and inflating to a randomly chosen 
volume (in this case 0.1 ml) did usually not evoke any response. After 5 min, the a-adrenoceptor 
antagonist phentolamine 2 mg/kg was injected through the right jugular vein. Immediately after this, 
the longitudinal coat contracted, and the spontaneous movements increased in amplitude. About 
1 min after injection, the pellet was propelled into the anal direction. After deflation and gentle with-
drawal of the empty balloon into the plastic cylinder, the balloon could be reinserted (ca. 1 min rest) 
and inflated to a different volume. 
Treatment with phentolamine 
Intravenous injection of phentolamine (2 mg/kg) caused an immediate fall 
in blood pressure and a reflex tachycardia, which remained stable for at least 
40 min (which was the maximum period of peristalsis assessment). Within 
1 min after injection, a contraction and an increase in the spontaneous activity of 
the longitudinal coat were induced, and within 2 min after injection (after 4 min 
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in 1 case), the balloon was propelled (Figure 9.2). During or previous to a 
peristaltic wave, the longitudinal coat contracted, but, even within the same 
animal, this was often not observed (Figure 9.2). Sham injections with saline had 
no effect (n = 4). In some cases, one or two pellets were expelled upon adminis-
tration of phentolamine, which apparently were still present in the distal part of 
the colon. There was no relationship between the distension of the balloon and 
the velocity of propulsion (Figure 9.3a+b), as the means of neither the average 
nor the maximum velocities at the different inflation volumes significantly 
differed from one another. The maximum velocity (which in most cases 
occurred in the last 2 or 3 cm) obtained was 4.57 ± 0.04 m m / s (n = 6; 0.1 ml 
inflation) and the maximum average velocity was 2.18 ± 0.12 m m / s (n = 6; 
0.05 ml inflation). The lag time between inflation and movement varied from a 
few seconds (Figure 9.2) to a few minutes. In some cases, the peristaltic propul-
sion was already triggered by the insertion of the empty balloon, and therefore, it 
was difficult to determine a lag time. 
Treatment with phentolamine and naloxone 
Animals treated with both phentolamine (2 mg/kg) and naloxone (1 mg/kg) 
responded similarly to phentolamine-treated animals, though the combination 
treatment significantly decreased maximum velocity of propulsion at 0.15 and 
0.2 ml (Figure 9.3b), while it tended to at 0.05 ml and 0.1 ml. The combination 
treatment with naloxone also tended to lower the average velocity of propulsion, 
though this was never statistically significant (Figure 9.3a). It was often difficult 
to insert the empty balloon into the lumen, and to pull it back after a peristaltic 
movement, which seemed to be caused by the high tone of the circular muscle. 
This was not observed if naloxone had not been administered. Hence, the 
decrease in maximum propulsion velocity of the balloon in the naloxone treated 
animals might reflect an increase in resistance due to high circular tone. 
Treatment with naloxone per se did not induce propulsion of the balloon (n = 3). 
Treatment with phentolamine and NG-nitro-L-arginine 
In guinea-pigs treated with both phentolamine and the NO synthase inhibitor 
NG-nitro-L-arginine (L-NNA; 25 mg/kg i.v.) average velocity of propulsion was 
increased at 0.05 ml, 0.10 ml and 0.15 ml inflation, but not at 0.20 ml inflation of 
the balloon (n = 3) (Figure 9.3b), as compared to treatment with phentolamine 
alone. However, maximum propulsion velocity was not significantly affected, as 
compared to treatment with phentolamine alone (Figure 9.3a). 
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Figure 9.3 Graphical representation of the mean propulsion velocity at different inflation volumes of 
the balloon. In Figure 9.3a, the maximum propulsion velocity is shown, while in Figure 9.3b the 
average velocity is depicted. Treatment with the opioid receptor antagonist naloxone (1 mg/kg i.v.) (•) 
in addition to the a-adrenoceptor antagonist phentolamine (2 mg/kg i.v.) significantly decreased the 
maximum, but not the average, propulsion velocity as compared to treatment with phentolamine alone 
(O) (denoted by an asterisk, P < 0.05). Treatment with the NO synthase inhibitor NG-nitro-L-arginine 
(25 mg/kg i.v.) (•) in addition to phentolamine, however, significantly increased average, but not 
maximum propulsion velocity as compared to treatment with phentolamine alone. Data points with 
error bars represent mean ± standard error of the mean. 
Discussion 
After injection of phentolamine, it was not possible to detect a difference at 
both maximal and average propulsion velocities of the balloon at the volumes 
that were studied. The diameter of the balloon ranged from about 4 (0.05 ml) to 
8 (0.2 ml) mm, while natural pellets have a diameter of about 5 mm in animals 
of about 800 g body weight. Hence, varying the balloon diameter around its 
physiological diameter does not greatly affect propulsion velocity. In isolated 
segments of the guinea-pig distal colon, it has been shown that the balloon 
diameter does influence the velocity of propulsion (Frigo & Lecchini, 1970). We 
have no explanation for these differences. However, it must be stated that the 
maximum velocity of propulsion in the isolated colon is about 1.5-1.9 m m / s 
(Frigo & Lecchini, 1970; Costa & Furness, 1976; Krantis & Kerr, 1981), whereas in 
our model it was about 2-3 times higher. Furthermore, in isolated segments 
peristalsis occurred spontaneously, whereas in vivo a-adrenoceptor blockade was 
necessary. This exemplifies the differences between in vitro and in vivo 
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measurements. In their paper, Frigo & Lecchini (1970) report that the threshold 
volume of the balloon was about 0.05 ml. However, in some cases they observed 
propulsion of the empty balloon, as we did in our model. 
Almost a century ago, Bayliss & Starling (1899) demonstrated that sponta-
neous and stimulated movements of the gastrointestinal tract could be inhibited 
by opening of the peritoneal cavity and by manipulation of the intestines. 
Abdominal surgery and anaesthesia are known stress factors that induce a 
temporal intestinal paralysis in animal and man, also named postoperative 
ileus, which is probably mainly caused by increased sympathetic activity (Dubois, 
1988; Livingston & Passaro, 1990). Circulating catecholamines from the adrenals 
and noradrenaline from the extrinsic sympathetic nerves may stimulate 
a-adrenoceptors on the enteric nerves. Stimulation of prejunctional 
(X2-adrenoceptors has been shown to inhibit the release of acetylcholine from 
enteric neurons (Kojima et al, 1988; Galligan, 1993). The myogenic spontaneous 
movements are known to be promoted by cholinergic neural activity, i.e. acetyl-
choline (Maggi & Meli, 1984; Maggi et al, 1985). After blocking the a-adreno-
ceptors with phentolamine, an increase in tone and in the amplitude of 
spontaneous phasic movements of the longitudinal coat were observed, and it 
was possible to evoke peristalsis. In the conscious guinea-pig, however, injection 
with phentolamine does not alter intestinal motility as assessed by myoelectric 
activity measurement (Galligan et al, 1986). Hence these observations are in 
concordance with a tonic sympathetic inhibition of the intestine due to the 
surgical procedure and the anaesthesia. a-Adrenergic blockade or other sympa-
thicolytic procedures have been used successfully to prevent or improve post-
operative ileus in dogs, rats and man (see: Dubois, 1988; Livingston & Passaro, 
1990). 
Giuliani et al (1993) reported that, in the urethane anaesthetized guinea-pig, 
after chemical sympathectomy with guanethidine, treatment with the non-
selective opioid receptor antagonist naloxone resulted in more reproducible 
effects during the measurement of circular muscle activity in the distal colon. In 
the Trendelenburg preparation of the guinea-pig ileum (Trendelenburg, 1917), 
Van Nueten et al (1976) have shown that naloxone reversed and prevented 
"fatigue" phenomena that normally occur during peristalsis in this set-up. 
Endogenous opioid peptides play a neurotransmitter or neuromodulator role in 
the enteric nervous system (see: Kromer, 1988) and, like exogenous opioids, may 
inhibit the release of excitatory of inhibitory neurotransmitters (Tonini et al, 
1985; Marino et al, 1992; Galligan, 1993). Therefore, we examined the effects of 
naloxone in our model. Injection of naloxone, after phentolamine, seemed to 
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slow or hamper propulsion of the balloon, which could be caused by the high 
tone of the circular muscle after naloxone treatment. Apparently, under our 
experimental conditions, opioid receptor blockade by naloxone disrupts the 
balance between inhibitory and excitatory influences of the circular muscle in 
favour of the excitatory input. 
The main inhibitory neurotransmitter of the intrinsic non-adrenergic 
neurons of the gut is currently thought to be NO, which is formed from 
L-arginine by Ca2+-activated NO synthase (see: Moncada et al, 1991). NO synthase 
can be inhibited with NG-nitro-L-arginine (L-NNA) (Moncada et al, 1991). NO 
synthase immunoreactive neurons have a widespread distribution the enteric 
nervous system (Bredt et al., 1990; McConalogue & Furness, 1993), and NO-
mediated responses have been extensively studied in many species, amongst 
which also the guinea-pig (Briejer et al, 1992; Meulemans et al, 1993). In our 
model, inhibition of the nitrergic transmission by L-NNA in combination with 
phentolamine induced an increase in average propulsion velocity as compared 
to treatment with phentolamine alone. Tonini (1993) also observed an increase 
in propulsion velocity of an artificial pellet in the rabbit isolated colon. Suzuki et 
al (1994) observed in the isolated guinea-pig ileum, that peristalsis was facilitated 
by treatment with L-NNA, and they suggested that this was caused by an increase 
in contractile activity of the circular muscle layer, which is normally inhibited by 
NO. A similar mechanism could also account for the increase in average propul-
sion velocity in our model after inhibition of NO synthesis. 
The model presented in this paper is the first to allow the evaluation of the 
effects of drugs on propulsion velocity in vivo. Drugs may induce propulsion 
(phentolamine), or may alter velocity of propulsion in preparations already 
treated with phentolamine. This model thus adds an important new tool to 
investigate pharmacological modulation of the motility of the gut. 
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Although the gastrointestinal motility-stimulating action of the prokinetic 
substituted benzamides is already known for more than 30 years, it is still not 
completely understood how they evoke this effect. A large part of this gap in our 
understanding is due to the fact that gastrointestinal motility (disorders) itself is 
still far from completely understood. Another part is caused by the limited 
attention the field of 5-HT receptor research received in the 1970s. Only in the 
second part of the 1980s, 5-HT and its receptors regained attention from the scien-
tific community, which soon culminated in an avalanche of papers in the field. 
Selective tools for 5-HT receptors, but also for other neurotransmitter receptors, 
have become available in recent years. Against this background, the investiga-
tions as described in this thesis were done. 
The occurence of 5-HT receptor subtypes in the guinea-pig proximal colon 
was found to be very similar to the situation in the ileum (see General introduc-
tion), which is the classical model for in vitro studies. To date, no important role 
has been implicated for the 5-HT2A receptors which are present on the smooth 
muscle of both the ileum and the colon (see Figure II). Like in the ileum, also in 
the colon 5-HT3 and 5-HT4 receptors are present on the enteric nerves. Both 
receptor subtypes were shown to be involved in the contraction to 5-HT of the 
colon. In the ileum, 5-HT3 receptors mediate by far the larger part of the contrac-
tion to 5-HT, while in the colon the relative contribution of 5-HT3 and 5-HT4 
receptors seems equal. These differences could reflect different receptor distribu-
tions. In the colon, the contraction to 5-HT was highly sensitive to atropine, 
suggesting that neuronally released acetylcholine mediates the contraction, but 
involvement of substance P could not be excluded. As substance P was found to 
evoke a contraction via NKi receptors, future studies could be designed to inves-
tigate the relative contribution of this tachykinin in 5-HT3 and 5-HT4 receptor-
mediated contraction. Both cisapride and R 76 186 were found to cause a contrac-
tion of the colon through stimulation of 5-HT4 receptors. Thus, with novel selec-
tive NKi receptor antagonists like CP 96-345, future studies could assess whether 
non-cholinergic transmission is facilitated next to cholinergic transmission. As 
pointed out in Chapter 1, the contribution of the non-cholinergic neurotrans-
mitters might turn out to be important for the understanding of the mechanism 
of action of the substituted benzamides. 
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Figure II Schematic representation of the innervation of the guinea-pig proximal colon, as deduced 
from the experiments described in this thesis. The longitudinal muscle layer and some myenteric 
neurons are depicted. The scheme has been greatly simplified as only the excitatory serotonergic, 
cholinergic and inhibitory non-adrenergic non-cholinergic (NANC) neurons are shown. Serotonin 
(5-HT) released from interneurons and consecutively released neurotransmitters can stimulate a 
variety of both neuronal and smooth muscle receptors in the colon causing either stimulation (+) or 
inhibition (-). After stimulation of 5-HT3 and 5-HT4 receptors, the release of acetylcholine (ACh) and 
neurokinins (NKs) is enhanced. 5-HT can also stimulate ö-HTg-like and unknown 5-HT receptors on 
the NANC inhibitory neurons inducing the release of the neurotransmitters nitric oxide (NO) and 
possibly adenosine triphosphate (ATP) or related purines. On the smooth muscle, it was shown that 
5-HT2A and neurokinin NKi receptors are present, which mediate contraction. 
In contrast to the ileum, 5-HT also induced relaxation by stimulation of a 
novel high affinity 5-HT2-like receptor and a low affinity 5-HT receptor on the 
nerves (see Figure II). Since the beginning of the 1970s, many researchers have 
attempted to establish the non-adrenergic non-cholinergic inhibitory neuro-
transmitter in the gastrointestinal tract. It was shown that stimulation of the 
196 General discussion 
5-HT2-like receptors evokes the release of nitric oxide. The low affinity 5-HT 
receptor, which could not be characterized, probably accounts for the release of 
adenosine triphosphate (ATP) (see Figure II). The involvement of a peptide like 
vasoactive intestinal polypeptide is not likely. It was found that some benza-
mides, e.g. cisapride, cinitapride, clebopride and dazopride, selectively enhance 
the ATP-mediated part of the relaxation to 5-HT. Furthermore, it was suggested 
that they were an antagonist at the 5-HT2-like receptor, which might mask 
enhancing effects on NO release. Although facilitation of relaxation next to the 
established facilitation of cholinergic contraction could theoretically contribute to 
the prokinetic effects of the benzamides (see Figure III), such an involvement has 
yet to be demonstrated in relevant in vivo models. 
cisapride 
sp longitudinal 
+ muscle 
myenteric 
plexus 
circular 
muscle 
lumen 
Figure III Schematical simplified representation of the hypothesis that substituted benzamides like 
cisapride exert their prokinetic action through facilitation of both excitatory (acetylcholine (ACh), 
substance P (SP)) and inhibitory (adenosine triphosphate (ATP) and possibly nitric oxide (NO)) 
neurotransmission upon demand. The demand is set by sensory neurons which are sensitive to 
stretch or pressure exerted by the intraluminal bolus. These sensory neurons consecutively release 
transmitters to excite serotonergic (5-HT) interneurons, which in turn activate inhibitory or excitatory 
neurons. Such a circuit must be repeated many times along the intestine to ensure ongoing 
peristalsis. The neurotransmitter(s) mediating relaxation of the circular smooth muscle coat have not 
been established yet. 
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R 76 186 appeared to be a specific 5-HT4 receptor agonist, but cisapride evoked 
part of its contraction on the colon via a direct action on the smooth muscle. 
Although we attempted to characterize this part of the response, it is still not 
known how this effect is caused, and whether this effect contributes to its pro-
kinetic actions in vivo. The interaction of benzamides with the 5-HT4 receptors 
is a complicated one, but again the relevance of this finding has yet to be 
established. 
The in vivo model of faecal pellet propulsion in the guinea-pig distal colon as 
presented in this thesis could prove a valuable model to test the above described 
hypotheses. Comparison of the effect of the specific benzamide R 76 186, cisapride 
and non-benzamide 5-HT4 receptor agonists might teach us more on the mecha-
nism of action of substituted benzamides. 
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Conclusions 
The conclusions to the aims of the investigations as described in this thesis (see: 
General introduction), are thus: 
• in the isolated guinea-pig colon (longitudinal muscle): 
1. 5-HT induces both contraction via 5-HT2A receptors on the smooth muscle 
and 5-HT3 and 5-HT4 receptors on the enteric nerves, and relaxation via 
unidentified 5-HT receptors on the nerves; 
2. NO and ATP, but not VIP, are involved in the relaxation to 5-HT after 
neuronal 5-HT receptor stimulation; acetylcholine and possibly a non-
cholinergic substance mediate the neurogenic contraction to 5-HT; 
3. substance P induces a contraction via tachykinin NKi receptors on the 
smooth muscle; 
4. cisapride and the structural analog, R 76 186 induce contractions through 
neuronal 5-HT4 receptor stimulation; however, cisapride also has a direct 
effect on the smooth muscle which remains unidentified; 
5. two neuronal 5-HT receptors seem to be involved in the relaxation to 
5-HT; the low affinity 5-HT receptor remains unidentified, but the high 
affinity 5-HT receptor is proposed to be a novel 5-HT2-like receptor; 
6. cisapride and some other benzamides selectively enhanced the ATP-
mediated part of the 5-HT-induced relaxations, while they inhibited the 
NO-mediated part. 
• in the guinea-pig colon in vivo: 
7. a model in the anaesthetized guinea-pig for the study of peristalsis in the 
distal colon was established, which could prove valuable for the 
assessment of drug effects which interfere with gastrointestinal motility. 
Summary 
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In vitro pharmacological studies of gastrointestinal tissues have classically 
been done on guinea-pig ileum. It is known however that the guinea-pig colon 
has different properties. For example, in the colon non-adrenergic non-choliner-
gic neurotransmitters seem to play a bigger role as compared to the ileum, and 
the colon develops a spontaneous tone, in contrast to the ileum. The gastro-
intestinal motility stimulating benzamides are known to interfere with several 
5-hydroxytryptamine (5-HT) receptor subtypes either as agonist or antagonist. 
Agonism at neuronal 5-HT4 receptors has been proposed as their common 
property to explain their prokinetic effects, thus facilitating cholinergic trans-
mission. However, many questions as to their mechanism of action still remain. 
The bulk of the studies in which this issue was investigated used the guinea-pig 
ileum. The studies in this thesis describe an investigation into the effects of 
prokinetic benzamides and 5-HT and their interaction on the guinea-pig colon. 
Chapter 1 describes and evaluates in detail the studies and the subsequent 
theories on the mechanism of action of the substituted benzamides that have 
been proposed during the last 30 years. In the 1970s, it was proposed that the 
prokinetic benzamide metoclopramide, and later clebopride act as antagonists of 
peripheral dopamine D2 receptors, but in the early 1980s this theory was aban-
doned. The benzamides that emerged in this decade (cisapride, renzapride) had a 
much lower affinity for dopamine D2 receptors, but a higher potency to stimulate 
motility than metoclopramide. Moreover, they still had a facilitory action on 
cholinergic neurotransmission in the guinea-pig ileum. In the late 1980s a fourth 
5-HT receptor subtype was discovered, named 5-HT4. It was found that the 
benzamides are agonists at this 5-HT4 receptor, and that stimulation of 5-HT4 
receptors on the myenteric neurons of the guinea-pig ileum causes facilitation of 
cholinergic transmission. However, though the benzamides are effective 
motility stimulants in man and animal, neuronal 5-HT4 receptors in the rat and 
human gastrointestinal tract have not yet been established. Also other questions 
as to their mechanism of action are dealt with in this chapter. 
Chapter 2 describes a study in which it was investigated which 5-HT receptors 
mediate the responses to 5-HT in the longitudinal muscle layer of the guinea-pig 
proximal colon, using selective 5-HT receptor antagonists and 5-HT analogues. 
5-HT as well as its analogues induced both contractions and relaxations. 
Tetrodotoxin (TTX) abolished the relaxations, and it inhibited the contractions to 
all agonists. In the presence of TTX, blockade of either 5-HT2A or 5-HT3 receptors 
reduced the contractions to 5-HT, whereas blockade of both 5-HT receptor types at 
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the same time abolished them. In the absence of TTX, the contractions to 5-HT 
were inhibited by antagonists at 5-HT2A/ 5-HT3 and also 5-HT4 receptors. 
Contractions to ot-methyl-5-HT did not seem to be sensitive to 5-HT2A receptor 
blockade, but in the presence of TTX the contractions were abolished by the 
5-HT2A receptor antagonist. A 5-HT3 receptor antagonist abolished contractions 
to 2-methyl-5-HT. In the presence of TTX, a 5-HT2A receptor antagonist abolished 
contractions to 5-methoxytryptamine (5-MeOT), and in the absence of TTX the 
contractions to 5-MeOT were highly sensitive to blockade of 5-HT4 receptors. 
Blockade of either 5-HTi-like, 5-HT2A/ 5-HT3 or 5-HT4 receptors did not abolish 
the relaxations to 5-HT or 5-MeOT. 
It was concluded that 5-HT induces contractions of the longitudinal muscle of 
the guinea-pig proximal colon, through the stimulation of 5-HT2A receptors on 
the smooth muscle and 5-HT3 receptors and neuronal 5-HT4 receptors. 5-HT 
evokes relaxations via an unknown neuronal receptor. 
To establish the receptor that mediates contraction to substance P, the effects of 
three tachykinin NKi receptor antagonists and a NK2 receptor antagonist against 
substance P-induced contractions of the guinea-pig proximal colon longitudinal 
muscle were investigated (Chapter 3). Atropine, TTX and phosphoramidon did 
not affect the concentration-response curve for substance P (pECso = 7.8). The 
NKi receptor antagonist, 2s,3S-cis-CP 96345, competitively inhibited the contrac-
tions due to substance P (pA2 = 8.5; pKb = 8.9), but at higher concentrations 
(> 0.3 |iM), CP 96345 also depressed the concentration-response curve for metha-
choline. The species-selective NKi receptor antagonists, WIN 51708 and 
WIN 62577, and the NK2 receptor antagonist, SR 48968, had no effect. 
It was concluded that substance P induces contractions through the stimula-
tion of NKi but not NK2 receptors on the smooth muscle cells. In future studies, 
N K i receptor antagonists could thus be used to study the involvement of 
substance P in benzamide-induced responses in this preparation. 
The purpose of the study described in Chapter 4 was to investigate whether the 
effects of cisapride and its close structural analogue R 76 186 on the isolated 
guinea-pig proximal colon are mediated through 5-HT4 receptors. Both cisapride 
and R 76 186 induced contractions which yielded monophasic concentration-
response curves (cisapride: EC50 = 0.11 uM; R 76 186: EC50 = 24 nM). Blockade of 
either 5-HT2 or 5-HT3 receptors did not affect the responses to cisapride, but 
5-HT4 receptor antagonists depressed the concentration-response curve to 
cisapride (to about 50 %), and the curve to R 76 186 was shifted to the right. The 
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estimated pA2 values were 6.6 (tropisetron), 6.3 (DAU 6285), and 7.5 
(SDZ 205-557). However, none of these antagonisms was purely competitive as 
higher concentrations of these antagonists depressed the curve to R 76 186. 
Desensitization of the 5-HT4 receptor with 5-MeOT inhibited the responses to 
cisapride, and abolished those to R 76 186. The contractions to cisapride and 
R 76 186 were sensitive to mutual antagonism, depressing their concentration-
response curves. 
It was concluded that both cisapride and R 76 186 are agonists at the 5-HT4 
receptor, though cisapride also uses a non-5-HT mechanism. R 76 186 is a 
selective and potent 5-HT4 receptor agonist. 
In Chapter 5 it was investigated whether nitric oxide (NO) is involved in the 
neurogenic relaxations to 5-HT on the guinea-pig colon. Antagonists to block the 
contractile responses to 5-HT via 5-HT2, 5-HT3 and 5-HT4 receptors were present 
throughout the experiments and methacholine was administered to elevate 
tone. Under these conditions, 5-HT concentration-dependently induced relax-
ations (EC50 = 258 nM). The relaxations were inhibited by metergoline and 
methiothepine and abolished by TTX. Guanethidine did not affect them. 
NG-nitro-L-arginine (L-NNA) inhibited the responses to 5-HT (IC50 = 18.7 uM); at 
the highest 5-HT concentration a maximum inhibition of about 75 % was 
observed with 0.3 mM L-NNA. This inhibition was reversed with L-arginine. 
Relaxations to glyceryl trinitrate (GTN) were not inhibited by L - N N A . 
Haemoglobin inhibited the relaxations to 5-HT and GTN, but not those to 
isoprenaline (ISO). Methylene blue inhibited the relaxations to 5-HT but did not 
affect those caused by GTN or ISO. 
It was concluded that 5-HT induces relaxations that involve NO. We also 
confirmed that 5-HT induces these relaxations via (a) 5-HTi receptor subtype(s), 
located on neurons. 
Subsequently, in Chapter 6 it is described whether the inhibitory neurotransmit-
ters adenosine 5'-triphosphate (ATP) and/or vasoactive intestinal polypeptide 
(VIP) could be involved as well in the neurogenic relaxation to 5-HT. Under the 
same conditions as described above, ATP, VIP and 5-HT induced concentration-
dependent relaxations. TTX, L-NNA and the combination treatment did not 
inhibit the relaxations induced by VIP or 0.3-3 \iM ATP but reduced those by 
10 uM ATP. Suramin strongly inhibited the relaxations to ATP and VIP. L-NNA 
and suramin also inhibited the relaxations to 5-HT. In the presence of L-NNA, 
suramin did not significantly inhibit the relaxations to 5-HT. Suramin did not 
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affect the relaxations to ISO, GTN or exogenous NO, demonstrating its specificity. 
Apamin inhibited both the relaxations to ATP (by 70-100 %) and to 5-HT; relaxa-
tions to ISO were partially inhibited, indicating a non-specific component in the 
inhibitory action of apamin. However, relaxations to exogenous VIP, NO and to 
GTN were not inhibited. In the presence of L-NNA, apamin inhibited the relaxa-
tions to 5-HT only at 30 uM. a,ß-methylene-ATP (a,ß-Me-ATP) did not desensi-
tize the responses to ATP. Reactive blue 2 affected the relaxations to ISO at 
concentrations necessary to significantly inhibit the relaxations to ATP. Thus, it 
was not possible to test either a,ß-Me-ATP or reactive blue 2 against the relaxa-
tions to 5-HT. a-Chymotrypsin and trypsin almost abolished the relaxations to 
VIP, but did not affect those to ISO and 5-HT. The VIP receptor antagonists 
[p-Cl-D-Phe6,Leu17]VIP and VIPio-28 did not affect the concentration-response 
curve to VIP and were hence not tested against 5-HT. Phosphoramidon had no 
effect on the relaxations to VIP or 5-HT. 
It was concluded that on the guinea-pig colon longitudinal muscle, VIP and 
ATP induce relaxation via a direct effect of the smooth muscle, not involving 
NO. 5-HT-induced relaxations are mediated by NO as well as by a substance 
which is sensitive to inhibition by suramin and apamin. It is suggested that this 
substance is ATP and not a peptide like VIP. 
Again under the same conditions as described for chapter 5 and 6, Chapter 7 
describes the characterization of the receptor(s) that mediate the neurogenic 
relaxation to 5-HT on the guinea-pig colon. The relaxations to 5-HT yielded a 
biphasic concentration-response curve. Other tryptamines were also agonists 
with the following rank order of potency: 5-HT > 5-carboxamidotryptamine = 
5-MeOT > ct-methyl-5-HT (partial agonist) > tryptamine (partial agonist). 
5-Hydroxytryptophan, 2-methyl-5-HT and N-methyl-tryptamine were virtually 
inactive as agonists. The concentration-response curve to 5-HT was not affected 
by pargyline, Citalopram, phentolamine, a tenfold increase of the ketanserin 
concentration, or by the 5-HT4 receptor antagonists SDZ 205-557 and SB 204070. 
8-OH-DPAT, RU 24969, WB 4101, mCPP, TFMPP, flesinoxan, sumatriptan and 
MK212 were inactive as 5-HT receptor agonists; some were found to antagonize 
methacholine-induced contractions. The first phase of the concentration-relaxa-
tion curve to 5-HT was inhibited by the following drugs: metergoline (pA2 = 8.8, 
against 5-MeOT 9.3), methysergide (non-surmountable; NS), methiothepin (NS), 
spiroxatrine (NS), MK212 (NS), mesulergine (7.8), mCPP (7.1), mianserin (7.0), 
ritanserin (8.9), rauwolscine (7.0), yohimbine (6.2), 1-NAP (7.7) and RU 24969 
(6.4), but not by NAN-190, spiperone, sumatriptan, 8-OH-DPAT and flesinoxan. 
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When compared with pharmacological affinity and efficacy profiles at the 
currently recognized 5-HT receptor subtypes, the guinea-pig colon high affinity 
5-HT receptor correlated only with receptors of the 5-HT2 group (significantly 
with 5-HT2C and near-significantly with 5 -HT2A)- The receptor under study 
however also displayed pronounced pharmacological differences with these 
receptors. 
It was therefore concluded that two 5-HT receptors are involved in the 
neurogenic relaxation to 5-HT: the high affinity receptor could be considered a 
5-HT2-like receptor, but the low affinity 5-HT receptor remains unidentified. 
In Chapter 8, the effects of cisapride and structural analogues on the 5-HT-
induced relaxations were investigated under conditions as described above 
(Chapters 5, 6 and 7). Cisapride (0.1-1 uM) enhanced the second phase of the 
concentration-response curve to 5-HT by about 20-40 %, while, from 0.3 |iM 
onwards it inhibited the first phase. Also in the presence of cisapride, TTX 
abolished the relaxations to 5-HT. Cisapride did not affect the concentration-
response curves to ISO, GTN, nitroprusside or exogenous ATP, demonstrating its 
specificity. The 5-HT-relaxation enhancing effects of cisapride were not mimicked 
by phentolamine, NAN-190, spiperone, Citalopram, paroxetine, pargyline or 
SDZ 205-557. In the presence of L-NNA, cisapride still enhanced the remaining 
relaxations to 5-HT (2-3 fold). However, in the presence of suramin, cisapride 
could not enhance the relaxations to 5-HT. In the presence of L-NNA, the 
cisapride-enhanced relaxations to 5-HT could be inhibited by about 90 % by 
suramin. 
It was concluded that cisapride selectively facilitates the suramin-sensitive, 
ATP-mediated, part of the relaxation to 5-HT via an unidentified effect on 
intramural nerves. 
A novel method for the study of colonic peristalsis in the anaesthetized guinea-
pig was developed (Chapter 9). After laparotomy, a rubber balloon was inserted 
into the lumen of the distal colon and inflated with 0.05-0.2 ml of water to mimic 
faecal pellet size. Thus, movement of the balloon and change in length of the 
longitudinal muscle could be assessed by isotonic recording. Inflation of the 
balloon per se did not induce propulsion of the balloon. Treatment with 
phentolamine (2 mg/kg i.v.) induced peristalsis and balloon displacement. This 
suggests that sympathetic nerve hyperactivity, probably due to anaesthesia and 
surgery, exerts a tonic inhibitory influence on the colon, which prevents co-
ordinated motor activity. Naloxone (1 mg/kg i.v.) did not promote peristalsis 
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when given alone. However, when naloxone was administered in addition to 
phentolamine, a decrease in the maximum, but not the average velocity of 
propulsion was observed compared to treatment with phentolamine alone. 
Treatment with L-NNA (25 mg/kg i.v.) in addition to phentolamine increased 
the average, but not the maximum, pellet propulsion velocity as compared to 
treatment with phentolamine alone. Irrespective of the treatment schedule 
employed, the velocity of propulsion was not dependent upon the inflation 
volume of the balloon. 
This model provides the first method to evaluate the effects of benzamides 
and 5-HT receptor (ant)agonists as described in the previous chapters, on colonic 
propulsion in the guinea-pig in vivo . 
Samenvatting 
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Farmacologische in-vitro-studies werden in het verleden doorgaans uitge-
voerd met voornamelijk geïsoleerde stukjes ileum van de cavia. Het is echter 
bekend dat het colon van de cavia andere eigenschappen heeft dan het ileum. Zo 
lijken bijvoorbeeld de niet-adrenerge niet-cholinerge neurotransmitters een 
grotere rol te spelen in het colon vergeleken met het ileum, en ontwikkeld het 
colon een spontane tonus, in tegenstelling tot het ileum. De benzamiden, die de 
gastrointestinale motiliteit stimuleren, gaan een interactie aan met verscheidene 
subtypen receptoren voor 5-hydroxytryptamine (5-HT), als agonist of als 
antagonist. Stimulatie van neuronale 5-HT4-receptoren gevolgd door facilitatie 
van cholinerge neurotransmissie is het mechanisme dat voorgesteld is verant-
woordelijk te zijn voor de prokinetische effecten van de benzamiden. Er zijn 
echter nog veel vragen omtrent het werkingsmechanisme van de benzamiden. 
De overgrote meerderheid van de studies waarin deze kwestie werd bestudeerd 
maakten gebruik van het ileum van de cavia. De studies die in dit proefschrift 
aan de orde komen beschrijven onderzoek naar de effecten van prokinetische 
benzamiden en 5-HT en hun interactie op het colon van de cavia. 
Chapter 1 beschrijft en evalueert gedetailleerd de studies en de theorieën die de 
laatste 30 jaar opgang hebben gedaan betreffende het werkingsmechanisme van 
de gesubstitueerde benzamiden. In de jaren '70 werd voorgesteld dat het 
prokinetische benzamide metoclopramide, en later ook clebopride, werkt als 
antagonist op perifere dopamine-D2-receptoren, maar in het begin van de 
tachtiger jaren was deze theorie alweer verlaten. De benzamiden die in dit 
decade ontwikkeld werden (cisapride, renzapride) hadden een veel lagere 
affiniteit voor dopamine-D2-receptoren, maar waren tevens potenter in hun 
prokinetische werking. De faciliterende werking op cholinerge neurotransmissie 
in het ileum van de cavia was echter behouden gebleven. Aan het einde van de 
tachtiger jaren werd er een nieuw type 5-HT-receptor ontdekt, die 5-HT4 gedoopt 
werd. Het bleek dat de benzamiden agonisten zijn op deze receptor, en dat stimu-
latie van deze receptoren op het ileum van de cavia facilitatie van cholinerge 
transmissie veroorzaakt. Hoewel gebleken is dat zowel in de mens als het dier de 
benzamiden effectieve stimulantia van de gastro-intestinale motoriek zijn, zijn 
neuronale 5-HT4-receptoren in de tractus digestivus van de rat en de mens (nog) 
niet gevonden. Ook vele andere vraagtekens die nog altijd rondom het wer-
kingsmechanisme bestaan komen in dit hoofdstuk aan de orde. 
Chapter 2 beschrijft een studie naar de typen 5-HT-receptoren die de effecten van 
5-HT op de longitudinale spierlaag van het proximale colon van de cavia 
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mediëren. Hiertoe werden analogen en selectieve antagonisten van 5-HT-
receptoren gebruikt. Zowel 5-HT als zijn analogen induceerde contracties en 
relaxaties. Tetrodotoxine (TTX) blokkeerde de relaxaties en remde de contracties, 
die geïnduceerd werden door alle geteste agonisten. Blokkade van 5-HT2A- of 
5-HT3-receptoren in de aanwezigheid van TTX remde de 5-HT-geïnduceerde 
contracties, terwijl blokkade van beide receptortypen te zelfder tijd een volledige 
remming gaf. In afwezigheid van TTX werden de contracties die door 5-HT geïn-
duceerd werden, geremd door antagonisten van 5-HT2A-/ 5-HT3- en 5-HT4-recep-
toren. Contracties na toediening van oc-methyl-5-HT bleken niet gevoelig te zijn 
voor blokkade van de 5-HT2A"receptor maar in aanwezigheid van TTX werden 
de contracties volledig geremd door de 5-HT2A-receptor-antagonist. Een 5-HT3-
receptor-antagonist remde de contracties geïnduceerd door 2-methyl-5-HT. In 
aanwezigheid van TTX blokkeerde een 5-HT2A-receptor-antagonist de contracties 
na toediening van 5-methoxytryptamine (5-MeOT), en in afwezigheid van TTX 
werden de contracties geremd door een 5-HT4-receptor-antagonist. Blokkade van 
5-HTi-achtige, 5-HT2A-, 5-HT3- of 5-HT4-receptoren had geen volledige remming 
van de relaxaties geïnduceerd door 5-HT of 5-MeOT tot gevolg. 
De conlcusie was dat 5-HT contracties van de longitudinale spierlaag van het 
proximale colon van de cavia induceert via 5-HT2A~receptoren op het gladde 
spierweefsel, 5-HT3-receptoren en neuronale 5-HT4-receptoren. De relaxaties 
worden gemedieerd via een onbekende neuronale 5-HT-receptor. 
De effecten van drie tachykinine NKi-receptor-antagonisten en een NK2-recep-
tor-antagonist op substance-P-geïnduceerde contracties van de longitudinale 
spierlaag van het colon van de cavia werden in deze studie onderzocht 
(Chapter 3). Atropine, TTX en fosforamidon hadden geen effect op de concen-
tratie-responscurve van substance P (pECso = 7.8). De NKi-receptor-antagonist 
2S,3S-cis-CP 96345 remde competitief de contracties die door substance P geïndu-
ceerd werden (pA2 = 8.5; pKb = 8.9). Bij hogere concentraties (> 0.3 uM) remde CP 
96345 echter ook contracties geïnduceerd door methacholine. De species-
selectieve NKi-receptor-antagonisten WIN 51708 en WIN 62577 en de NK2-
receptor-antagonist SR 48968 hadden geen effect. 
Geconcludeerd werd dat substantie P zijn contractiele werking op de longitu-
dinale spierlaag van de cavia medieert via NKi- en niet via NK2-receptoren op 
de gladde-spiercellen in dit preparaat. 
Het doel van de studie zoals beschreven in Chapter 4 was na te gaan of cisapride 
en zijn structuuranaloog R 76 186 hun effect op het geïsoleerde colon van de 
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cavia uitoefenen via 5-HT4-receptoren. Zowel cisapride als R 76 186 induceerde 
contracties, hetgeen monofasische concentratie-responscurven opleverde (cisa-
pride: EC50 = 0.11 nM; R 76186: EC50 = 24 nM). Antagonisten van 5-HT2- en 
5-HT3-receptoren hadden geen effect op de responsen geïnduceerd door cisapride 
en R 76 186, maar 5-HT4-receptor-antagonisten veroorzaakten een depressie van 
de concentratie-responscurve van cisapride (tot ca. 50 %), en de curve van 
R 76 186 werd naar rechts verschoven. De geschatte pA2-waarden waren 6.6 
(tropisetron), 6.3 (DAU 6285) en 7.5 (SDZ 205-557). Geen van de remmingen was 
echter zuiver competitief van aard, daar hogere concentraties van deze antago-
nisten de curve van R 76 186 deprimeerden. Desensitisatie van de 5-HT4-recep-
toren met 5-MeOT remde de contracties geïnduceerd door cisapride gedeeltelijk, 
en remde die geïnduceerd door R 76 186 volledig. De contracties geïnduceerd 
door R 76 186 en cisapride waren onderhevig aan wederzijds antagonisme, waar-
bij er een depressie van de curven optrad. 
Er werd geconcludeerd dat zowel cisapride als R 76 186 agonisten zijn van de 
5-HT4-receptor, hoewel cisapride ook nog via een mechanisme werkt dat niet 
met 5-HT-receptoren te maken heeft. 
In Chapter 5 wordt een onderzoek beschreven naar de betrokkeheid van 
stikstofoxide (NO) bij de neurogene relaxaties, die door 5-HT op het proximale 
colon worden geïnduceerd. Gedurende alle experimenten waren er antagonisten 
in de badvloeistof om contracties gemediëerd via 5-HT2A-/ 5-HT3- en 5-HT4-
receptoren te blokkeren, en methacholine werd telkens toegevoegd om de tonus 
van de strips te verhogen. Onder deze omstandigheden induceerde 5-HT relaxa-
ties (EC50 = 258 nM). Deze relaxaties werden geremd door metergoline en 
methiothepine en geblokkeerd door TTX. Guanethidine had geen effect. 
NG-nitro-L-arginine (L-NNA) remde de relaxaties geïnduceerd door 5-HT (IC50 = 
18.7 M-M); bij de hoogste concentratie 5-HT bedroeg de remming door 0.3 mM 
L-NNA ca. 75 %. De inhibitie kon gedeeltelijk opgeheven worden door tevens 
L-arginine toe te voegen. Relaxaties geïnduceerd door nitroglycerine (GTN) 
werden niet geremd door L-NNA. Hemoglobine remde de relaxaties geïnduceerd 
door 5-HT en GTN, maar niet die door isoprenaline (ISO). Methyleenblauw 
remde de relaxaties geïnduceerd door 5-HT maar niet die door GTN of ISO. 
Geconcludeerd werd dat 5-HT relaxaties induceert via NO. De resultaten 
bevestigen, dat de neuronale 5-HT-receptor(en) die hierbij betrokken zijn, van 
het 5-HTi-achtige subtype zijn. 
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Vervolgens wordt in Chapter 6 beschreven of de inhibitoire neurotransmitters 
adenosine 5'-trifosfaat (ATP) en/of vasoactief intestinaal polypeptide (VIP) 
betrokken zouden kunnen zijn bij de 5-HT-geïnduceerde neurogene relaxaties. 
Onder dezelfde omstandigheden als boven beschreven induceerden 5-HT, ATP 
en VIP concentratie-afhankelijke relaxaties. TTX, L-NNA en de combinatie van 
beide hadden geen effect op de relaxaties geïnduceerd door VIP of door 0.3-3 uM 
ATP maar reduceerde de relaxaties geïnduceerd door 10 uM ATP. Suramine 
remde de ATP- en VIP-geïnduceerde relaxaties in sterke mate. L-NNA en 
suramine remden ook de relaxaties geïnduceerd door 5-HT. In aanwezigheid van 
L-NNA remde suramine de relaxaties geïnduceerd door 5-HT niet significant. 
Suramine had geen effect op de relaxaties na toediening van ISO, GTN of exo-
geen NO, hetgeen de specificiteit van suramine aantoont. Apamine remde zowel 
de ATP- (tot 70-100 %) als de 5-HT-geïnduceerde relaxaties. De relaxaties geïndu-
ceerd door ISO werden gedeeltelijk geremd, hetgeen een niet-specifieke compo-
nent in het remmende effect van apamine aantoont. De relaxaties na toediening 
van exogeen VIP, NO of GTN werden echter niet geremd. In aanwezigheid van 
L-NNA remde apamine de 5-HT-geïnduceerde relaxaties alleen bij 30 uM 5-HT. 
a, ß-methyleen-ATP (a, ß-Me-ATP) desensitiseerde de respons van ATP niet. 
Reactive blue 2 remde in concentraties benodigd om ATP-geïnduceerde relaxa-
ties te remmen tevens de relaxaties op ISO-toediening. Het was dus niet zinvol 
om a, ß-Me-ATP of reactive blue 2 te testen op 5-HT-geïnduceerde relaxaties, a-
Chymotrypsine en trypsine remden de relaxaties geïnduceerd door VIP bijna 
volledig, maar hadden geen effect op ISO- en 5-HT-geïnduceerde relaxaties. De 
VIP-receptor-antagonisten [p-Cl-D-Phe6,Leu17]VIP en VIPio-28 hadden geen effect 
op de concentratie-responscurve van VIP en werden daarom niet verder getest 
op die van 5-HT. Fosforamidon had geen effect op de VIP- en 5-HT-geïnduceerde 
relaxaties. 
Er werd geconcludeerd dat VIP en ATP een relaxatie van het colon van de 
cavia induceren door een direct effect op de gladde-spiercellen, zonder betrok-
kenheid van NO. De 5-HT-geïnduceerde relaxaties worden zowel door NO 
gemedieerd als door een substantie die gevoelig is voor remming door suramine 
en apamine. Deze substantie is waarschijnlijk ATP en geen peptide zoals VIP. 
Eveneens onder dezelfde condities als beschreven in Chapter 5 en 6, wordt in 
Chapter 7 de karakterisering van de 5-HT-receptor beschreven die de neurogene 
relaxatie van 5-HT medieert. De concentratie-responscurve van de 5-HT-geïn-
duceerde relaxaties was bifasisch. Ondere tryptaminen waren ook agonisten met 
de volgende rangorde van potentie: 5-HT > 5-carboxamidotryptamine = 5-MeOT 
212 Samenvatting 
> a-methyl-5-HT (partial agonist) > tryptamine (partial agonist). 5-Hydroxy-
tryptophan, 2-methyl-5-HT en N-methyltryptamine waren nagenoeg inactief als 
agonist. The concentratie-responscurve van 5-HT werd niet veranderd door de 
aanwezigheid van pargyline, Citalopram, fentolamine, een tienvoudige toename 
van de concentratie ketanserine, of door de 5-HT4-receptor-antagonisten SDZ 
205-557 en SB 204070. 8-OH-DPAT, RU 24969, WB 4101, mCPP, TFMPP, 
flesinoxan, sumatriptan en MK212 waren inactief als 5-HT-receptor-agonist; 
sommige van voornoemde stoffen echter remden methacholine-geïnduceerde 
contracties. De eerste fase van de curve van 5-HT werd geremd door de volgende 
stoffen: metergoline (pA2 = 8.8, voor 5-MeOT 9.3), methysergide (depressie: NS), 
methiothepine (NS), spiroxatrine (NS), MK212 (NS), mesulergine (7.8), mCPP 
(7.1), mianserine (7.0), ritanserine (8.9), rauwolscine (7.0), yohimbine (6.2), 1-NAP 
(7.7) en RU 24969 (6.4), maar niet door NAN-190, spiperon, sumatriptan, 8-OH-
DPAT en flesinoxan. Bij vergelijking van de farmacologische affiniteits- en 
efficaciteitsprofielen met de thans bekende subtypen 5-HT-receptoren werd 
alleen een correlatie met receptoren uit de 5-HT2-groep gevonden (significant 
met 5-HT20 bijna-significant met 5-HT2A)- De receptor onder studie vertoonde 
echter ook duidelijke farmacologische verschillen. 
Het werd daarom geconcludeerd dat twee typen 5-HT-receptor de neurogene 
relaxaties die geïnduceerd worden door 5-HT mediëren: de 5-HT-receptor die een 
hoge affiniteit heeft voor 5-HT kan als een 5-HT2-achtige receptor beschouwd 
worden, maar de andere werd niet geïdentificeerd. 
In Chapter 8 wordt het onderzoek naar de effecten van cisapride en structurele 
analogen op de 5-HT-geïnduceerde relaxaties beschreven. De omstandigheden 
waaronder de studie gebeurde waren identiek aan die bij de boven beschreven 
studies (Chapters 5, 6 en 7). Cisapride (0.1-1 uM) versterkte de tweede fase van de 
concentratie-responscurve van 5-HT met ca. 20-40 %, terwijl vanaf 0.3 uM het de 
eerste fase remde. Ook in aanwezigheid van cisapride remde TTX de relaxaties 
geïnduceerd door cisapride volledig. Cisapride had geen effect op de concentratie-
responscurven van ISO, GTN, nitroprusside of exogeen ATP, hetgeen de speci-
ficiteit van het effect van cisapride onderstreept. De 5-HT-relaxatie-versterkende 
effect van cisapride kon niet worden nagebootst met fentolamine, NAN-190, 
spiperon, Citalopram, paroxetine, pargyline of SDZ 205-557. In aanwezigheid van 
L-NNA versterkte cisapride nog steeds de overgebleven relaxaties na toediening 
van 5-HT (2- tot 3-voudig). In de aanwezigheid van suramine echter versterkte 
cisapride de 5-HT-geïnduceerde relaxaties niet. In aanwezigheid van L-NNA kon 
suramine de cisapride-versterkte relaxaties met 90 % remmen. 
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Uit deze gegevens werd de conclusie getrokken dat cisapride selectief het 
suramine-gevoelige, ATP-gemedieerde, deel van de relaxaties geïnduceerd door 
5-HT faciliteert via een ongeïdentificeerd effect op de intramurale zenuwen. 
Een nieuwe methode voor de bestudering van peristaltiek in het colon van de 
geanaestheseerde cavia werd ontwikkeld (Chapter 9). Na laparotomie werd een 
rubber ballonnetje in het lumen van het distale deel van het colon ingebracht en 
opgeblazen met 0.05-0.2 ml water, teneinde een keutel na te bootsen. De bewe-
ging van de ballon en van de longitudinale spierlaag kon met isotonische 
opnemers worden gemeten. Opblazen van de ballon per se induceerde geen 
propulsie. Na behandeling met fentolamine echter (2 mg/kg i.v.) trad propulsie 
van de ballon op. Deze observatie suggereert een sympatische over-activiteit ten 
gevolge van de anaesthesie en de chirurgische handelingen, hetgeen resulteert 
in een tonische remmende invloed op het colon. Naloxon (1 mg/kg i.v.) alleen 
had geen stimulerend effect op de peristaltiek. Wanneer echter naloxon gegeven 
werd als toevoeging met fentolamine, dan werd een afname van de maximale, 
maar niet de gemiddelde propulsiesnelheid waargenomen in vergelijking met 
behandeling met alleen fentolamine. Behandeling met L-NNA (25 mg/kg i.v.) 
als toevoeging met fentolamine induceerde een toename in de gemiddelde maar 
niet in de maximale propulsiesnelheid vergeleken met behandeling met alleen 
fentolamine. De propulsiesnelheid was niet afhankelijk van het volume van de 
ballon, onafhankelijk van welk stoffen vooraf toegediend waren. 
Dit model voorziet in de eerste methode om de effecten op propulsie van 
benzamiden en 5-HT-receptor-(ant)agonisten, zoals in de voorgaande hoofdstuk-
ken beschreven, te kunnen evalueren in vivo in de cavia. 
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